id	sid	tid	token	lemma	pos
cord-325956-1kxxg0s9	1	1	key	key	NN
cord-325956-1kxxg0s9	1	2	:	:	:
cord-325956-1kxxg0s9	2	1	cord-325956	cord-325956	NNP
cord-325956-1kxxg0s9	2	2	-	-	HYPH
cord-325956-1kxxg0s9	2	3	1kxxg0s9	1kxxg0s9	CD
cord-325956-1kxxg0s9	2	4	authors	author	NNS
cord-325956-1kxxg0s9	2	5	:	:	:
cord-325956-1kxxg0s9	2	6	Potluri	Potluri	NNP
cord-325956-1kxxg0s9	2	7	,	,	,
cord-325956-1kxxg0s9	2	8	Rahul	Rahul	NNP
cord-325956-1kxxg0s9	2	9	;	;	:
cord-325956-1kxxg0s9	2	10	Lavu	Lavu	NNP
cord-325956-1kxxg0s9	2	11	,	,	,
cord-325956-1kxxg0s9	2	12	Deepthi	Deepthi	NNP
cord-325956-1kxxg0s9	2	13	title	title	NN
cord-325956-1kxxg0s9	2	14	:	:	:
cord-325956-1kxxg0s9	2	15	Making	make	VBG
cord-325956-1kxxg0s9	2	16	sense	sense	NN
cord-325956-1kxxg0s9	2	17	of	of	IN
cord-325956-1kxxg0s9	2	18	the	the	DT
cord-325956-1kxxg0s9	2	19	Global	Global	NNP
cord-325956-1kxxg0s9	2	20	Coronavirus	Coronavirus	NNP
cord-325956-1kxxg0s9	2	21	Data	Data	NNP
cord-325956-1kxxg0s9	2	22	:	:	:
cord-325956-1kxxg0s9	3	1	The	the	DT
cord-325956-1kxxg0s9	3	2	role	role	NN
cord-325956-1kxxg0s9	3	3	of	of	IN
cord-325956-1kxxg0s9	3	4	testing	test	VBG
cord-325956-1kxxg0s9	3	5	rates	rate	NNS
cord-325956-1kxxg0s9	3	6	in	in	IN
cord-325956-1kxxg0s9	3	7	understanding	understand	VBG
cord-325956-1kxxg0s9	3	8	the	the	DT
cord-325956-1kxxg0s9	3	9	pandemic	pandemic	NN
cord-325956-1kxxg0s9	3	10	and	and	CC
cord-325956-1kxxg0s9	3	11	our	-PRON-	PRP$
cord-325956-1kxxg0s9	3	12	exit	exit	NN
cord-325956-1kxxg0s9	3	13	strategy	strategy	NN
cord-325956-1kxxg0s9	3	14	date	date	NN
cord-325956-1kxxg0s9	3	15	:	:	:
cord-325956-1kxxg0s9	3	16	2020	2020	CD
cord-325956-1kxxg0s9	3	17	-	-	HYPH
cord-325956-1kxxg0s9	3	18	04	04	CD
cord-325956-1kxxg0s9	3	19	-	-	HYPH
cord-325956-1kxxg0s9	3	20	11	11	CD
cord-325956-1kxxg0s9	3	21	journal	journal	NN
cord-325956-1kxxg0s9	3	22	:	:	:
cord-325956-1kxxg0s9	3	23	nan	nan	NNP
cord-325956-1kxxg0s9	3	24	DOI	DOI	NNP
cord-325956-1kxxg0s9	3	25	:	:	:
cord-325956-1kxxg0s9	3	26	10.1101/2020.04.06.20054239	10.1101/2020.04.06.20054239	CD
cord-325956-1kxxg0s9	3	27	sha	sha	NNP
cord-325956-1kxxg0s9	3	28	:	:	:
cord-325956-1kxxg0s9	3	29	707211c1510a7a9405c1faaaa3fae36da1951013	707211c1510a7a9405c1faaaa3fae36da1951013	CD
cord-325956-1kxxg0s9	3	30	doc_id	doc_id	CD
cord-325956-1kxxg0s9	3	31	:	:	:
cord-325956-1kxxg0s9	3	32	325956	325956	CD
cord-325956-1kxxg0s9	3	33	cord_uid	cord_uid	NNS
cord-325956-1kxxg0s9	3	34	:	:	:
cord-325956-1kxxg0s9	3	35	1kxxg0s9	1kxxg0s9	CD
cord-325956-1kxxg0s9	4	1	The	the	DT
cord-325956-1kxxg0s9	4	2	Coronavirus	Coronavirus	NNP
cord-325956-1kxxg0s9	4	3	disease	disease	NN
cord-325956-1kxxg0s9	4	4	2019(COVID-19	2019(covid-19	CD
cord-325956-1kxxg0s9	4	5	)	)	-RRB-
cord-325956-1kxxg0s9	4	6	outbreak	outbreak	NN
cord-325956-1kxxg0s9	4	7	has	have	VBZ
cord-325956-1kxxg0s9	4	8	caused	cause	VBN
cord-325956-1kxxg0s9	4	9	havoc	havoc	NN
cord-325956-1kxxg0s9	4	10	across	across	IN
cord-325956-1kxxg0s9	4	11	the	the	DT
cord-325956-1kxxg0s9	4	12	world	world	NN
cord-325956-1kxxg0s9	4	13	.	.	.
cord-325956-1kxxg0s9	5	1	Subsequently	subsequently	RB
cord-325956-1kxxg0s9	5	2	,	,	,
cord-325956-1kxxg0s9	5	3	research	research	NN
cord-325956-1kxxg0s9	5	4	on	on	IN
cord-325956-1kxxg0s9	5	5	COVID-19	COVID-19	NNP
cord-325956-1kxxg0s9	5	6	has	have	VBZ
cord-325956-1kxxg0s9	5	7	focused	focus	VBN
cord-325956-1kxxg0s9	5	8	on	on	IN
cord-325956-1kxxg0s9	5	9	number	number	NN
cord-325956-1kxxg0s9	5	10	of	of	IN
cord-325956-1kxxg0s9	5	11	cases	case	NNS
cord-325956-1kxxg0s9	5	12	and	and	CC
cord-325956-1kxxg0s9	5	13	deaths	death	NNS
cord-325956-1kxxg0s9	5	14	and	and	CC
cord-325956-1kxxg0s9	5	15	predicted	predict	VBD
cord-325956-1kxxg0s9	5	16	projections	projection	NNS
cord-325956-1kxxg0s9	5	17	have	have	VBP
cord-325956-1kxxg0s9	5	18	focused	focus	VBN
cord-325956-1kxxg0s9	5	19	on	on	IN
cord-325956-1kxxg0s9	5	20	these	these	DT
cord-325956-1kxxg0s9	5	21	parameters	parameter	NNS
cord-325956-1kxxg0s9	5	22	.	.	.
cord-325956-1kxxg0s9	6	1	We	-PRON-	PRP
cord-325956-1kxxg0s9	6	2	propose	propose	VBP
cord-325956-1kxxg0s9	6	3	that	that	IN
cord-325956-1kxxg0s9	6	4	the	the	DT
cord-325956-1kxxg0s9	6	5	number	number	NN
cord-325956-1kxxg0s9	6	6	of	of	IN
cord-325956-1kxxg0s9	6	7	tests	test	NNS
cord-325956-1kxxg0s9	6	8	performed	perform	VBN
cord-325956-1kxxg0s9	6	9	is	be	VBZ
cord-325956-1kxxg0s9	6	10	a	a	DT
cord-325956-1kxxg0s9	6	11	very	very	RB
cord-325956-1kxxg0s9	6	12	important	important	JJ
cord-325956-1kxxg0s9	6	13	denominator	denominator	NN
cord-325956-1kxxg0s9	6	14	in	in	IN
cord-325956-1kxxg0s9	6	15	understanding	understand	VBG
cord-325956-1kxxg0s9	6	16	the	the	DT
cord-325956-1kxxg0s9	6	17	COVID-19	COVID-19	NNP
cord-325956-1kxxg0s9	6	18	data	datum	NNS
cord-325956-1kxxg0s9	6	19	.	.	.
cord-325956-1kxxg0s9	7	1	We	-PRON-	PRP
cord-325956-1kxxg0s9	7	2	analysed	analyse	VBD
cord-325956-1kxxg0s9	7	3	the	the	DT
cord-325956-1kxxg0s9	7	4	number	number	NN
cord-325956-1kxxg0s9	7	5	of	of	IN
cord-325956-1kxxg0s9	7	6	diagnostic	diagnostic	JJ
cord-325956-1kxxg0s9	7	7	tests	test	NNS
cord-325956-1kxxg0s9	7	8	performed	perform	VBN
cord-325956-1kxxg0s9	7	9	in	in	IN
cord-325956-1kxxg0s9	7	10	proportion	proportion	NN
cord-325956-1kxxg0s9	7	11	to	to	IN
cord-325956-1kxxg0s9	7	12	the	the	DT
cord-325956-1kxxg0s9	7	13	number	number	NN
cord-325956-1kxxg0s9	7	14	of	of	IN
cord-325956-1kxxg0s9	7	15	cases	case	NNS
cord-325956-1kxxg0s9	7	16	and	and	CC
cord-325956-1kxxg0s9	7	17	subsequently	subsequently	RB
cord-325956-1kxxg0s9	7	18	deaths	death	NNS
cord-325956-1kxxg0s9	7	19	across	across	IN
cord-325956-1kxxg0s9	7	20	different	different	JJ
cord-325956-1kxxg0s9	7	21	countries	country	NNS
cord-325956-1kxxg0s9	7	22	and	and	CC
cord-325956-1kxxg0s9	7	23	projected	project	VBN
cord-325956-1kxxg0s9	7	24	pandemic	pandemic	NN
cord-325956-1kxxg0s9	7	25	outcomes	outcome	NNS
cord-325956-1kxxg0s9	7	26	.	.	.
cord-325956-1kxxg0s9	8	1	We	-PRON-	PRP
cord-325956-1kxxg0s9	8	2	obtained	obtain	VBD
cord-325956-1kxxg0s9	8	3	real	real	JJ
cord-325956-1kxxg0s9	8	4	time	time	NN
cord-325956-1kxxg0s9	8	5	COVID-19	COVID-19	NNP
cord-325956-1kxxg0s9	8	6	data	datum	NNS
cord-325956-1kxxg0s9	8	7	from	from	IN
cord-325956-1kxxg0s9	8	8	the	the	DT
cord-325956-1kxxg0s9	8	9	reference	reference	NN
cord-325956-1kxxg0s9	8	10	website	website	NN
cord-325956-1kxxg0s9	8	11	Worldometer	Worldometer	NNP
cord-325956-1kxxg0s9	8	12	at	at	IN
cord-325956-1kxxg0s9	8	13	0900	0900	CD
cord-325956-1kxxg0s9	8	14	BST	bst	NN
cord-325956-1kxxg0s9	8	15	on	on	IN
cord-325956-1kxxg0s9	8	16	Saturday	Saturday	NNP
cord-325956-1kxxg0s9	8	17	4th	4th	JJ
cord-325956-1kxxg0s9	8	18	April	April	NNP
cord-325956-1kxxg0s9	8	19	,	,	,
cord-325956-1kxxg0s9	8	20	2020	2020	CD
cord-325956-1kxxg0s9	8	21	and	and	CC
cord-325956-1kxxg0s9	8	22	collated	collate	VBD
cord-325956-1kxxg0s9	8	23	the	the	DT
cord-325956-1kxxg0s9	8	24	information	information	NN
cord-325956-1kxxg0s9	8	25	obtained	obtain	VBN
cord-325956-1kxxg0s9	8	26	on	on	IN
cord-325956-1kxxg0s9	8	27	the	the	DT
cord-325956-1kxxg0s9	8	28	top	top	JJ
cord-325956-1kxxg0s9	8	29	50	50	CD
cord-325956-1kxxg0s9	8	30	countries	country	NNS
cord-325956-1kxxg0s9	8	31	with	with	IN
cord-325956-1kxxg0s9	8	32	the	the	DT
cord-325956-1kxxg0s9	8	33	highest	high	JJS
cord-325956-1kxxg0s9	8	34	number	number	NN
cord-325956-1kxxg0s9	8	35	of	of	IN
cord-325956-1kxxg0s9	8	36	COVID	COVID	NNP
cord-325956-1kxxg0s9	8	37	19	19	CD
cord-325956-1kxxg0s9	8	38	cases	case	NNS
cord-325956-1kxxg0s9	8	39	.	.	.
cord-325956-1kxxg0s9	9	1	We	-PRON-	PRP
cord-325956-1kxxg0s9	9	2	analysed	analyse	VBD
cord-325956-1kxxg0s9	9	3	this	this	DT
cord-325956-1kxxg0s9	9	4	data	datum	NNS
cord-325956-1kxxg0s9	9	5	according	accord	VBG
cord-325956-1kxxg0s9	9	6	to	to	IN
cord-325956-1kxxg0s9	9	7	the	the	DT
cord-325956-1kxxg0s9	9	8	number	number	NN
cord-325956-1kxxg0s9	9	9	of	of	IN
cord-325956-1kxxg0s9	9	10	tests	test	NNS
cord-325956-1kxxg0s9	9	11	performed	perform	VBN
cord-325956-1kxxg0s9	9	12	as	as	IN
cord-325956-1kxxg0s9	9	13	the	the	DT
cord-325956-1kxxg0s9	9	14	main	main	JJ
cord-325956-1kxxg0s9	9	15	denominator	denominator	NN
cord-325956-1kxxg0s9	9	16	.	.	.
cord-325956-1kxxg0s9	10	1	Country	country	NN
cord-325956-1kxxg0s9	10	2	wise	wise	JJ
cord-325956-1kxxg0s9	10	3	population	population	NN
cord-325956-1kxxg0s9	10	4	level	level	NN
cord-325956-1kxxg0s9	10	5	pandemic	pandemic	NN
cord-325956-1kxxg0s9	10	6	projections	projection	NNS
cord-325956-1kxxg0s9	10	7	were	be	VBD
cord-325956-1kxxg0s9	10	8	extrapolated	extrapolate	VBN
cord-325956-1kxxg0s9	10	9	utilising	utilise	VBG
cord-325956-1kxxg0s9	10	10	three	three	CD
cord-325956-1kxxg0s9	10	11	models	model	NNS
cord-325956-1kxxg0s9	10	12	-	-	:
cord-325956-1kxxg0s9	10	13	1	1	CD
cord-325956-1kxxg0s9	10	14	)	)	-RRB-
cord-325956-1kxxg0s9	10	15	inherent	inherent	JJ
cord-325956-1kxxg0s9	10	16	case	case	NN
cord-325956-1kxxg0s9	10	17	per	per	IN
cord-325956-1kxxg0s9	10	18	test	test	NN
cord-325956-1kxxg0s9	10	19	and	and	CC
cord-325956-1kxxg0s9	10	20	death	death	NN
cord-325956-1kxxg0s9	10	21	per	per	IN
cord-325956-1kxxg0s9	10	22	test	test	NN
cord-325956-1kxxg0s9	10	23	rates	rate	NNS
cord-325956-1kxxg0s9	10	24	at	at	IN
cord-325956-1kxxg0s9	10	25	the	the	DT
cord-325956-1kxxg0s9	10	26	time	time	NN
cord-325956-1kxxg0s9	10	27	of	of	IN
cord-325956-1kxxg0s9	10	28	obtaining	obtain	VBG
cord-325956-1kxxg0s9	10	29	the	the	DT
cord-325956-1kxxg0s9	10	30	data	datum	NNS
cord-325956-1kxxg0s9	10	31	(	(	-LRB-
cord-325956-1kxxg0s9	10	32	4/4/2020	4/4/2020	CD
cord-325956-1kxxg0s9	10	33	0900	0900	CD
cord-325956-1kxxg0s9	10	34	BST	BST	NNP
cord-325956-1kxxg0s9	10	35	)	)	-RRB-
cord-325956-1kxxg0s9	10	36	for	for	IN
cord-325956-1kxxg0s9	10	37	each	each	DT
cord-325956-1kxxg0s9	10	38	country	country	NN
cord-325956-1kxxg0s9	10	39	;	;	:
cord-325956-1kxxg0s9	10	40	2	2	LS
cord-325956-1kxxg0s9	10	41	)	)	-RRB-
cord-325956-1kxxg0s9	10	42	rates	rate	NNS
cord-325956-1kxxg0s9	10	43	adjusted	adjust	VBN
cord-325956-1kxxg0s9	10	44	according	accord	VBG
cord-325956-1kxxg0s9	10	45	to	to	IN
cord-325956-1kxxg0s9	10	46	the	the	DT
cord-325956-1kxxg0s9	10	47	countries	country	NNS
cord-325956-1kxxg0s9	10	48	who	who	WP
cord-325956-1kxxg0s9	10	49	conducted	conduct	VBD
cord-325956-1kxxg0s9	10	50	at	at	IN
cord-325956-1kxxg0s9	10	51	least	least	JJS
cord-325956-1kxxg0s9	10	52	100000	100000	CD
cord-325956-1kxxg0s9	10	53	tests	test	NNS
cord-325956-1kxxg0s9	10	54	and	and	CC
cord-325956-1kxxg0s9	10	55	3	3	CD
cord-325956-1kxxg0s9	10	56	)	)	-RRB-
cord-325956-1kxxg0s9	10	57	rates	rate	NNS
cord-325956-1kxxg0s9	10	58	adjusted	adjust	VBN
cord-325956-1kxxg0s9	10	59	according	accord	VBG
cord-325956-1kxxg0s9	10	60	to	to	IN
cord-325956-1kxxg0s9	10	61	South	South	NNP
cord-325956-1kxxg0s9	10	62	Korea	Korea	NNP
cord-325956-1kxxg0s9	10	63	.	.	.
cord-325956-1kxxg0s9	11	1	We	-PRON-	PRP
cord-325956-1kxxg0s9	11	2	showed	show	VBD
cord-325956-1kxxg0s9	11	3	that	that	IN
cord-325956-1kxxg0s9	11	4	testing	testing	NN
cord-325956-1kxxg0s9	11	5	rates	rate	NNS
cord-325956-1kxxg0s9	11	6	impact	impact	VBP
cord-325956-1kxxg0s9	11	7	on	on	IN
cord-325956-1kxxg0s9	11	8	the	the	DT
cord-325956-1kxxg0s9	11	9	number	number	NN
cord-325956-1kxxg0s9	11	10	of	of	IN
cord-325956-1kxxg0s9	11	11	cases	case	NNS
cord-325956-1kxxg0s9	11	12	and	and	CC
cord-325956-1kxxg0s9	11	13	deaths	death	NNS
cord-325956-1kxxg0s9	11	14	and	and	CC
cord-325956-1kxxg0s9	11	15	ultimately	ultimately	RB
cord-325956-1kxxg0s9	11	16	on	on	IN
cord-325956-1kxxg0s9	11	17	future	future	JJ
cord-325956-1kxxg0s9	11	18	projections	projection	NNS
cord-325956-1kxxg0s9	11	19	for	for	IN
cord-325956-1kxxg0s9	11	20	the	the	DT
cord-325956-1kxxg0s9	11	21	pandemic	pandemic	NN
cord-325956-1kxxg0s9	11	22	across	across	IN
cord-325956-1kxxg0s9	11	23	different	different	JJ
cord-325956-1kxxg0s9	11	24	countries	country	NNS
cord-325956-1kxxg0s9	11	25	.	.	.
cord-325956-1kxxg0s9	12	1	We	-PRON-	PRP
cord-325956-1kxxg0s9	12	2	found	find	VBD
cord-325956-1kxxg0s9	12	3	that	that	IN
cord-325956-1kxxg0s9	12	4	countries	country	NNS
cord-325956-1kxxg0s9	12	5	with	with	IN
cord-325956-1kxxg0s9	12	6	the	the	DT
cord-325956-1kxxg0s9	12	7	highest	high	JJS
cord-325956-1kxxg0s9	12	8	testing	testing	NN
cord-325956-1kxxg0s9	12	9	rates	rate	NNS
cord-325956-1kxxg0s9	12	10	per	per	IN
cord-325956-1kxxg0s9	12	11	population	population	NN
cord-325956-1kxxg0s9	12	12	have	have	VBP
cord-325956-1kxxg0s9	12	13	the	the	DT
cord-325956-1kxxg0s9	12	14	lowest	low	JJS
cord-325956-1kxxg0s9	12	15	death	death	NN
cord-325956-1kxxg0s9	12	16	rates	rate	NNS
cord-325956-1kxxg0s9	12	17	and	and	CC
cord-325956-1kxxg0s9	12	18	give	give	VB
cord-325956-1kxxg0s9	12	19	us	-PRON-	PRP
cord-325956-1kxxg0s9	12	20	an	an	DT
cord-325956-1kxxg0s9	12	21	early	early	JJ
cord-325956-1kxxg0s9	12	22	indication	indication	NN
cord-325956-1kxxg0s9	12	23	of	of	IN
cord-325956-1kxxg0s9	12	24	an	an	DT
cord-325956-1kxxg0s9	12	25	eventual	eventual	JJ
cord-325956-1kxxg0s9	12	26	COVID-19	COVID-19	NNP
cord-325956-1kxxg0s9	12	27	mortality	mortality	NN
cord-325956-1kxxg0s9	12	28	rate	rate	NN
cord-325956-1kxxg0s9	12	29	.	.	.
cord-325956-1kxxg0s9	13	1	It	-PRON-	PRP
cord-325956-1kxxg0s9	13	2	is	be	VBZ
cord-325956-1kxxg0s9	13	3	only	only	RB
cord-325956-1kxxg0s9	13	4	by	by	IN
cord-325956-1kxxg0s9	13	5	continued	continue	VBN
cord-325956-1kxxg0s9	13	6	testing	testing	NN
cord-325956-1kxxg0s9	13	7	on	on	IN
cord-325956-1kxxg0s9	13	8	a	a	DT
cord-325956-1kxxg0s9	13	9	large	large	JJ
cord-325956-1kxxg0s9	13	10	scale	scale	NN
cord-325956-1kxxg0s9	13	11	that	that	WDT
cord-325956-1kxxg0s9	13	12	will	will	MD
cord-325956-1kxxg0s9	13	13	enable	enable	VB
cord-325956-1kxxg0s9	13	14	us	-PRON-	PRP
cord-325956-1kxxg0s9	13	15	to	to	TO
cord-325956-1kxxg0s9	13	16	know	know	VB
cord-325956-1kxxg0s9	13	17	if	if	IN
cord-325956-1kxxg0s9	13	18	the	the	DT
cord-325956-1kxxg0s9	13	19	increasing	increase	VBG
cord-325956-1kxxg0s9	13	20	number	number	NN
cord-325956-1kxxg0s9	13	21	of	of	IN
cord-325956-1kxxg0s9	13	22	patients	patient	NNS
cord-325956-1kxxg0s9	13	23	who	who	WP
cord-325956-1kxxg0s9	13	24	are	be	VBP
cord-325956-1kxxg0s9	13	25	seriously	seriously	RB
cord-325956-1kxxg0s9	13	26	unwell	unwell	JJ
cord-325956-1kxxg0s9	13	27	in	in	IN
cord-325956-1kxxg0s9	13	28	hospitals	hospital	NNS
cord-325956-1kxxg0s9	13	29	across	across	IN
cord-325956-1kxxg0s9	13	30	the	the	DT
cord-325956-1kxxg0s9	13	31	world	world	NN
cord-325956-1kxxg0s9	13	32	are	be	VBP
cord-325956-1kxxg0s9	13	33	the	the	DT
cord-325956-1kxxg0s9	13	34	tip	tip	NN
cord-325956-1kxxg0s9	13	35	of	of	IN
cord-325956-1kxxg0s9	13	36	the	the	DT
cord-325956-1kxxg0s9	13	37	iceberg	iceberg	NN
cord-325956-1kxxg0s9	13	38	or	or	CC
cord-325956-1kxxg0s9	13	39	not	not	RB
cord-325956-1kxxg0s9	13	40	.	.	.
cord-325956-1kxxg0s9	14	1	Accordingly	accordingly	RB
cord-325956-1kxxg0s9	14	2	,	,	,
cord-325956-1kxxg0s9	14	3	obtaining	obtain	VBG
cord-325956-1kxxg0s9	14	4	this	this	DT
cord-325956-1kxxg0s9	14	5	information	information	NN
cord-325956-1kxxg0s9	14	6	through	through	IN
cord-325956-1kxxg0s9	14	7	a	a	DT
cord-325956-1kxxg0s9	14	8	rapid	rapid	JJ
cord-325956-1kxxg0s9	14	9	increase	increase	NN
cord-325956-1kxxg0s9	14	10	in	in	IN
cord-325956-1kxxg0s9	14	11	testing	testing	NN
cord-325956-1kxxg0s9	14	12	globally	globally	RB
cord-325956-1kxxg0s9	14	13	is	be	VBZ
cord-325956-1kxxg0s9	14	14	the	the	DT
cord-325956-1kxxg0s9	14	15	only	only	JJ
cord-325956-1kxxg0s9	14	16	way	way	NN
cord-325956-1kxxg0s9	14	17	which	which	WDT
cord-325956-1kxxg0s9	14	18	will	will	MD
cord-325956-1kxxg0s9	14	19	enable	enable	VB
cord-325956-1kxxg0s9	14	20	us	-PRON-	PRP
cord-325956-1kxxg0s9	14	21	to	to	TO
cord-325956-1kxxg0s9	14	22	exit	exit	VB
cord-325956-1kxxg0s9	14	23	the	the	DT
cord-325956-1kxxg0s9	14	24	COVID-19	covid-19	JJ
cord-325956-1kxxg0s9	14	25	pandemic	pandemic	NN
cord-325956-1kxxg0s9	14	26	and	and	CC
cord-325956-1kxxg0s9	14	27	reduce	reduce	VB
cord-325956-1kxxg0s9	14	28	economic	economic	JJ
cord-325956-1kxxg0s9	14	29	and	and	CC
cord-325956-1kxxg0s9	14	30	social	social	JJ
cord-325956-1kxxg0s9	14	31	instability	instability	NN
cord-325956-1kxxg0s9	14	32	.	.	.
cord-325956-1kxxg0s9	15	1	The	the	DT
cord-325956-1kxxg0s9	15	2	Coronavirus	Coronavirus	NNP
cord-325956-1kxxg0s9	15	3	disease	disease	NN
cord-325956-1kxxg0s9	15	4	2019(COVID-19	2019(covid-19	CD
cord-325956-1kxxg0s9	15	5	)	)	-RRB-
cord-325956-1kxxg0s9	15	6	outbreak	outbreak	NN
cord-325956-1kxxg0s9	15	7	has	have	VBZ
cord-325956-1kxxg0s9	15	8	caused	cause	VBN
cord-325956-1kxxg0s9	15	9	havoc	havoc	NN
cord-325956-1kxxg0s9	15	10	across	across	IN
cord-325956-1kxxg0s9	15	11	the	the	DT
cord-325956-1kxxg0s9	15	12	world	world	NN
cord-325956-1kxxg0s9	15	13	after	after	IN
cord-325956-1kxxg0s9	15	14	it	-PRON-	PRP
cord-325956-1kxxg0s9	15	15	was	be	VBD
cord-325956-1kxxg0s9	15	16	first	first	RB
cord-325956-1kxxg0s9	15	17	reported	report	VBN
cord-325956-1kxxg0s9	15	18	in	in	IN
cord-325956-1kxxg0s9	15	19	Wuhan	Wuhan	NNP
cord-325956-1kxxg0s9	15	20	,	,	,
cord-325956-1kxxg0s9	15	21	China	China	NNP
cord-325956-1kxxg0s9	15	22	1,2	1,2	CD
cord-325956-1kxxg0s9	15	23	.	.	.
cord-325956-1kxxg0s9	16	1	Subsequently	subsequently	RB
cord-325956-1kxxg0s9	16	2	,	,	,
cord-325956-1kxxg0s9	16	3	research	research	NN
cord-325956-1kxxg0s9	16	4	on	on	IN
cord-325956-1kxxg0s9	16	5	COVID-19	COVID-19	NNP
cord-325956-1kxxg0s9	16	6	has	have	VBZ
cord-325956-1kxxg0s9	16	7	exploded	explode	VBN
cord-325956-1kxxg0s9	16	8	to	to	TO
cord-325956-1kxxg0s9	16	9	understand	understand	VB
cord-325956-1kxxg0s9	16	10	the	the	DT
cord-325956-1kxxg0s9	16	11	new	new	JJ
cord-325956-1kxxg0s9	16	12	disease	disease	NN
cord-325956-1kxxg0s9	16	13	and	and	CC
cord-325956-1kxxg0s9	16	14	its	-PRON-	PRP$
cord-325956-1kxxg0s9	16	15	impact	impact	NN
cord-325956-1kxxg0s9	16	16	on	on	IN
cord-325956-1kxxg0s9	16	17	mankind	mankind	NN
cord-325956-1kxxg0s9	16	18	[	[	-LRB-
cord-325956-1kxxg0s9	16	19	3	3	CD
cord-325956-1kxxg0s9	16	20	]	]	-RRB-
cord-325956-1kxxg0s9	16	21	[	[	-LRB-
cord-325956-1kxxg0s9	16	22	4	4	CD
cord-325956-1kxxg0s9	16	23	]	]	-RRB-
cord-325956-1kxxg0s9	16	24	[	[	-LRB-
cord-325956-1kxxg0s9	16	25	5	5	CD
cord-325956-1kxxg0s9	16	26	]	]	-RRB-
cord-325956-1kxxg0s9	16	27	[	[	-LRB-
cord-325956-1kxxg0s9	16	28	6	6	CD
cord-325956-1kxxg0s9	16	29	]	]	-RRB-
cord-325956-1kxxg0s9	16	30	[	[	-LRB-
cord-325956-1kxxg0s9	16	31	7	7	CD
cord-325956-1kxxg0s9	16	32	]	]	-RRB-
cord-325956-1kxxg0s9	17	1	[	[	-LRB-
cord-325956-1kxxg0s9	17	2	8	8	CD
cord-325956-1kxxg0s9	17	3	]	]	-RRB-
cord-325956-1kxxg0s9	17	4	[	[	-LRB-
cord-325956-1kxxg0s9	17	5	9	9	CD
cord-325956-1kxxg0s9	17	6	]	]	-RRB-
cord-325956-1kxxg0s9	17	7	[	[	-LRB-
cord-325956-1kxxg0s9	17	8	10	10	CD
cord-325956-1kxxg0s9	17	9	]	]	-RRB-
cord-325956-1kxxg0s9	17	10	[	[	-LRB-
cord-325956-1kxxg0s9	17	11	11	11	CD
cord-325956-1kxxg0s9	17	12	]	]	-RRB-
cord-325956-1kxxg0s9	18	1	[	[	-LRB-
cord-325956-1kxxg0s9	18	2	12	12	CD
cord-325956-1kxxg0s9	18	3	]	]	-RRB-
cord-325956-1kxxg0s9	18	4	[	[	-LRB-
cord-325956-1kxxg0s9	18	5	13	13	CD
cord-325956-1kxxg0s9	18	6	]	]	-RRB-
cord-325956-1kxxg0s9	19	1	[	[	-LRB-
cord-325956-1kxxg0s9	19	2	14	14	CD
cord-325956-1kxxg0s9	19	3	]	]	-RRB-
cord-325956-1kxxg0s9	19	4	[	[	-LRB-
cord-325956-1kxxg0s9	19	5	15	15	CD
cord-325956-1kxxg0s9	19	6	]	]	-RRB-
cord-325956-1kxxg0s9	19	7	[	[	-LRB-
cord-325956-1kxxg0s9	19	8	16	16	CD
cord-325956-1kxxg0s9	19	9	]	]	-RRB-
cord-325956-1kxxg0s9	19	10	.	.	.
cord-325956-1kxxg0s9	20	1	However	however	RB
cord-325956-1kxxg0s9	20	2	,	,	,
cord-325956-1kxxg0s9	20	3	the	the	DT
cord-325956-1kxxg0s9	20	4	number	number	NN
cord-325956-1kxxg0s9	20	5	of	of	IN
cord-325956-1kxxg0s9	20	6	baseless	baseless	JJ
cord-325956-1kxxg0s9	20	7	articles	article	NNS
cord-325956-1kxxg0s9	20	8	resulting	result	VBG
cord-325956-1kxxg0s9	20	9	in	in	IN
cord-325956-1kxxg0s9	20	10	fake	fake	JJ
cord-325956-1kxxg0s9	20	11	news	news	NN
cord-325956-1kxxg0s9	20	12	articles	article	NNS
cord-325956-1kxxg0s9	20	13	has	have	VBZ
cord-325956-1kxxg0s9	20	14	also	also	RB
cord-325956-1kxxg0s9	20	15	gone	go	VBN
cord-325956-1kxxg0s9	20	16	up	up	RP
cord-325956-1kxxg0s9	20	17	exponentially	exponentially	RB
cord-325956-1kxxg0s9	20	18	[	[	-LRB-
cord-325956-1kxxg0s9	20	19	17	17	CD
cord-325956-1kxxg0s9	20	20	]	]	-RRB-
cord-325956-1kxxg0s9	20	21	[	[	-LRB-
cord-325956-1kxxg0s9	20	22	18	18	CD
cord-325956-1kxxg0s9	20	23	]	]	-RRB-
cord-325956-1kxxg0s9	20	24	[	[	-LRB-
cord-325956-1kxxg0s9	20	25	19	19	CD
cord-325956-1kxxg0s9	20	26	]	]	-RRB-
cord-325956-1kxxg0s9	20	27	.	.	.
cord-325956-1kxxg0s9	21	1	A	a	DT
cord-325956-1kxxg0s9	21	2	number	number	NN
cord-325956-1kxxg0s9	21	3	of	of	IN
cord-325956-1kxxg0s9	21	4	models	model	NNS
cord-325956-1kxxg0s9	21	5	have	have	VBP
cord-325956-1kxxg0s9	21	6	been	be	VBN
cord-325956-1kxxg0s9	21	7	adapted	adapt	VBN
cord-325956-1kxxg0s9	21	8	by	by	IN
cord-325956-1kxxg0s9	21	9	policymakers	policymaker	NNS
cord-325956-1kxxg0s9	21	10	to	to	TO
cord-325956-1kxxg0s9	21	11	predict	predict	VB
cord-325956-1kxxg0s9	21	12	the	the	DT
cord-325956-1kxxg0s9	21	13	course	course	NN
cord-325956-1kxxg0s9	21	14	of	of	IN
cord-325956-1kxxg0s9	21	15	COVID-19	COVID-19	NNP
cord-325956-1kxxg0s9	21	16	across	across	IN
cord-325956-1kxxg0s9	21	17	the	the	DT
cord-325956-1kxxg0s9	21	18	world	world	NN
cord-325956-1kxxg0s9	21	19	4	4	CD
cord-325956-1kxxg0s9	21	20	,	,	,
cord-325956-1kxxg0s9	21	21	6	6	CD
cord-325956-1kxxg0s9	21	22	,	,	,
cord-325956-1kxxg0s9	21	23	13	13	CD
cord-325956-1kxxg0s9	21	24	,	,	,
cord-325956-1kxxg0s9	21	25	20	20	CD
cord-325956-1kxxg0s9	21	26	.	.	.
cord-325956-1kxxg0s9	22	1	The	the	DT
cord-325956-1kxxg0s9	22	2	reason	reason	NN
cord-325956-1kxxg0s9	22	3	for	for	IN
cord-325956-1kxxg0s9	22	4	such	such	JJ
cord-325956-1kxxg0s9	22	5	models	model	NNS
cord-325956-1kxxg0s9	22	6	is	be	VBZ
cord-325956-1kxxg0s9	22	7	to	to	TO
cord-325956-1kxxg0s9	22	8	ensure	ensure	VB
cord-325956-1kxxg0s9	22	9	that	that	IN
cord-325956-1kxxg0s9	22	10	healthcare	healthcare	NN
cord-325956-1kxxg0s9	22	11	systems	system	NNS
cord-325956-1kxxg0s9	22	12	can	can	MD
cord-325956-1kxxg0s9	22	13	plan	plan	VB
cord-325956-1kxxg0s9	22	14	services	service	NNS
cord-325956-1kxxg0s9	22	15	to	to	TO
cord-325956-1kxxg0s9	22	16	help	help	VB
cord-325956-1kxxg0s9	22	17	them	-PRON-	PRP
cord-325956-1kxxg0s9	22	18	cope	cope	VB
cord-325956-1kxxg0s9	22	19	with	with	IN
cord-325956-1kxxg0s9	22	20	the	the	DT
cord-325956-1kxxg0s9	22	21	demands	demand	NNS
cord-325956-1kxxg0s9	22	22	of	of	IN
cord-325956-1kxxg0s9	22	23	this	this	DT
cord-325956-1kxxg0s9	22	24	new	new	JJ
cord-325956-1kxxg0s9	22	25	disease	disease	NN
cord-325956-1kxxg0s9	22	26	which	which	WDT
cord-325956-1kxxg0s9	22	27	is	be	VBZ
cord-325956-1kxxg0s9	22	28	resulting	result	VBG
cord-325956-1kxxg0s9	22	29	in	in	IN
cord-325956-1kxxg0s9	22	30	serious	serious	JJ
cord-325956-1kxxg0s9	22	31	cases	case	NNS
cord-325956-1kxxg0s9	22	32	leading	lead	VBG
cord-325956-1kxxg0s9	22	33	to	to	IN
cord-325956-1kxxg0s9	22	34	hospitalisation	hospitalisation	NN
cord-325956-1kxxg0s9	22	35	3	3	CD
cord-325956-1kxxg0s9	22	36	,	,	,
cord-325956-1kxxg0s9	22	37	8	8	CD
cord-325956-1kxxg0s9	22	38	.	.	.
cord-325956-1kxxg0s9	23	1	Core	core	NN
cord-325956-1kxxg0s9	23	2	elements	element	NNS
cord-325956-1kxxg0s9	23	3	of	of	IN
cord-325956-1kxxg0s9	23	4	the	the	DT
cord-325956-1kxxg0s9	23	5	prediction	prediction	NN
cord-325956-1kxxg0s9	23	6	models	model	NNS
cord-325956-1kxxg0s9	23	7	have	have	VBP
cord-325956-1kxxg0s9	23	8	been	be	VBN
cord-325956-1kxxg0s9	23	9	the	the	DT
cord-325956-1kxxg0s9	23	10	number	number	NN
cord-325956-1kxxg0s9	23	11	of	of	IN
cord-325956-1kxxg0s9	23	12	cases	case	NNS
cord-325956-1kxxg0s9	23	13	and	and	CC
cord-325956-1kxxg0s9	23	14	deaths	death	NNS
cord-325956-1kxxg0s9	23	15	reported	report	VBN
cord-325956-1kxxg0s9	23	16	and	and	CC
cord-325956-1kxxg0s9	23	17	these	these	DT
cord-325956-1kxxg0s9	23	18	studies	study	NNS
cord-325956-1kxxg0s9	23	19	extrapolated	extrapolate	VBD
cord-325956-1kxxg0s9	23	20	the	the	DT
cord-325956-1kxxg0s9	23	21	numbers	number	NNS
cord-325956-1kxxg0s9	23	22	forward	forward	RB
cord-325956-1kxxg0s9	23	23	to	to	IN
cord-325956-1kxxg0s9	23	24	the	the	DT
cord-325956-1kxxg0s9	23	25	population	population	NN
cord-325956-1kxxg0s9	23	26	over	over	IN
cord-325956-1kxxg0s9	23	27	time	time	NN
cord-325956-1kxxg0s9	23	28	4	4	CD
cord-325956-1kxxg0s9	23	29	,	,	,
cord-325956-1kxxg0s9	23	30	6	6	CD
cord-325956-1kxxg0s9	23	31	,	,	,
cord-325956-1kxxg0s9	23	32	13	13	CD
cord-325956-1kxxg0s9	23	33	,	,	,
cord-325956-1kxxg0s9	23	34	20	20	CD
cord-325956-1kxxg0s9	23	35	.	.	.
cord-325956-1kxxg0s9	24	1	Given	give	VBN
cord-325956-1kxxg0s9	24	2	the	the	DT
cord-325956-1kxxg0s9	24	3	pandemic	pandemic	NN
cord-325956-1kxxg0s9	24	4	course	course	NN
cord-325956-1kxxg0s9	24	5	of	of	IN
cord-325956-1kxxg0s9	24	6	COVID-19	COVID-19	NNP
cord-325956-1kxxg0s9	24	7	,	,	,
cord-325956-1kxxg0s9	24	8	it	-PRON-	PRP
cord-325956-1kxxg0s9	24	9	has	have	VBZ
cord-325956-1kxxg0s9	24	10	become	become	VBN
cord-325956-1kxxg0s9	24	11	common	common	JJ
cord-325956-1kxxg0s9	24	12	practice	practice	NN
cord-325956-1kxxg0s9	24	13	to	to	TO
cord-325956-1kxxg0s9	24	14	compare	compare	VB
cord-325956-1kxxg0s9	24	15	its	-PRON-	PRP$
cord-325956-1kxxg0s9	24	16	spread	spread	NN
cord-325956-1kxxg0s9	24	17	in	in	IN
cord-325956-1kxxg0s9	24	18	different	different	JJ
cord-325956-1kxxg0s9	24	19	countries	country	NNS
cord-325956-1kxxg0s9	24	20	using	use	VBG
cord-325956-1kxxg0s9	24	21	case	case	NN
cord-325956-1kxxg0s9	24	22	fatality	fatality	NN
cord-325956-1kxxg0s9	24	23	rates	rate	NNS
cord-325956-1kxxg0s9	24	24	3	3	CD
cord-325956-1kxxg0s9	24	25	,	,	,
cord-325956-1kxxg0s9	24	26	4	4	CD
cord-325956-1kxxg0s9	24	27	,	,	,
cord-325956-1kxxg0s9	24	28	7	7	CD
cord-325956-1kxxg0s9	24	29	,	,	,
cord-325956-1kxxg0s9	24	30	13	13	CD
cord-325956-1kxxg0s9	24	31	.	.	.
cord-325956-1kxxg0s9	25	1	However	however	RB
cord-325956-1kxxg0s9	25	2	,	,	,
cord-325956-1kxxg0s9	25	3	such	such	JJ
cord-325956-1kxxg0s9	25	4	methods	method	NNS
cord-325956-1kxxg0s9	25	5	only	only	RB
cord-325956-1kxxg0s9	25	6	tell	tell	VBP
cord-325956-1kxxg0s9	25	7	us	-PRON-	PRP
cord-325956-1kxxg0s9	25	8	part	part	NN
cord-325956-1kxxg0s9	25	9	of	of	IN
cord-325956-1kxxg0s9	25	10	the	the	DT
cord-325956-1kxxg0s9	25	11	story	story	NN
cord-325956-1kxxg0s9	25	12	.	.	.
cord-325956-1kxxg0s9	26	1	Vast	vast	JJ
cord-325956-1kxxg0s9	26	2	differences	difference	NNS
cord-325956-1kxxg0s9	26	3	amongst	amongst	IN
cord-325956-1kxxg0s9	26	4	countries	country	NNS
cord-325956-1kxxg0s9	26	5	in	in	IN
cord-325956-1kxxg0s9	26	6	their	-PRON-	PRP$
cord-325956-1kxxg0s9	26	7	testing	testing	NN
cord-325956-1kxxg0s9	26	8	policies	policy	NNS
cord-325956-1kxxg0s9	26	9	for	for	IN
cord-325956-1kxxg0s9	26	10	varied	varied	JJ
cord-325956-1kxxg0s9	26	11	reasons	reason	NNS
cord-325956-1kxxg0s9	26	12	including	include	VBG
cord-325956-1kxxg0s9	26	13	availability	availability	NN
cord-325956-1kxxg0s9	26	14	of	of	IN
cord-325956-1kxxg0s9	26	15	testing	test	VBG
cord-325956-1kxxg0s9	26	16	equipment	equipment	NN
cord-325956-1kxxg0s9	26	17	,	,	,
cord-325956-1kxxg0s9	26	18	infrastructure	infrastructure	NN
cord-325956-1kxxg0s9	26	19	,	,	,
cord-325956-1kxxg0s9	26	20	resources	resource	NNS
cord-325956-1kxxg0s9	26	21	and	and	CC
cord-325956-1kxxg0s9	26	22	local	local	JJ
cord-325956-1kxxg0s9	26	23	governing	govern	VBG
cord-325956-1kxxg0s9	26	24	policies	policy	NNS
cord-325956-1kxxg0s9	26	25	affect	affect	VBP
cord-325956-1kxxg0s9	26	26	case	case	NN
cord-325956-1kxxg0s9	26	27	fatality	fatality	NN
cord-325956-1kxxg0s9	26	28	rates	rate	NNS
cord-325956-1kxxg0s9	26	29	.	.	.
cord-325956-1kxxg0s9	27	1	In	in	IN
cord-325956-1kxxg0s9	27	2	addition	addition	NN
cord-325956-1kxxg0s9	27	3	,	,	,
cord-325956-1kxxg0s9	27	4	comparing	compare	VBG
cord-325956-1kxxg0s9	27	5	case	case	NN
cord-325956-1kxxg0s9	27	6	fatality	fatality	NN
cord-325956-1kxxg0s9	27	7	rates	rate	NNS
cord-325956-1kxxg0s9	27	8	between	between	IN
cord-325956-1kxxg0s9	27	9	countries	country	NNS
cord-325956-1kxxg0s9	27	10	which	which	WDT
cord-325956-1kxxg0s9	27	11	are	be	VBP
cord-325956-1kxxg0s9	27	12	at	at	IN
cord-325956-1kxxg0s9	27	13	different	different	JJ
cord-325956-1kxxg0s9	27	14	stages	stage	NNS
cord-325956-1kxxg0s9	27	15	of	of	IN
cord-325956-1kxxg0s9	27	16	the	the	DT
cord-325956-1kxxg0s9	27	17	epidemic	epidemic	NN
cord-325956-1kxxg0s9	27	18	in	in	IN
cord-325956-1kxxg0s9	27	19	their	-PRON-	PRP$
cord-325956-1kxxg0s9	27	20	region	region	NN
cord-325956-1kxxg0s9	27	21	would	would	MD
cord-325956-1kxxg0s9	27	22	be	be	VB
cord-325956-1kxxg0s9	27	23	erroneous	erroneous	JJ
cord-325956-1kxxg0s9	27	24	as	as	IN
cord-325956-1kxxg0s9	27	25	rates	rate	NNS
cord-325956-1kxxg0s9	27	26	at	at	IN
cord-325956-1kxxg0s9	27	27	the	the	DT
cord-325956-1kxxg0s9	27	28	beginning	beginning	NN
cord-325956-1kxxg0s9	27	29	and	and	CC
cord-325956-1kxxg0s9	27	30	end	end	NN
cord-325956-1kxxg0s9	27	31	would	would	MD
cord-325956-1kxxg0s9	27	32	be	be	VB
cord-325956-1kxxg0s9	27	33	lower	low	JJR
cord-325956-1kxxg0s9	27	34	compared	compare	VBN
cord-325956-1kxxg0s9	27	35	to	to	IN
cord-325956-1kxxg0s9	27	36	rates	rate	NNS
cord-325956-1kxxg0s9	27	37	at	at	IN
cord-325956-1kxxg0s9	27	38	the	the	DT
cord-325956-1kxxg0s9	27	39	peak	peak	NN
cord-325956-1kxxg0s9	27	40	when	when	WRB
cord-325956-1kxxg0s9	27	41	healthcare	healthcare	NN
cord-325956-1kxxg0s9	27	42	services	service	NNS
cord-325956-1kxxg0s9	27	43	are	be	VBP
cord-325956-1kxxg0s9	27	44	stretched	stretch	VBN
cord-325956-1kxxg0s9	27	45	to	to	IN
cord-325956-1kxxg0s9	27	46	their	-PRON-	PRP$
cord-325956-1kxxg0s9	27	47	limits	limit	NNS
cord-325956-1kxxg0s9	27	48	.	.	.
cord-325956-1kxxg0s9	28	1	Therefore	therefore	RB
cord-325956-1kxxg0s9	28	2	,	,	,
cord-325956-1kxxg0s9	28	3	the	the	DT
cord-325956-1kxxg0s9	28	4	search	search	NN
cord-325956-1kxxg0s9	28	5	for	for	IN
cord-325956-1kxxg0s9	28	6	a	a	DT
cord-325956-1kxxg0s9	28	7	common	common	JJ
cord-325956-1kxxg0s9	28	8	yardstick	yardstick	NN
cord-325956-1kxxg0s9	28	9	or	or	CC
cord-325956-1kxxg0s9	28	10	denominator	denominator	NN
cord-325956-1kxxg0s9	28	11	is	be	VBZ
cord-325956-1kxxg0s9	28	12	necessary	necessary	JJ
cord-325956-1kxxg0s9	28	13	to	to	TO
cord-325956-1kxxg0s9	28	14	compare	compare	VB
cord-325956-1kxxg0s9	28	15	different	different	JJ
cord-325956-1kxxg0s9	28	16	countries	country	NNS
cord-325956-1kxxg0s9	28	17	so	so	IN
cord-325956-1kxxg0s9	28	18	that	that	IN
cord-325956-1kxxg0s9	28	19	the	the	DT
cord-325956-1kxxg0s9	28	20	data	datum	NNS
cord-325956-1kxxg0s9	28	21	can	can	MD
cord-325956-1kxxg0s9	28	22	be	be	VB
cord-325956-1kxxg0s9	28	23	extrapolated	extrapolate	VBN
cord-325956-1kxxg0s9	28	24	for	for	IN
cord-325956-1kxxg0s9	28	25	global	global	JJ
cord-325956-1kxxg0s9	28	26	comparison	comparison	NN
cord-325956-1kxxg0s9	28	27	.	.	.
cord-325956-1kxxg0s9	29	1	Over	over	IN
cord-325956-1kxxg0s9	29	2	the	the	DT
cord-325956-1kxxg0s9	29	3	past	past	JJ
cord-325956-1kxxg0s9	29	4	four	four	CD
cord-325956-1kxxg0s9	29	5	weeks	week	NNS
cord-325956-1kxxg0s9	29	6	,	,	,
cord-325956-1kxxg0s9	29	7	as	as	IN
cord-325956-1kxxg0s9	29	8	COVID-19	COVID-19	NNP
cord-325956-1kxxg0s9	29	9	spread	spread	VBN
cord-325956-1kxxg0s9	29	10	further	further	RB
cord-325956-1kxxg0s9	29	11	around	around	IN
cord-325956-1kxxg0s9	29	12	the	the	DT
cord-325956-1kxxg0s9	29	13	world	world	NN
cord-325956-1kxxg0s9	29	14	,	,	,
cord-325956-1kxxg0s9	29	15	testing	testing	NN
cord-325956-1kxxg0s9	29	16	rates	rate	NNS
cord-325956-1kxxg0s9	29	17	have	have	VBP
cord-325956-1kxxg0s9	29	18	picked	pick	VBN
cord-325956-1kxxg0s9	29	19	up	up	RP
cord-325956-1kxxg0s9	29	20	in	in	IN
cord-325956-1kxxg0s9	29	21	most	most	JJS
cord-325956-1kxxg0s9	29	22	countries	country	NNS
cord-325956-1kxxg0s9	29	23	.	.	.
cord-325956-1kxxg0s9	30	1	We	-PRON-	PRP
cord-325956-1kxxg0s9	30	2	propose	propose	VBP
cord-325956-1kxxg0s9	30	3	that	that	DT
cord-325956-1kxxg0s9	30	4	analysis	analysis	NN
cord-325956-1kxxg0s9	30	5	of	of	IN
cord-325956-1kxxg0s9	30	6	the	the	DT
cord-325956-1kxxg0s9	30	7	number	number	NN
cord-325956-1kxxg0s9	30	8	of	of	IN
cord-325956-1kxxg0s9	30	9	diagnostic	diagnostic	JJ
cord-325956-1kxxg0s9	30	10	tests	test	NNS
cord-325956-1kxxg0s9	30	11	performed	perform	VBN
cord-325956-1kxxg0s9	30	12	in	in	IN
cord-325956-1kxxg0s9	30	13	proportion	proportion	NN
cord-325956-1kxxg0s9	30	14	to	to	IN
cord-325956-1kxxg0s9	30	15	the	the	DT
cord-325956-1kxxg0s9	30	16	number	number	NN
cord-325956-1kxxg0s9	30	17	of	of	IN
cord-325956-1kxxg0s9	30	18	cases	case	NNS
cord-325956-1kxxg0s9	30	19	and	and	CC
cord-325956-1kxxg0s9	30	20	subsequently	subsequently	RB
cord-325956-1kxxg0s9	30	21	deaths	death	NNS
cord-325956-1kxxg0s9	30	22	in	in	IN
cord-325956-1kxxg0s9	30	23	the	the	DT
cord-325956-1kxxg0s9	30	24	underlying	underlie	VBG
cord-325956-1kxxg0s9	30	25	populations	population	NNS
cord-325956-1kxxg0s9	30	26	of	of	IN
cord-325956-1kxxg0s9	30	27	different	different	JJ
cord-325956-1kxxg0s9	30	28	countries	country	NNS
cord-325956-1kxxg0s9	30	29	is	be	VBZ
cord-325956-1kxxg0s9	30	30	the	the	DT
cord-325956-1kxxg0s9	30	31	best	good	JJS
cord-325956-1kxxg0s9	30	32	way	way	NN
cord-325956-1kxxg0s9	30	33	to	to	TO
cord-325956-1kxxg0s9	30	34	predict	predict	VB
cord-325956-1kxxg0s9	30	35	what	what	WP
cord-325956-1kxxg0s9	30	36	might	may	MD
cord-325956-1kxxg0s9	30	37	happen	happen	VB
cord-325956-1kxxg0s9	30	38	next	next	RB
cord-325956-1kxxg0s9	30	39	.	.	.
cord-325956-1kxxg0s9	31	1	We	-PRON-	PRP
cord-325956-1kxxg0s9	31	2	analysed	analyse	VBD
cord-325956-1kxxg0s9	31	3	this	this	DT
cord-325956-1kxxg0s9	31	4	from	from	IN
cord-325956-1kxxg0s9	31	5	the	the	DT
cord-325956-1kxxg0s9	31	6	ACALM	ACALM	NNP
cord-325956-1kxxg0s9	31	7	Big	Big	NNP
cord-325956-1kxxg0s9	31	8	Data	Data	NNP
cord-325956-1kxxg0s9	31	9	research	research	NN
cord-325956-1kxxg0s9	31	10	unit	unit	NN
cord-325956-1kxxg0s9	31	11	.	.	.
cord-325956-1kxxg0s9	31	12	.	.	.
cord-325956-1kxxg0s9	32	1	CC	CC	NNP
cord-325956-1kxxg0s9	32	2	-	-	:
cord-325956-1kxxg0s9	32	3	BY	by	IN
cord-325956-1kxxg0s9	32	4	4.0	4.0	CD
cord-325956-1kxxg0s9	32	5	International	international	JJ
cord-325956-1kxxg0s9	32	6	license	license	NN
cord-325956-1kxxg0s9	33	1	It	-PRON-	PRP
cord-325956-1kxxg0s9	33	2	is	be	VBZ
cord-325956-1kxxg0s9	33	3	made	make	VBN
cord-325956-1kxxg0s9	33	4	available	available	JJ
cord-325956-1kxxg0s9	33	5	under	under	IN
cord-325956-1kxxg0s9	33	6	a	a	DT
cord-325956-1kxxg0s9	34	1	is	be	VBZ
cord-325956-1kxxg0s9	34	2	the	the	DT
cord-325956-1kxxg0s9	34	3	author	author	NN
cord-325956-1kxxg0s9	34	4	/	/	SYM
cord-325956-1kxxg0s9	34	5	funder	funder	NN
cord-325956-1kxxg0s9	34	6	,	,	,
cord-325956-1kxxg0s9	34	7	who	who	WP
cord-325956-1kxxg0s9	34	8	has	have	VBZ
cord-325956-1kxxg0s9	34	9	granted	grant	VBN
cord-325956-1kxxg0s9	34	10	medRxiv	medRxiv	NNS
cord-325956-1kxxg0s9	34	11	a	a	DT
cord-325956-1kxxg0s9	34	12	license	license	NN
cord-325956-1kxxg0s9	34	13	to	to	TO
cord-325956-1kxxg0s9	34	14	display	display	VB
cord-325956-1kxxg0s9	34	15	the	the	DT
cord-325956-1kxxg0s9	34	16	preprint	preprint	NN
cord-325956-1kxxg0s9	34	17	in	in	IN
cord-325956-1kxxg0s9	34	18	perpetuity	perpetuity	NN
cord-325956-1kxxg0s9	34	19	.	.	.
cord-325956-1kxxg0s9	35	1	(	(	-LRB-
cord-325956-1kxxg0s9	35	2	which	which	WDT
cord-325956-1kxxg0s9	35	3	was	be	VBD
cord-325956-1kxxg0s9	35	4	not	not	RB
cord-325956-1kxxg0s9	35	5	peer	peer	NN
cord-325956-1kxxg0s9	35	6	-	-	HYPH
cord-325956-1kxxg0s9	35	7	reviewed	review	VBN
cord-325956-1kxxg0s9	35	8	)	)	-RRB-
cord-325956-1kxxg0s9	36	1	The	the	DT
cord-325956-1kxxg0s9	36	2	copyright	copyright	NN
cord-325956-1kxxg0s9	36	3	holder	holder	NN
cord-325956-1kxxg0s9	36	4	for	for	IN
cord-325956-1kxxg0s9	36	5	this	this	DT
cord-325956-1kxxg0s9	36	6	preprint	preprint	NN
cord-325956-1kxxg0s9	36	7	.	.	.
cord-325956-1kxxg0s9	37	1	https://doi.org/10.1101/2020.04.06.20054239	https://doi.org/10.1101/2020.04.06.20054239	NNP
cord-325956-1kxxg0s9	37	2	doi	doi	NN
cord-325956-1kxxg0s9	37	3	:	:	:
cord-325956-1kxxg0s9	38	1	medRxiv	medRxiv	NNP
cord-325956-1kxxg0s9	38	2	preprint	preprint	NNP
cord-325956-1kxxg0s9	39	1	We	-PRON-	PRP
cord-325956-1kxxg0s9	39	2	obtained	obtain	VBD
cord-325956-1kxxg0s9	39	3	real	real	JJ
cord-325956-1kxxg0s9	39	4	time	time	NN
cord-325956-1kxxg0s9	40	1	COVID-19	COVID-19	NNP
cord-325956-1kxxg0s9	40	2	data	datum	NNS
cord-325956-1kxxg0s9	40	3	from	from	IN
cord-325956-1kxxg0s9	40	4	the	the	DT
cord-325956-1kxxg0s9	40	5	reference	reference	NN
cord-325956-1kxxg0s9	40	6	website	website	NN
cord-325956-1kxxg0s9	40	7	Worldometer	Worldometer	NNP
cord-325956-1kxxg0s9	40	8	at	at	IN
cord-325956-1kxxg0s9	40	9	0900	0900	CD
cord-325956-1kxxg0s9	40	10	BST	bst	NN
cord-325956-1kxxg0s9	40	11	on	on	IN
cord-325956-1kxxg0s9	40	12	Saturday	Saturday	NNP
cord-325956-1kxxg0s9	40	13	4	4	CD
cord-325956-1kxxg0s9	40	14	th	th	CD
cord-325956-1kxxg0s9	40	15	April	April	NNP
cord-325956-1kxxg0s9	40	16	,	,	,
cord-325956-1kxxg0s9	40	17	2020	2020	CD
cord-325956-1kxxg0s9	40	18	and	and	CC
cord-325956-1kxxg0s9	40	19	collated	collate	VBD
cord-325956-1kxxg0s9	40	20	the	the	DT
cord-325956-1kxxg0s9	40	21	information	information	NN
cord-325956-1kxxg0s9	40	22	obtained	obtain	VBN
cord-325956-1kxxg0s9	40	23	on	on	IN
cord-325956-1kxxg0s9	40	24	the	the	DT
cord-325956-1kxxg0s9	40	25	top	top	JJ
cord-325956-1kxxg0s9	40	26	50	50	CD
cord-325956-1kxxg0s9	40	27	countries	country	NNS
cord-325956-1kxxg0s9	40	28	with	with	IN
cord-325956-1kxxg0s9	40	29	the	the	DT
cord-325956-1kxxg0s9	40	30	highest	high	JJS
cord-325956-1kxxg0s9	40	31	number	number	NN
cord-325956-1kxxg0s9	40	32	of	of	IN
cord-325956-1kxxg0s9	40	33	COVID-19	covid-19	JJ
cord-325956-1kxxg0s9	40	34	cases	case	NNS
cord-325956-1kxxg0s9	40	35	21	21	CD
cord-325956-1kxxg0s9	40	36	.	.	.
cord-325956-1kxxg0s9	41	1	From	from	IN
cord-325956-1kxxg0s9	41	2	this	this	DT
cord-325956-1kxxg0s9	41	3	source	source	NN
cord-325956-1kxxg0s9	41	4	,	,	,
cord-325956-1kxxg0s9	41	5	we	-PRON-	PRP
cord-325956-1kxxg0s9	41	6	obtained	obtain	VBD
cord-325956-1kxxg0s9	41	7	many	many	JJ
cord-325956-1kxxg0s9	41	8	parameters	parameter	NNS
cord-325956-1kxxg0s9	41	9	including	include	VBG
cord-325956-1kxxg0s9	41	10	the	the	DT
cord-325956-1kxxg0s9	41	11	number	number	NN
cord-325956-1kxxg0s9	41	12	of	of	IN
cord-325956-1kxxg0s9	41	13	country	country	NN
cord-325956-1kxxg0s9	41	14	wise	wise	JJ
cord-325956-1kxxg0s9	41	15	COVID-19	covid-19	JJ
cord-325956-1kxxg0s9	41	16	cases	case	NNS
cord-325956-1kxxg0s9	41	17	,	,	,
cord-325956-1kxxg0s9	41	18	deaths	death	NNS
cord-325956-1kxxg0s9	41	19	,	,	,
cord-325956-1kxxg0s9	41	20	tests	test	NNS
cord-325956-1kxxg0s9	41	21	performed	perform	VBN
cord-325956-1kxxg0s9	41	22	,	,	,
cord-325956-1kxxg0s9	41	23	cases	case	NNS
cord-325956-1kxxg0s9	41	24	per	per	IN
cord-325956-1kxxg0s9	41	25	million	million	CD
cord-325956-1kxxg0s9	41	26	population	population	NN
cord-325956-1kxxg0s9	41	27	,	,	,
cord-325956-1kxxg0s9	41	28	deaths	death	NNS
cord-325956-1kxxg0s9	41	29	per	per	IN
cord-325956-1kxxg0s9	41	30	million	million	CD
cord-325956-1kxxg0s9	41	31	population	population	NN
cord-325956-1kxxg0s9	41	32	and	and	CC
cord-325956-1kxxg0s9	41	33	tests	test	NNS
cord-325956-1kxxg0s9	41	34	per	per	IN
cord-325956-1kxxg0s9	41	35	million	million	CD
cord-325956-1kxxg0s9	41	36	population	population	NN
cord-325956-1kxxg0s9	41	37	.	.	.
cord-325956-1kxxg0s9	42	1	China	China	NNP
cord-325956-1kxxg0s9	42	2	and	and	CC
cord-325956-1kxxg0s9	42	3	Saudi	Saudi	NNP
cord-325956-1kxxg0s9	42	4	Arabia	Arabia	NNP
cord-325956-1kxxg0s9	42	5	were	be	VBD
cord-325956-1kxxg0s9	42	6	excluded	exclude	VBN
cord-325956-1kxxg0s9	42	7	due	due	IN
cord-325956-1kxxg0s9	42	8	to	to	IN
cord-325956-1kxxg0s9	42	9	lack	lack	NN
cord-325956-1kxxg0s9	42	10	of	of	IN
cord-325956-1kxxg0s9	42	11	data	datum	NNS
cord-325956-1kxxg0s9	42	12	on	on	IN
cord-325956-1kxxg0s9	42	13	number	number	NN
cord-325956-1kxxg0s9	42	14	of	of	IN
cord-325956-1kxxg0s9	42	15	diagnostic	diagnostic	JJ
cord-325956-1kxxg0s9	42	16	tests	test	NNS
cord-325956-1kxxg0s9	42	17	performed	perform	VBN
cord-325956-1kxxg0s9	42	18	,	,	,
cord-325956-1kxxg0s9	42	19	therefore	therefore	RB
cord-325956-1kxxg0s9	42	20	numbers	number	VBZ
cord-325956-1kxxg0s9	42	21	51	51	CD
cord-325956-1kxxg0s9	42	22	and	and	CC
cord-325956-1kxxg0s9	42	23	52	52	CD
cord-325956-1kxxg0s9	42	24	were	be	VBD
cord-325956-1kxxg0s9	42	25	included	include	VBN
cord-325956-1kxxg0s9	42	26	in	in	IN
cord-325956-1kxxg0s9	42	27	the	the	DT
cord-325956-1kxxg0s9	42	28	compiled	compile	VBN
cord-325956-1kxxg0s9	42	29	top	top	NN
cord-325956-1kxxg0s9	42	30	50	50	CD
cord-325956-1kxxg0s9	42	31	list	list	NN
cord-325956-1kxxg0s9	42	32	.	.	.
cord-325956-1kxxg0s9	43	1	We	-PRON-	PRP
cord-325956-1kxxg0s9	43	2	obtained	obtain	VBD
cord-325956-1kxxg0s9	43	3	case	case	NN
cord-325956-1kxxg0s9	43	4	fatality	fatality	NN
cord-325956-1kxxg0s9	43	5	rates	rate	NNS
cord-325956-1kxxg0s9	43	6	by	by	IN
cord-325956-1kxxg0s9	43	7	dividing	divide	VBG
cord-325956-1kxxg0s9	43	8	the	the	DT
cord-325956-1kxxg0s9	43	9	number	number	NN
cord-325956-1kxxg0s9	43	10	of	of	IN
cord-325956-1kxxg0s9	43	11	deaths	death	NNS
cord-325956-1kxxg0s9	43	12	by	by	IN
cord-325956-1kxxg0s9	43	13	the	the	DT
cord-325956-1kxxg0s9	43	14	number	number	NN
cord-325956-1kxxg0s9	43	15	of	of	IN
cord-325956-1kxxg0s9	43	16	cases	case	NNS
cord-325956-1kxxg0s9	43	17	represented	represent	VBN
cord-325956-1kxxg0s9	43	18	as	as	IN
cord-325956-1kxxg0s9	43	19	a	a	DT
cord-325956-1kxxg0s9	43	20	percentage	percentage	NN
cord-325956-1kxxg0s9	43	21	.	.	.
cord-325956-1kxxg0s9	44	1	Next	next	RB
cord-325956-1kxxg0s9	44	2	,	,	,
cord-325956-1kxxg0s9	44	3	tests	test	NNS
cord-325956-1kxxg0s9	44	4	per	per	IN
cord-325956-1kxxg0s9	44	5	positive	positive	JJ
cord-325956-1kxxg0s9	44	6	case	case	NN
cord-325956-1kxxg0s9	44	7	were	be	VBD
cord-325956-1kxxg0s9	44	8	calculated	calculate	VBN
cord-325956-1kxxg0s9	44	9	by	by	IN
cord-325956-1kxxg0s9	44	10	dividing	divide	VBG
cord-325956-1kxxg0s9	44	11	the	the	DT
cord-325956-1kxxg0s9	44	12	number	number	NN
cord-325956-1kxxg0s9	44	13	of	of	IN
cord-325956-1kxxg0s9	44	14	tests	test	NNS
cord-325956-1kxxg0s9	44	15	by	by	IN
cord-325956-1kxxg0s9	44	16	the	the	DT
cord-325956-1kxxg0s9	44	17	number	number	NN
cord-325956-1kxxg0s9	44	18	of	of	IN
cord-325956-1kxxg0s9	44	19	cases	case	NNS
cord-325956-1kxxg0s9	44	20	.	.	.
cord-325956-1kxxg0s9	45	1	We	-PRON-	PRP
cord-325956-1kxxg0s9	45	2	then	then	RB
cord-325956-1kxxg0s9	45	3	calculated	calculate	VBD
cord-325956-1kxxg0s9	45	4	the	the	DT
cord-325956-1kxxg0s9	45	5	number	number	NN
cord-325956-1kxxg0s9	45	6	of	of	IN
cord-325956-1kxxg0s9	45	7	cases	case	NNS
cord-325956-1kxxg0s9	45	8	per	per	IN
cord-325956-1kxxg0s9	45	9	test	test	NN
cord-325956-1kxxg0s9	45	10	and	and	CC
cord-325956-1kxxg0s9	45	11	number	number	NN
cord-325956-1kxxg0s9	45	12	of	of	IN
cord-325956-1kxxg0s9	45	13	deaths	death	NNS
cord-325956-1kxxg0s9	45	14	per	per	IN
cord-325956-1kxxg0s9	45	15	test	test	NN
cord-325956-1kxxg0s9	45	16	by	by	IN
cord-325956-1kxxg0s9	45	17	dividing	divide	VBG
cord-325956-1kxxg0s9	45	18	the	the	DT
cord-325956-1kxxg0s9	45	19	number	number	NN
cord-325956-1kxxg0s9	45	20	of	of	IN
cord-325956-1kxxg0s9	45	21	cases	case	NNS
cord-325956-1kxxg0s9	45	22	and	and	CC
cord-325956-1kxxg0s9	45	23	deaths	death	NNS
cord-325956-1kxxg0s9	45	24	respectively	respectively	RB
cord-325956-1kxxg0s9	45	25	,	,	,
cord-325956-1kxxg0s9	45	26	by	by	IN
cord-325956-1kxxg0s9	45	27	the	the	DT
cord-325956-1kxxg0s9	45	28	number	number	NN
cord-325956-1kxxg0s9	45	29	of	of	IN
cord-325956-1kxxg0s9	45	30	tests	test	NNS
cord-325956-1kxxg0s9	45	31	represented	represent	VBN
cord-325956-1kxxg0s9	45	32	as	as	IN
cord-325956-1kxxg0s9	45	33	a	a	DT
cord-325956-1kxxg0s9	45	34	percentage	percentage	NN
cord-325956-1kxxg0s9	45	35	(	(	-LRB-
cord-325956-1kxxg0s9	45	36	a	a	DT
cord-325956-1kxxg0s9	45	37	case	case	NN
cord-325956-1kxxg0s9	45	38	per	per	IN
cord-325956-1kxxg0s9	45	39	test	test	NN
cord-325956-1kxxg0s9	45	40	rate	rate	NN
cord-325956-1kxxg0s9	45	41	and	and	CC
cord-325956-1kxxg0s9	45	42	a	a	DT
cord-325956-1kxxg0s9	45	43	death	death	NN
cord-325956-1kxxg0s9	45	44	per	per	IN
cord-325956-1kxxg0s9	45	45	test	test	NN
cord-325956-1kxxg0s9	45	46	rate	rate	NN
cord-325956-1kxxg0s9	45	47	)	)	-RRB-
cord-325956-1kxxg0s9	45	48	.	.	.
cord-325956-1kxxg0s9	46	1	Subsequently	subsequently	RB
cord-325956-1kxxg0s9	46	2	,	,	,
cord-325956-1kxxg0s9	46	3	we	-PRON-	PRP
cord-325956-1kxxg0s9	46	4	obtained	obtain	VBD
cord-325956-1kxxg0s9	46	5	the	the	DT
cord-325956-1kxxg0s9	46	6	population	population	NN
cord-325956-1kxxg0s9	46	7	of	of	IN
cord-325956-1kxxg0s9	46	8	these	these	DT
cord-325956-1kxxg0s9	46	9	countries	country	NNS
cord-325956-1kxxg0s9	46	10	(	(	-LRB-
cord-325956-1kxxg0s9	46	11	in	in	IN
cord-325956-1kxxg0s9	46	12	millions	million	NNS
cord-325956-1kxxg0s9	46	13	)	)	-RRB-
cord-325956-1kxxg0s9	46	14	from	from	IN
cord-325956-1kxxg0s9	46	15	the	the	DT
cord-325956-1kxxg0s9	46	16	number	number	NN
cord-325956-1kxxg0s9	46	17	of	of	IN
cord-325956-1kxxg0s9	46	18	cases	case	NNS
cord-325956-1kxxg0s9	46	19	divided	divide	VBN
cord-325956-1kxxg0s9	46	20	by	by	IN
cord-325956-1kxxg0s9	46	21	the	the	DT
cord-325956-1kxxg0s9	46	22	number	number	NN
cord-325956-1kxxg0s9	46	23	of	of	IN
cord-325956-1kxxg0s9	46	24	cases	case	NNS
cord-325956-1kxxg0s9	46	25	per	per	IN
cord-325956-1kxxg0s9	46	26	million	million	CD
cord-325956-1kxxg0s9	46	27	.	.	.
cord-325956-1kxxg0s9	47	1	We	-PRON-	PRP
cord-325956-1kxxg0s9	47	2	can	can	MD
cord-325956-1kxxg0s9	47	3	obviously	obviously	RB
cord-325956-1kxxg0s9	47	4	obtain	obtain	VB
cord-325956-1kxxg0s9	47	5	more	more	RBR
cord-325956-1kxxg0s9	47	6	accurate	accurate	JJ
cord-325956-1kxxg0s9	47	7	country	country	NN
cord-325956-1kxxg0s9	47	8	population	population	NN
cord-325956-1kxxg0s9	47	9	statistics	statistic	NNS
cord-325956-1kxxg0s9	47	10	from	from	IN
cord-325956-1kxxg0s9	47	11	other	other	JJ
cord-325956-1kxxg0s9	47	12	sources	source	NNS
cord-325956-1kxxg0s9	47	13	but	but	CC
cord-325956-1kxxg0s9	47	14	to	to	TO
cord-325956-1kxxg0s9	47	15	maintain	maintain	VB
cord-325956-1kxxg0s9	47	16	our	-PRON-	PRP$
cord-325956-1kxxg0s9	47	17	consistency	consistency	NN
cord-325956-1kxxg0s9	47	18	of	of	IN
cord-325956-1kxxg0s9	47	19	the	the	DT
cord-325956-1kxxg0s9	47	20	data	data	NN
cord-325956-1kxxg0s9	47	21	source	source	NN
cord-325956-1kxxg0s9	47	22	and	and	CC
cord-325956-1kxxg0s9	47	23	methodology	methodology	NN
cord-325956-1kxxg0s9	47	24	(	(	-LRB-
cord-325956-1kxxg0s9	47	25	for	for	IN
cord-325956-1kxxg0s9	47	26	all	all	DT
cord-325956-1kxxg0s9	47	27	countries	country	NNS
cord-325956-1kxxg0s9	47	28	)	)	-RRB-
cord-325956-1kxxg0s9	47	29	,	,	,
cord-325956-1kxxg0s9	47	30	we	-PRON-	PRP
cord-325956-1kxxg0s9	47	31	derived	derive	VBD
cord-325956-1kxxg0s9	47	32	the	the	DT
cord-325956-1kxxg0s9	47	33	information	information	NN
cord-325956-1kxxg0s9	47	34	from	from	IN
cord-325956-1kxxg0s9	47	35	this	this	DT
cord-325956-1kxxg0s9	47	36	data	data	NN
cord-325956-1kxxg0s9	47	37	only	only	RB
cord-325956-1kxxg0s9	47	38	.	.	.
cord-325956-1kxxg0s9	48	1	We	-PRON-	PRP
cord-325956-1kxxg0s9	48	2	then	then	RB
cord-325956-1kxxg0s9	48	3	analysed	analyse	VBD
cord-325956-1kxxg0s9	48	4	the	the	DT
cord-325956-1kxxg0s9	48	5	above	above	JJ
cord-325956-1kxxg0s9	48	6	in	in	IN
cord-325956-1kxxg0s9	48	7	three	three	CD
cord-325956-1kxxg0s9	48	8	steps	step	NNS
cord-325956-1kxxg0s9	48	9	.	.	.
cord-325956-1kxxg0s9	49	1	Firstly	firstly	RB
cord-325956-1kxxg0s9	49	2	,	,	,
cord-325956-1kxxg0s9	49	3	we	-PRON-	PRP
cord-325956-1kxxg0s9	49	4	extrapolated	extrapolate	VBD
cord-325956-1kxxg0s9	49	5	the	the	DT
cord-325956-1kxxg0s9	49	6	population	population	NN
cord-325956-1kxxg0s9	49	7	level	level	NN
cord-325956-1kxxg0s9	49	8	pandemic	pandemic	NN
cord-325956-1kxxg0s9	49	9	data	datum	NNS
cord-325956-1kxxg0s9	49	10	for	for	IN
cord-325956-1kxxg0s9	49	11	each	each	DT
cord-325956-1kxxg0s9	49	12	country	country	NN
cord-325956-1kxxg0s9	49	13	in	in	IN
cord-325956-1kxxg0s9	49	14	terms	term	NNS
cord-325956-1kxxg0s9	49	15	of	of	IN
cord-325956-1kxxg0s9	49	16	cases	case	NNS
cord-325956-1kxxg0s9	49	17	and	and	CC
cord-325956-1kxxg0s9	49	18	number	number	NN
cord-325956-1kxxg0s9	49	19	of	of	IN
cord-325956-1kxxg0s9	49	20	deaths	death	NNS
cord-325956-1kxxg0s9	49	21	according	accord	VBG
cord-325956-1kxxg0s9	49	22	to	to	IN
cord-325956-1kxxg0s9	49	23	each	each	DT
cord-325956-1kxxg0s9	49	24	country	country	NN
cord-325956-1kxxg0s9	49	25	's	's	POS
cord-325956-1kxxg0s9	49	26	case	case	NN
cord-325956-1kxxg0s9	49	27	per	per	IN
cord-325956-1kxxg0s9	49	28	test	test	NN
cord-325956-1kxxg0s9	49	29	rate	rate	NN
cord-325956-1kxxg0s9	49	30	and	and	CC
cord-325956-1kxxg0s9	49	31	death	death	NN
cord-325956-1kxxg0s9	49	32	per	per	IN
cord-325956-1kxxg0s9	49	33	test	test	NN
cord-325956-1kxxg0s9	49	34	rate	rate	NN
cord-325956-1kxxg0s9	49	35	as	as	IN
cord-325956-1kxxg0s9	49	36	calculated	calculate	VBN
cord-325956-1kxxg0s9	49	37	as	as	IN
cord-325956-1kxxg0s9	49	38	a	a	DT
cord-325956-1kxxg0s9	49	39	snapshot	snapshot	NN
cord-325956-1kxxg0s9	49	40	at	at	IN
cord-325956-1kxxg0s9	49	41	the	the	DT
cord-325956-1kxxg0s9	49	42	time	time	NN
cord-325956-1kxxg0s9	49	43	of	of	IN
cord-325956-1kxxg0s9	49	44	obtaining	obtain	VBG
cord-325956-1kxxg0s9	49	45	the	the	DT
cord-325956-1kxxg0s9	49	46	data	datum	NNS
cord-325956-1kxxg0s9	49	47	.	.	.
cord-325956-1kxxg0s9	50	1	There	there	EX
cord-325956-1kxxg0s9	50	2	are	be	VBP
cord-325956-1kxxg0s9	50	3	a	a	DT
cord-325956-1kxxg0s9	50	4	number	number	NN
cord-325956-1kxxg0s9	50	5	of	of	IN
cord-325956-1kxxg0s9	50	6	limitations	limitation	NNS
cord-325956-1kxxg0s9	50	7	to	to	IN
cord-325956-1kxxg0s9	50	8	the	the	DT
cord-325956-1kxxg0s9	50	9	methodology	methodology	NN
cord-325956-1kxxg0s9	50	10	used	use	VBN
cord-325956-1kxxg0s9	50	11	when	when	WRB
cord-325956-1kxxg0s9	50	12	taking	take	VBG
cord-325956-1kxxg0s9	50	13	a	a	DT
cord-325956-1kxxg0s9	50	14	snapshot	snapshot	NN
cord-325956-1kxxg0s9	50	15	of	of	IN
cord-325956-1kxxg0s9	50	16	these	these	DT
cord-325956-1kxxg0s9	50	17	countries	country	NNS
cord-325956-1kxxg0s9	50	18	at	at	IN
cord-325956-1kxxg0s9	50	19	a	a	DT
cord-325956-1kxxg0s9	50	20	point	point	NN
cord-325956-1kxxg0s9	50	21	in	in	IN
cord-325956-1kxxg0s9	50	22	time	time	NN
cord-325956-1kxxg0s9	50	23	,	,	,
cord-325956-1kxxg0s9	50	24	as	as	IN
cord-325956-1kxxg0s9	50	25	done	do	VBN
cord-325956-1kxxg0s9	50	26	above	above	RB
cord-325956-1kxxg0s9	50	27	,	,	,
cord-325956-1kxxg0s9	50	28	especially	especially	RB
cord-325956-1kxxg0s9	50	29	because	because	IN
cord-325956-1kxxg0s9	50	30	each	each	DT
cord-325956-1kxxg0s9	50	31	country	country	NN
cord-325956-1kxxg0s9	50	32	is	be	VBZ
cord-325956-1kxxg0s9	50	33	likely	likely	JJ
cord-325956-1kxxg0s9	50	34	to	to	TO
cord-325956-1kxxg0s9	50	35	be	be	VB
cord-325956-1kxxg0s9	50	36	on	on	IN
cord-325956-1kxxg0s9	50	37	a	a	DT
cord-325956-1kxxg0s9	50	38	different	different	JJ
cord-325956-1kxxg0s9	50	39	part	part	NN
cord-325956-1kxxg0s9	50	40	of	of	IN
cord-325956-1kxxg0s9	50	41	the	the	DT
cord-325956-1kxxg0s9	50	42	pandemic	pandemic	NN
cord-325956-1kxxg0s9	50	43	curve	curve	NN
cord-325956-1kxxg0s9	50	44	and	and	CC
cord-325956-1kxxg0s9	50	45	extrapolating	extrapolate	VBG
cord-325956-1kxxg0s9	50	46	to	to	IN
cord-325956-1kxxg0s9	50	47	the	the	DT
cord-325956-1kxxg0s9	50	48	population	population	NN
cord-325956-1kxxg0s9	50	49	level	level	NN
cord-325956-1kxxg0s9	50	50	data	data	NN
cord-325956-1kxxg0s9	50	51	is	be	VBZ
cord-325956-1kxxg0s9	50	52	not	not	RB
cord-325956-1kxxg0s9	50	53	likely	likely	JJ
cord-325956-1kxxg0s9	50	54	to	to	TO
cord-325956-1kxxg0s9	50	55	be	be	VB
cord-325956-1kxxg0s9	50	56	.	.	.
cord-325956-1kxxg0s9	51	1	CC	CC	NNP
cord-325956-1kxxg0s9	51	2	-	-	:
cord-325956-1kxxg0s9	51	3	BY	by	IN
cord-325956-1kxxg0s9	51	4	4.0	4.0	CD
cord-325956-1kxxg0s9	51	5	International	international	JJ
cord-325956-1kxxg0s9	51	6	license	license	NN
cord-325956-1kxxg0s9	52	1	It	-PRON-	PRP
cord-325956-1kxxg0s9	52	2	is	be	VBZ
cord-325956-1kxxg0s9	52	3	made	make	VBN
cord-325956-1kxxg0s9	52	4	available	available	JJ
cord-325956-1kxxg0s9	52	5	under	under	IN
cord-325956-1kxxg0s9	52	6	a	a	DT
cord-325956-1kxxg0s9	53	1	is	be	VBZ
cord-325956-1kxxg0s9	53	2	the	the	DT
cord-325956-1kxxg0s9	53	3	author	author	NN
cord-325956-1kxxg0s9	53	4	/	/	SYM
cord-325956-1kxxg0s9	53	5	funder	funder	NN
cord-325956-1kxxg0s9	53	6	,	,	,
cord-325956-1kxxg0s9	53	7	who	who	WP
cord-325956-1kxxg0s9	53	8	has	have	VBZ
cord-325956-1kxxg0s9	53	9	granted	grant	VBN
cord-325956-1kxxg0s9	53	10	medRxiv	medRxiv	NNS
cord-325956-1kxxg0s9	53	11	a	a	DT
cord-325956-1kxxg0s9	53	12	license	license	NN
cord-325956-1kxxg0s9	53	13	to	to	TO
cord-325956-1kxxg0s9	53	14	display	display	VB
cord-325956-1kxxg0s9	53	15	the	the	DT
cord-325956-1kxxg0s9	53	16	preprint	preprint	NN
cord-325956-1kxxg0s9	53	17	in	in	IN
cord-325956-1kxxg0s9	53	18	perpetuity	perpetuity	NN
cord-325956-1kxxg0s9	53	19	.	.	.
cord-325956-1kxxg0s9	54	1	(	(	-LRB-
cord-325956-1kxxg0s9	54	2	which	which	WDT
cord-325956-1kxxg0s9	54	3	was	be	VBD
cord-325956-1kxxg0s9	54	4	not	not	RB
cord-325956-1kxxg0s9	54	5	peer	peer	NN
cord-325956-1kxxg0s9	54	6	-	-	HYPH
cord-325956-1kxxg0s9	54	7	reviewed	review	VBN
cord-325956-1kxxg0s9	54	8	)	)	-RRB-
cord-325956-1kxxg0s9	55	1	The	the	DT
cord-325956-1kxxg0s9	55	2	copyright	copyright	NN
cord-325956-1kxxg0s9	55	3	holder	holder	NN
cord-325956-1kxxg0s9	55	4	for	for	IN
cord-325956-1kxxg0s9	55	5	this	this	DT
cord-325956-1kxxg0s9	55	6	preprint	preprint	NN
cord-325956-1kxxg0s9	55	7	.	.	.
cord-325956-1kxxg0s9	56	1	https://doi.org/10.1101/2020.04.06.20054239	https://doi.org/10.1101/2020.04.06.20054239	NNP
cord-325956-1kxxg0s9	56	2	doi	doi	NN
cord-325956-1kxxg0s9	56	3	:	:	:
cord-325956-1kxxg0s9	57	1	medRxiv	medRxiv	NNP
cord-325956-1kxxg0s9	57	2	preprint	preprint	NN
cord-325956-1kxxg0s9	57	3	accurate	accurate	JJ
cord-325956-1kxxg0s9	57	4	.	.	.
cord-325956-1kxxg0s9	58	1	Therefore	therefore	RB
cord-325956-1kxxg0s9	58	2	,	,	,
cord-325956-1kxxg0s9	58	3	we	-PRON-	PRP
cord-325956-1kxxg0s9	58	4	further	further	RB
cord-325956-1kxxg0s9	58	5	undertook	undertake	VBD
cord-325956-1kxxg0s9	58	6	a	a	DT
cord-325956-1kxxg0s9	58	7	consistent	consistent	JJ
cord-325956-1kxxg0s9	58	8	adjustment	adjustment	NN
cord-325956-1kxxg0s9	58	9	according	accord	VBG
cord-325956-1kxxg0s9	58	10	to	to	IN
cord-325956-1kxxg0s9	58	11	countries	country	NNS
cord-325956-1kxxg0s9	58	12	which	which	WDT
cord-325956-1kxxg0s9	58	13	performed	perform	VBD
cord-325956-1kxxg0s9	58	14	the	the	DT
cord-325956-1kxxg0s9	58	15	most	most	JJS
cord-325956-1kxxg0s9	58	16	tests	test	NNS
cord-325956-1kxxg0s9	58	17	;	;	:
cord-325956-1kxxg0s9	58	18	in	in	IN
cord-325956-1kxxg0s9	58	19	favour	favour	NN
cord-325956-1kxxg0s9	58	20	of	of	IN
cord-325956-1kxxg0s9	58	21	larger	large	JJR
cord-325956-1kxxg0s9	58	22	countries	country	NNS
cord-325956-1kxxg0s9	58	23	with	with	IN
cord-325956-1kxxg0s9	58	24	bigger	big	JJR
cord-325956-1kxxg0s9	58	25	populations	population	NNS
cord-325956-1kxxg0s9	58	26	we	-PRON-	PRP
cord-325956-1kxxg0s9	58	27	chose	choose	VBD
cord-325956-1kxxg0s9	58	28	an	an	DT
cord-325956-1kxxg0s9	58	29	arbitrary	arbitrary	JJ
cord-325956-1kxxg0s9	58	30	cut	cut	NN
cord-325956-1kxxg0s9	58	31	off	off	IN
cord-325956-1kxxg0s9	58	32	of	of	IN
cord-325956-1kxxg0s9	58	33	100,000	100,000	CD
cord-325956-1kxxg0s9	58	34	tests	test	NNS
cord-325956-1kxxg0s9	58	35	per	per	IN
cord-325956-1kxxg0s9	58	36	country	country	NN
cord-325956-1kxxg0s9	58	37	.	.	.
cord-325956-1kxxg0s9	59	1	15	15	CD
cord-325956-1kxxg0s9	59	2	countries	country	NNS
cord-325956-1kxxg0s9	59	3	had	have	VBD
cord-325956-1kxxg0s9	59	4	undertaken	undertake	VBN
cord-325956-1kxxg0s9	59	5	more	more	JJR
cord-325956-1kxxg0s9	59	6	than	than	IN
cord-325956-1kxxg0s9	59	7	100,000	100,000	CD
cord-325956-1kxxg0s9	59	8	tests	test	NNS
cord-325956-1kxxg0s9	59	9	and	and	CC
cord-325956-1kxxg0s9	59	10	as	as	IN
cord-325956-1kxxg0s9	59	11	all	all	PDT
cord-325956-1kxxg0s9	59	12	these	these	DT
cord-325956-1kxxg0s9	59	13	countries	country	NNS
cord-325956-1kxxg0s9	59	14	showed	show	VBD
cord-325956-1kxxg0s9	59	15	differences	difference	NNS
cord-325956-1kxxg0s9	59	16	in	in	IN
cord-325956-1kxxg0s9	59	17	their	-PRON-	PRP$
cord-325956-1kxxg0s9	59	18	cases	case	NNS
cord-325956-1kxxg0s9	59	19	/	/	SYM
cord-325956-1kxxg0s9	59	20	test	test	NN
cord-325956-1kxxg0s9	59	21	and	and	CC
cord-325956-1kxxg0s9	59	22	deaths	death	NNS
cord-325956-1kxxg0s9	59	23	/	/	SYM
cord-325956-1kxxg0s9	59	24	test	test	NN
cord-325956-1kxxg0s9	59	25	we	-PRON-	PRP
cord-325956-1kxxg0s9	59	26	took	take	VBD
cord-325956-1kxxg0s9	59	27	the	the	DT
cord-325956-1kxxg0s9	59	28	15	15	CD
cord-325956-1kxxg0s9	59	29	country	country	NN
cord-325956-1kxxg0s9	59	30	group	group	NN
cord-325956-1kxxg0s9	59	31	as	as	IN
cord-325956-1kxxg0s9	59	32	a	a	DT
cord-325956-1kxxg0s9	59	33	whole	whole	NN
cord-325956-1kxxg0s9	59	34	to	to	TO
cord-325956-1kxxg0s9	59	35	obtain	obtain	VB
cord-325956-1kxxg0s9	59	36	an	an	DT
cord-325956-1kxxg0s9	59	37	adjustment	adjustment	NN
cord-325956-1kxxg0s9	59	38	factor	factor	NN
cord-325956-1kxxg0s9	59	39	according	accord	VBG
cord-325956-1kxxg0s9	59	40	to	to	IN
cord-325956-1kxxg0s9	59	41	the	the	DT
cord-325956-1kxxg0s9	59	42	cases	case	NNS
cord-325956-1kxxg0s9	59	43	/	/	SYM
cord-325956-1kxxg0s9	59	44	test	test	NN
cord-325956-1kxxg0s9	59	45	and	and	CC
cord-325956-1kxxg0s9	59	46	deaths	death	NNS
cord-325956-1kxxg0s9	59	47	/	/	SYM
cord-325956-1kxxg0s9	59	48	test	test	NN
cord-325956-1kxxg0s9	59	49	.	.	.
cord-325956-1kxxg0s9	60	1	Using	use	VBG
cord-325956-1kxxg0s9	60	2	this	this	DT
cord-325956-1kxxg0s9	60	3	we	-PRON-	PRP
cord-325956-1kxxg0s9	60	4	derived	derive	VBD
cord-325956-1kxxg0s9	60	5	a	a	DT
cord-325956-1kxxg0s9	60	6	case	case	NN
cord-325956-1kxxg0s9	60	7	per	per	IN
cord-325956-1kxxg0s9	60	8	test	test	NN
cord-325956-1kxxg0s9	60	9	rate	rate	NN
cord-325956-1kxxg0s9	60	10	of	of	IN
cord-325956-1kxxg0s9	60	11	13.53	13.53	CD
cord-325956-1kxxg0s9	60	12	%	%	NN
cord-325956-1kxxg0s9	60	13	and	and	CC
cord-325956-1kxxg0s9	60	14	a	a	DT
cord-325956-1kxxg0s9	60	15	death	death	NN
cord-325956-1kxxg0s9	60	16	per	per	IN
cord-325956-1kxxg0s9	60	17	test	test	NN
cord-325956-1kxxg0s9	60	18	rate	rate	NN
cord-325956-1kxxg0s9	60	19	of	of	IN
cord-325956-1kxxg0s9	60	20	0.77	0.77	CD
cord-325956-1kxxg0s9	60	21	%	%	NN
cord-325956-1kxxg0s9	60	22	for	for	IN
cord-325956-1kxxg0s9	60	23	the	the	DT
cord-325956-1kxxg0s9	60	24	15	15	CD
cord-325956-1kxxg0s9	60	25	country	country	NN
cord-325956-1kxxg0s9	60	26	group	group	NN
cord-325956-1kxxg0s9	60	27	.	.	.
cord-325956-1kxxg0s9	61	1	Based	base	VBN
cord-325956-1kxxg0s9	61	2	on	on	IN
cord-325956-1kxxg0s9	61	3	the	the	DT
cord-325956-1kxxg0s9	61	4	above	above	JJ
cord-325956-1kxxg0s9	61	5	numbers	number	NNS
cord-325956-1kxxg0s9	61	6	,	,	,
cord-325956-1kxxg0s9	61	7	we	-PRON-	PRP
cord-325956-1kxxg0s9	61	8	extrapolated	extrapolate	VBD
cord-325956-1kxxg0s9	61	9	figures	figure	NNS
cord-325956-1kxxg0s9	61	10	at	at	IN
cord-325956-1kxxg0s9	61	11	the	the	DT
cord-325956-1kxxg0s9	61	12	population	population	NN
cord-325956-1kxxg0s9	61	13	level	level	NN
cord-325956-1kxxg0s9	61	14	for	for	IN
cord-325956-1kxxg0s9	61	15	all	all	DT
cord-325956-1kxxg0s9	61	16	50	50	CD
cord-325956-1kxxg0s9	61	17	countries	country	NNS
cord-325956-1kxxg0s9	61	18	to	to	TO
cord-325956-1kxxg0s9	61	19	calculate	calculate	VB
cord-325956-1kxxg0s9	61	20	the	the	DT
cord-325956-1kxxg0s9	61	21	predicated	predicated	JJ
cord-325956-1kxxg0s9	61	22	number	number	NN
cord-325956-1kxxg0s9	61	23	of	of	IN
cord-325956-1kxxg0s9	61	24	cases	case	NNS
cord-325956-1kxxg0s9	61	25	and	and	CC
cord-325956-1kxxg0s9	61	26	deaths	death	NNS
cord-325956-1kxxg0s9	61	27	.	.	.
cord-325956-1kxxg0s9	62	1	We	-PRON-	PRP
cord-325956-1kxxg0s9	62	2	felt	feel	VBD
cord-325956-1kxxg0s9	62	3	it	-PRON-	PRP
cord-325956-1kxxg0s9	62	4	necessary	necessary	JJ
cord-325956-1kxxg0s9	62	5	to	to	TO
cord-325956-1kxxg0s9	62	6	undertake	undertake	VB
cord-325956-1kxxg0s9	62	7	further	further	JJ
cord-325956-1kxxg0s9	62	8	analysis	analysis	NN
cord-325956-1kxxg0s9	62	9	,	,	,
cord-325956-1kxxg0s9	62	10	the	the	DT
cord-325956-1kxxg0s9	62	11	third	third	JJ
cord-325956-1kxxg0s9	62	12	analysis	analysis	NN
cord-325956-1kxxg0s9	62	13	,	,	,
cord-325956-1kxxg0s9	62	14	to	to	TO
cord-325956-1kxxg0s9	62	15	adjust	adjust	VB
cord-325956-1kxxg0s9	62	16	the	the	DT
cord-325956-1kxxg0s9	62	17	data	datum	NNS
cord-325956-1kxxg0s9	62	18	to	to	IN
cord-325956-1kxxg0s9	62	19	a	a	DT
cord-325956-1kxxg0s9	62	20	country	country	NN
cord-325956-1kxxg0s9	62	21	which	which	WDT
cord-325956-1kxxg0s9	62	22	is	be	VBZ
cord-325956-1kxxg0s9	62	23	progressing	progress	VBG
cord-325956-1kxxg0s9	62	24	towards	towards	IN
cord-325956-1kxxg0s9	62	25	the	the	DT
cord-325956-1kxxg0s9	62	26	latter	latter	JJ
cord-325956-1kxxg0s9	62	27	half	half	NN
cord-325956-1kxxg0s9	62	28	of	of	IN
cord-325956-1kxxg0s9	62	29	the	the	DT
cord-325956-1kxxg0s9	62	30	pandemic	pandemic	NN
cord-325956-1kxxg0s9	62	31	curve	curve	NN
cord-325956-1kxxg0s9	62	32	-South	-South	:
cord-325956-1kxxg0s9	62	33	Korea	Korea	NNP
cord-325956-1kxxg0s9	62	34	[	[	-LRB-
cord-325956-1kxxg0s9	62	35	22	22	CD
cord-325956-1kxxg0s9	62	36	]	]	-RRB-
cord-325956-1kxxg0s9	62	37	[	[	-LRB-
cord-325956-1kxxg0s9	62	38	23	23	CD
cord-325956-1kxxg0s9	62	39	]	]	-RRB-
cord-325956-1kxxg0s9	62	40	[	[	-LRB-
cord-325956-1kxxg0s9	62	41	24	24	CD
cord-325956-1kxxg0s9	62	42	]	]	-RRB-
cord-325956-1kxxg0s9	62	43	.	.	.
cord-325956-1kxxg0s9	63	1	Ideally	ideally	RB
cord-325956-1kxxg0s9	63	2	,	,	,
cord-325956-1kxxg0s9	63	3	undertaking	undertake	VBG
cord-325956-1kxxg0s9	63	4	this	this	DT
cord-325956-1kxxg0s9	63	5	adjustment	adjustment	NN
cord-325956-1kxxg0s9	63	6	with	with	IN
cord-325956-1kxxg0s9	63	7	data	datum	NNS
cord-325956-1kxxg0s9	63	8	from	from	IN
cord-325956-1kxxg0s9	63	9	China	China	NNP
cord-325956-1kxxg0s9	63	10	would	would	MD
cord-325956-1kxxg0s9	63	11	be	be	VB
cord-325956-1kxxg0s9	63	12	most	most	RBS
cord-325956-1kxxg0s9	63	13	appropriate	appropriate	JJ
cord-325956-1kxxg0s9	63	14	but	but	CC
cord-325956-1kxxg0s9	63	15	data	datum	NNS
cord-325956-1kxxg0s9	63	16	for	for	IN
cord-325956-1kxxg0s9	63	17	the	the	DT
cord-325956-1kxxg0s9	63	18	number	number	NN
cord-325956-1kxxg0s9	63	19	of	of	IN
cord-325956-1kxxg0s9	63	20	diagnostic	diagnostic	JJ
cord-325956-1kxxg0s9	63	21	tests	test	NNS
cord-325956-1kxxg0s9	63	22	performed	perform	VBN
cord-325956-1kxxg0s9	63	23	in	in	IN
cord-325956-1kxxg0s9	63	24	China	China	NNP
cord-325956-1kxxg0s9	63	25	was	be	VBD
cord-325956-1kxxg0s9	63	26	not	not	RB
cord-325956-1kxxg0s9	63	27	available	available	JJ
cord-325956-1kxxg0s9	63	28	.	.	.
cord-325956-1kxxg0s9	64	1	The	the	DT
cord-325956-1kxxg0s9	64	2	adjustment	adjustment	NN
cord-325956-1kxxg0s9	64	3	factor	factor	NN
cord-325956-1kxxg0s9	64	4	for	for	IN
cord-325956-1kxxg0s9	64	5	South	South	NNP
cord-325956-1kxxg0s9	64	6	Korea	Korea	NNP
cord-325956-1kxxg0s9	64	7	was	be	VBD
cord-325956-1kxxg0s9	64	8	a	a	DT
cord-325956-1kxxg0s9	64	9	case	case	NN
cord-325956-1kxxg0s9	64	10	per	per	IN
cord-325956-1kxxg0s9	64	11	test	test	NN
cord-325956-1kxxg0s9	64	12	rate	rate	NN
cord-325956-1kxxg0s9	64	13	of	of	IN
cord-325956-1kxxg0s9	64	14	2.23	2.23	CD
cord-325956-1kxxg0s9	64	15	%	%	NN
cord-325956-1kxxg0s9	64	16	and	and	CC
cord-325956-1kxxg0s9	64	17	0.04	0.04	CD
cord-325956-1kxxg0s9	64	18	%	%	NN
cord-325956-1kxxg0s9	64	19	death	death	NN
cord-325956-1kxxg0s9	64	20	per	per	IN
cord-325956-1kxxg0s9	64	21	test	test	NN
cord-325956-1kxxg0s9	64	22	rate	rate	NN
cord-325956-1kxxg0s9	64	23	.	.	.
cord-325956-1kxxg0s9	65	1	Hence	hence	RB
cord-325956-1kxxg0s9	65	2	our	-PRON-	PRP$
cord-325956-1kxxg0s9	65	3	country	country	NN
cord-325956-1kxxg0s9	65	4	wise	wise	JJ
cord-325956-1kxxg0s9	65	5	population	population	NN
cord-325956-1kxxg0s9	65	6	level	level	NN
cord-325956-1kxxg0s9	65	7	pandemic	pandemic	NN
cord-325956-1kxxg0s9	65	8	projections	projection	NNS
cord-325956-1kxxg0s9	65	9	were	be	VBD
cord-325956-1kxxg0s9	65	10	based	base	VBN
cord-325956-1kxxg0s9	65	11	on	on	IN
cord-325956-1kxxg0s9	65	12	1	1	CD
cord-325956-1kxxg0s9	65	13	)	)	-RRB-
cord-325956-1kxxg0s9	65	14	inherent	inherent	JJ
cord-325956-1kxxg0s9	65	15	case	case	NN
cord-325956-1kxxg0s9	65	16	per	per	IN
cord-325956-1kxxg0s9	65	17	test	test	NN
cord-325956-1kxxg0s9	65	18	and	and	CC
cord-325956-1kxxg0s9	65	19	death	death	NN
cord-325956-1kxxg0s9	65	20	per	per	IN
cord-325956-1kxxg0s9	65	21	test	test	NN
cord-325956-1kxxg0s9	65	22	rates	rate	NNS
cord-325956-1kxxg0s9	65	23	at	at	IN
cord-325956-1kxxg0s9	65	24	the	the	DT
cord-325956-1kxxg0s9	65	25	time	time	NN
cord-325956-1kxxg0s9	65	26	of	of	IN
cord-325956-1kxxg0s9	65	27	obtaining	obtain	VBG
cord-325956-1kxxg0s9	65	28	the	the	DT
cord-325956-1kxxg0s9	65	29	data	datum	NNS
cord-325956-1kxxg0s9	65	30	(	(	-LRB-
cord-325956-1kxxg0s9	65	31	4/4/2020	4/4/2020	CD
cord-325956-1kxxg0s9	65	32	0900	0900	CD
cord-325956-1kxxg0s9	65	33	BST	BST	NNP
cord-325956-1kxxg0s9	65	34	)	)	-RRB-
cord-325956-1kxxg0s9	65	35	for	for	IN
cord-325956-1kxxg0s9	65	36	each	each	DT
cord-325956-1kxxg0s9	65	37	country	country	NN
cord-325956-1kxxg0s9	65	38	2	2	CD
cord-325956-1kxxg0s9	65	39	)	)	-RRB-
cord-325956-1kxxg0s9	65	40	rates	rate	NNS
cord-325956-1kxxg0s9	65	41	adjusted	adjust	VBN
cord-325956-1kxxg0s9	65	42	according	accord	VBG
cord-325956-1kxxg0s9	65	43	to	to	IN
cord-325956-1kxxg0s9	65	44	the	the	DT
cord-325956-1kxxg0s9	65	45	countries	country	NNS
cord-325956-1kxxg0s9	65	46	who	who	WP
cord-325956-1kxxg0s9	65	47	conducted	conduct	VBD
cord-325956-1kxxg0s9	65	48	at	at	IN
cord-325956-1kxxg0s9	65	49	least	least	JJS
cord-325956-1kxxg0s9	65	50	100000	100000	CD
cord-325956-1kxxg0s9	65	51	tests	test	NNS
cord-325956-1kxxg0s9	65	52	and	and	CC
cord-325956-1kxxg0s9	65	53	3	3	CD
cord-325956-1kxxg0s9	65	54	)	)	-RRB-
cord-325956-1kxxg0s9	65	55	rates	rate	NNS
cord-325956-1kxxg0s9	65	56	adjusted	adjust	VBN
cord-325956-1kxxg0s9	65	57	according	accord	VBG
cord-325956-1kxxg0s9	65	58	to	to	IN
cord-325956-1kxxg0s9	65	59	South	South	NNP
cord-325956-1kxxg0s9	65	60	Korea	Korea	NNP
cord-325956-1kxxg0s9	65	61	.	.	.
cord-325956-1kxxg0s9	66	1	Our	-PRON-	PRP$
cord-325956-1kxxg0s9	66	2	analyses	analysis	NNS
cord-325956-1kxxg0s9	66	3	are	be	VBP
cord-325956-1kxxg0s9	66	4	shown	show	VBN
cord-325956-1kxxg0s9	66	5	in	in	IN
cord-325956-1kxxg0s9	66	6	the	the	DT
cord-325956-1kxxg0s9	66	7	tables	table	NNS
cord-325956-1kxxg0s9	66	8	and	and	CC
cord-325956-1kxxg0s9	66	9	figures	figure	NNS
cord-325956-1kxxg0s9	66	10	.	.	.
cord-325956-1kxxg0s9	67	1	No	no	DT
cord-325956-1kxxg0s9	67	2	additional	additional	JJ
cord-325956-1kxxg0s9	67	3	analyses	analysis	NNS
cord-325956-1kxxg0s9	67	4	were	be	VBD
cord-325956-1kxxg0s9	67	5	performed	perform	VBN
cord-325956-1kxxg0s9	67	6	.	.	.
cord-325956-1kxxg0s9	67	7	.	.	.
cord-325956-1kxxg0s9	68	1	CC	CC	NNP
cord-325956-1kxxg0s9	68	2	-	-	:
cord-325956-1kxxg0s9	68	3	BY	by	IN
cord-325956-1kxxg0s9	68	4	4.0	4.0	CD
cord-325956-1kxxg0s9	68	5	International	international	JJ
cord-325956-1kxxg0s9	68	6	license	license	NN
cord-325956-1kxxg0s9	69	1	It	-PRON-	PRP
cord-325956-1kxxg0s9	69	2	is	be	VBZ
cord-325956-1kxxg0s9	69	3	made	make	VBN
cord-325956-1kxxg0s9	69	4	available	available	JJ
cord-325956-1kxxg0s9	69	5	under	under	IN
cord-325956-1kxxg0s9	69	6	a	a	DT
cord-325956-1kxxg0s9	70	1	is	be	VBZ
cord-325956-1kxxg0s9	70	2	the	the	DT
cord-325956-1kxxg0s9	70	3	author	author	NN
cord-325956-1kxxg0s9	70	4	/	/	SYM
cord-325956-1kxxg0s9	70	5	funder	funder	NN
cord-325956-1kxxg0s9	70	6	,	,	,
cord-325956-1kxxg0s9	70	7	who	who	WP
cord-325956-1kxxg0s9	70	8	has	have	VBZ
cord-325956-1kxxg0s9	70	9	granted	grant	VBN
cord-325956-1kxxg0s9	70	10	medRxiv	medRxiv	NNS
cord-325956-1kxxg0s9	70	11	a	a	DT
cord-325956-1kxxg0s9	70	12	license	license	NN
cord-325956-1kxxg0s9	70	13	to	to	TO
cord-325956-1kxxg0s9	70	14	display	display	VB
cord-325956-1kxxg0s9	70	15	the	the	DT
cord-325956-1kxxg0s9	70	16	preprint	preprint	NN
cord-325956-1kxxg0s9	70	17	in	in	IN
cord-325956-1kxxg0s9	70	18	perpetuity	perpetuity	NN
cord-325956-1kxxg0s9	70	19	.	.	.
cord-325956-1kxxg0s9	71	1	The	the	DT
cord-325956-1kxxg0s9	71	2	copyright	copyright	NN
cord-325956-1kxxg0s9	71	3	holder	holder	NN
cord-325956-1kxxg0s9	71	4	for	for	IN
cord-325956-1kxxg0s9	71	5	this	this	DT
cord-325956-1kxxg0s9	71	6	preprint	preprint	NN
cord-325956-1kxxg0s9	71	7	.	.	.
cord-325956-1kxxg0s9	72	1	https://doi.org/10.1101/2020.04.06.20054239	https://doi.org/10.1101/2020.04.06.20054239	NNP
cord-325956-1kxxg0s9	72	2	doi	doi	NN
cord-325956-1kxxg0s9	72	3	:	:	:
cord-325956-1kxxg0s9	73	1	medRxiv	medRxiv	NNP
cord-325956-1kxxg0s9	73	2	preprint	preprint	NN
cord-325956-1kxxg0s9	73	3	Full	Full	NNP
cord-325956-1kxxg0s9	73	4	data	datum	NNS
cord-325956-1kxxg0s9	73	5	obtained	obtain	VBN
cord-325956-1kxxg0s9	73	6	on	on	IN
cord-325956-1kxxg0s9	73	7	4/4/2020	4/4/2020	CD
cord-325956-1kxxg0s9	73	8	are	be	VBP
cord-325956-1kxxg0s9	73	9	shown	show	VBN
cord-325956-1kxxg0s9	73	10	in	in	IN
cord-325956-1kxxg0s9	73	11	Table	Table	NNP
cord-325956-1kxxg0s9	73	12	1	1	CD
cord-325956-1kxxg0s9	73	13	for	for	IN
cord-325956-1kxxg0s9	73	14	the	the	DT
cord-325956-1kxxg0s9	73	15	top	top	JJ
cord-325956-1kxxg0s9	73	16	50	50	CD
cord-325956-1kxxg0s9	73	17	countries	country	NNS
cord-325956-1kxxg0s9	73	18	with	with	IN
cord-325956-1kxxg0s9	73	19	highest	high	JJS
cord-325956-1kxxg0s9	73	20	number	number	NN
cord-325956-1kxxg0s9	73	21	of	of	IN
cord-325956-1kxxg0s9	73	22	COVID-19	covid-19	JJ
cord-325956-1kxxg0s9	73	23	cases	case	NNS
cord-325956-1kxxg0s9	73	24	in	in	IN
cord-325956-1kxxg0s9	73	25	the	the	DT
cord-325956-1kxxg0s9	73	26	world	world	NN
cord-325956-1kxxg0s9	73	27	.	.	.
cord-325956-1kxxg0s9	74	1	Table	table	NN
cord-325956-1kxxg0s9	74	2	2	2	CD
cord-325956-1kxxg0s9	74	3	shows	show	VBZ
cord-325956-1kxxg0s9	74	4	the	the	DT
cord-325956-1kxxg0s9	74	5	countries	country	NNS
cord-325956-1kxxg0s9	74	6	according	accord	VBG
cord-325956-1kxxg0s9	74	7	to	to	IN
cord-325956-1kxxg0s9	74	8	number	number	NN
cord-325956-1kxxg0s9	74	9	of	of	IN
cord-325956-1kxxg0s9	74	10	tests	test	NNS
cord-325956-1kxxg0s9	74	11	performed	perform	VBN
cord-325956-1kxxg0s9	74	12	per	per	IN
cord-325956-1kxxg0s9	74	13	positive	positive	JJ
cord-325956-1kxxg0s9	74	14	diagnosed	diagnose	VBN
cord-325956-1kxxg0s9	74	15	COVID-19	covid-19	CD
cord-325956-1kxxg0s9	74	16	cases	case	NNS
cord-325956-1kxxg0s9	74	17	.	.	.
cord-325956-1kxxg0s9	75	1	Table	table	NN
cord-325956-1kxxg0s9	75	2	3	3	CD
cord-325956-1kxxg0s9	75	3	shows	show	VBZ
cord-325956-1kxxg0s9	75	4	population	population	NN
cord-325956-1kxxg0s9	75	5	level	level	NN
cord-325956-1kxxg0s9	75	6	pandemic	pandemic	NN
cord-325956-1kxxg0s9	75	7	projections	projection	NNS
cord-325956-1kxxg0s9	75	8	for	for	IN
cord-325956-1kxxg0s9	75	9	cases	case	NNS
cord-325956-1kxxg0s9	75	10	and	and	CC
cord-325956-1kxxg0s9	75	11	deaths	death	NNS
cord-325956-1kxxg0s9	75	12	according	accord	VBG
cord-325956-1kxxg0s9	75	13	to	to	IN
cord-325956-1kxxg0s9	75	14	each	each	DT
cord-325956-1kxxg0s9	75	15	individual	individual	JJ
cord-325956-1kxxg0s9	75	16	country	country	NN
cord-325956-1kxxg0s9	75	17	's	's	POS
cord-325956-1kxxg0s9	75	18	case	case	NN
cord-325956-1kxxg0s9	75	19	per	per	IN
cord-325956-1kxxg0s9	75	20	test	test	NN
cord-325956-1kxxg0s9	75	21	and	and	CC
cord-325956-1kxxg0s9	75	22	death	death	NN
cord-325956-1kxxg0s9	75	23	per	per	IN
cord-325956-1kxxg0s9	75	24	test	test	NN
cord-325956-1kxxg0s9	75	25	rate	rate	NN
cord-325956-1kxxg0s9	75	26	on	on	IN
cord-325956-1kxxg0s9	75	27	4/4/2020	4/4/2020	CD
cord-325956-1kxxg0s9	75	28	0900	0900	CD
cord-325956-1kxxg0s9	75	29	BST	bst	NN
cord-325956-1kxxg0s9	75	30	.	.	.
cord-325956-1kxxg0s9	76	1	Table	table	NN
cord-325956-1kxxg0s9	76	2	4	4	CD
cord-325956-1kxxg0s9	76	3	shows	show	VBZ
cord-325956-1kxxg0s9	76	4	population	population	NN
cord-325956-1kxxg0s9	76	5	level	level	NN
cord-325956-1kxxg0s9	76	6	pandemic	pandemic	NN
cord-325956-1kxxg0s9	76	7	projections	projection	NNS
cord-325956-1kxxg0s9	76	8	adjusted	adjust	VBN
cord-325956-1kxxg0s9	76	9	for	for	IN
cord-325956-1kxxg0s9	76	10	the	the	DT
cord-325956-1kxxg0s9	76	11	combined	combine	VBN
cord-325956-1kxxg0s9	76	12	case	case	NN
cord-325956-1kxxg0s9	76	13	per	per	IN
cord-325956-1kxxg0s9	76	14	test	test	NN
cord-325956-1kxxg0s9	76	15	and	and	CC
cord-325956-1kxxg0s9	76	16	death	death	NN
cord-325956-1kxxg0s9	76	17	per	per	IN
cord-325956-1kxxg0s9	76	18	test	test	NN
cord-325956-1kxxg0s9	76	19	rate	rate	NN
cord-325956-1kxxg0s9	76	20	of	of	IN
cord-325956-1kxxg0s9	76	21	the	the	DT
cord-325956-1kxxg0s9	76	22	15	15	CD
cord-325956-1kxxg0s9	76	23	countries	country	NNS
cord-325956-1kxxg0s9	76	24	group	group	NN
cord-325956-1kxxg0s9	76	25	that	that	WDT
cord-325956-1kxxg0s9	76	26	have	have	VBP
cord-325956-1kxxg0s9	76	27	performed	perform	VBN
cord-325956-1kxxg0s9	76	28	at	at	IN
cord-325956-1kxxg0s9	76	29	least	least	JJS
cord-325956-1kxxg0s9	76	30	100000	100000	CD
cord-325956-1kxxg0s9	76	31	tests	test	NNS
cord-325956-1kxxg0s9	76	32	.	.	.
cord-325956-1kxxg0s9	77	1	Table	table	NN
cord-325956-1kxxg0s9	77	2	5	5	CD
cord-325956-1kxxg0s9	77	3	shows	show	VBZ
cord-325956-1kxxg0s9	77	4	the	the	DT
cord-325956-1kxxg0s9	77	5	population	population	NN
cord-325956-1kxxg0s9	77	6	level	level	NN
cord-325956-1kxxg0s9	77	7	pandemic	pandemic	NN
cord-325956-1kxxg0s9	77	8	projections	projection	NNS
cord-325956-1kxxg0s9	77	9	adjusted	adjust	VBN
cord-325956-1kxxg0s9	77	10	for	for	IN
cord-325956-1kxxg0s9	77	11	the	the	DT
cord-325956-1kxxg0s9	77	12	case	case	NN
cord-325956-1kxxg0s9	77	13	per	per	IN
cord-325956-1kxxg0s9	77	14	test	test	NN
cord-325956-1kxxg0s9	77	15	and	and	CC
cord-325956-1kxxg0s9	77	16	death	death	NN
cord-325956-1kxxg0s9	77	17	per	per	IN
cord-325956-1kxxg0s9	77	18	test	test	NN
cord-325956-1kxxg0s9	77	19	rate	rate	NN
cord-325956-1kxxg0s9	77	20	of	of	IN
cord-325956-1kxxg0s9	77	21	South	South	NNP
cord-325956-1kxxg0s9	77	22	Korea	Korea	NNP
cord-325956-1kxxg0s9	77	23	.	.	.
cord-325956-1kxxg0s9	78	1	Figure	figure	NN
cord-325956-1kxxg0s9	78	2	1	1	CD
cord-325956-1kxxg0s9	78	3	show	show	VBP
cord-325956-1kxxg0s9	78	4	a	a	DT
cord-325956-1kxxg0s9	78	5	scatter	scatter	NN
cord-325956-1kxxg0s9	78	6	plot	plot	NN
cord-325956-1kxxg0s9	78	7	to	to	TO
cord-325956-1kxxg0s9	78	8	show	show	VB
cord-325956-1kxxg0s9	78	9	the	the	DT
cord-325956-1kxxg0s9	78	10	relationship	relationship	NN
cord-325956-1kxxg0s9	78	11	between	between	IN
cord-325956-1kxxg0s9	78	12	the	the	DT
cord-325956-1kxxg0s9	78	13	case	case	NN
cord-325956-1kxxg0s9	78	14	fatality	fatality	NN
cord-325956-1kxxg0s9	78	15	rate	rate	NN
cord-325956-1kxxg0s9	78	16	and	and	CC
cord-325956-1kxxg0s9	78	17	the	the	DT
cord-325956-1kxxg0s9	78	18	testing	testing	NN
cord-325956-1kxxg0s9	78	19	rate	rate	NN
cord-325956-1kxxg0s9	78	20	as	as	IN
cord-325956-1kxxg0s9	78	21	a	a	DT
cord-325956-1kxxg0s9	78	22	percentage	percentage	NN
cord-325956-1kxxg0s9	78	23	of	of	IN
cord-325956-1kxxg0s9	78	24	the	the	DT
cord-325956-1kxxg0s9	78	25	total	total	JJ
cord-325956-1kxxg0s9	78	26	population	population	NN
cord-325956-1kxxg0s9	78	27	of	of	IN
cord-325956-1kxxg0s9	78	28	the	the	DT
cord-325956-1kxxg0s9	78	29	country	country	NN
cord-325956-1kxxg0s9	78	30	for	for	IN
cord-325956-1kxxg0s9	78	31	the	the	DT
cord-325956-1kxxg0s9	78	32	countries	country	NNS
cord-325956-1kxxg0s9	78	33	which	which	WDT
cord-325956-1kxxg0s9	78	34	have	have	VBP
cord-325956-1kxxg0s9	78	35	tested	test	VBN
cord-325956-1kxxg0s9	78	36	at	at	IN
cord-325956-1kxxg0s9	78	37	least	least	JJS
cord-325956-1kxxg0s9	78	38	1	1	CD
cord-325956-1kxxg0s9	78	39	%	%	NN
cord-325956-1kxxg0s9	78	40	of	of	IN
cord-325956-1kxxg0s9	78	41	their	-PRON-	PRP$
cord-325956-1kxxg0s9	78	42	total	total	JJ
cord-325956-1kxxg0s9	78	43	population	population	NN
cord-325956-1kxxg0s9	78	44	.	.	.
cord-325956-1kxxg0s9	79	1	Italy	Italy	NNP
cord-325956-1kxxg0s9	79	2	was	be	VBD
cord-325956-1kxxg0s9	79	3	excluded	exclude	VBN
cord-325956-1kxxg0s9	79	4	from	from	IN
cord-325956-1kxxg0s9	79	5	this	this	DT
cord-325956-1kxxg0s9	79	6	scatter	scatter	NN
cord-325956-1kxxg0s9	79	7	plot	plot	NN
cord-325956-1kxxg0s9	79	8	as	as	IN
cord-325956-1kxxg0s9	79	9	it	-PRON-	PRP
cord-325956-1kxxg0s9	79	10	was	be	VBD
cord-325956-1kxxg0s9	79	11	an	an	DT
cord-325956-1kxxg0s9	79	12	outlier	outlier	NN
cord-325956-1kxxg0s9	79	13	with	with	IN
cord-325956-1kxxg0s9	79	14	a	a	DT
cord-325956-1kxxg0s9	79	15	case	case	NN
cord-325956-1kxxg0s9	79	16	fatality	fatality	NN
cord-325956-1kxxg0s9	79	17	rate	rate	NN
cord-325956-1kxxg0s9	79	18	of	of	IN
cord-325956-1kxxg0s9	79	19	12.25	12.25	CD
cord-325956-1kxxg0s9	79	20	%	%	NN
cord-325956-1kxxg0s9	79	21	.	.	.
cord-325956-1kxxg0s9	79	22	.	.	.
cord-325956-1kxxg0s9	80	1	CC	CC	NNP
cord-325956-1kxxg0s9	80	2	-	-	:
cord-325956-1kxxg0s9	80	3	BY	by	IN
cord-325956-1kxxg0s9	80	4	4.0	4.0	CD
cord-325956-1kxxg0s9	80	5	International	international	JJ
cord-325956-1kxxg0s9	80	6	license	license	NN
cord-325956-1kxxg0s9	81	1	It	-PRON-	PRP
cord-325956-1kxxg0s9	81	2	is	be	VBZ
cord-325956-1kxxg0s9	81	3	made	make	VBN
cord-325956-1kxxg0s9	81	4	available	available	JJ
cord-325956-1kxxg0s9	81	5	under	under	IN
cord-325956-1kxxg0s9	81	6	a	a	DT
cord-325956-1kxxg0s9	82	1	is	be	VBZ
cord-325956-1kxxg0s9	82	2	the	the	DT
cord-325956-1kxxg0s9	82	3	author	author	NN
cord-325956-1kxxg0s9	82	4	/	/	SYM
cord-325956-1kxxg0s9	82	5	funder	funder	NN
cord-325956-1kxxg0s9	82	6	,	,	,
cord-325956-1kxxg0s9	82	7	who	who	WP
cord-325956-1kxxg0s9	82	8	has	have	VBZ
cord-325956-1kxxg0s9	82	9	granted	grant	VBN
cord-325956-1kxxg0s9	82	10	medRxiv	medRxiv	NNS
cord-325956-1kxxg0s9	82	11	a	a	DT
cord-325956-1kxxg0s9	82	12	license	license	NN
cord-325956-1kxxg0s9	82	13	to	to	TO
cord-325956-1kxxg0s9	82	14	display	display	VB
cord-325956-1kxxg0s9	82	15	the	the	DT
cord-325956-1kxxg0s9	82	16	preprint	preprint	NN
cord-325956-1kxxg0s9	82	17	in	in	IN
cord-325956-1kxxg0s9	82	18	perpetuity	perpetuity	NN
cord-325956-1kxxg0s9	82	19	.	.	.
cord-325956-1kxxg0s9	83	1	The	the	DT
cord-325956-1kxxg0s9	83	2	copyright	copyright	NN
cord-325956-1kxxg0s9	83	3	holder	holder	NN
cord-325956-1kxxg0s9	83	4	for	for	IN
cord-325956-1kxxg0s9	83	5	this	this	DT
cord-325956-1kxxg0s9	83	6	preprint	preprint	NN
cord-325956-1kxxg0s9	83	7	.	.	.
cord-325956-1kxxg0s9	84	1	https://doi.org/10.1101/2020.04.06.20054239	https://doi.org/10.1101/2020.04.06.20054239	NNP
cord-325956-1kxxg0s9	84	2	doi	doi	NN
cord-325956-1kxxg0s9	84	3	:	:	:
cord-325956-1kxxg0s9	85	1	medRxiv	medRxiv	NNP
cord-325956-1kxxg0s9	85	2	preprint	preprint	NNP
cord-325956-1kxxg0s9	85	3	Discussion	Discussion	NNP
cord-325956-1kxxg0s9	86	1	COVID-19	COVID-19	NNP
cord-325956-1kxxg0s9	86	2	statistics	statistic	NNS
cord-325956-1kxxg0s9	86	3	are	be	VBP
cord-325956-1kxxg0s9	86	4	complex	complex	JJ
cord-325956-1kxxg0s9	86	5	and	and	CC
cord-325956-1kxxg0s9	86	6	comparing	compare	VBG
cord-325956-1kxxg0s9	86	7	different	different	JJ
cord-325956-1kxxg0s9	86	8	countries	country	NNS
cord-325956-1kxxg0s9	86	9	based	base	VBN
cord-325956-1kxxg0s9	86	10	on	on	IN
cord-325956-1kxxg0s9	86	11	number	number	NN
cord-325956-1kxxg0s9	86	12	of	of	IN
cord-325956-1kxxg0s9	86	13	total	total	JJ
cord-325956-1kxxg0s9	86	14	cases	case	NNS
cord-325956-1kxxg0s9	86	15	,	,	,
cord-325956-1kxxg0s9	86	16	deaths	death	NNS
cord-325956-1kxxg0s9	86	17	and/or	and/or	CC
cord-325956-1kxxg0s9	86	18	case	case	NN
cord-325956-1kxxg0s9	87	1	fatality	fatality	NN
cord-325956-1kxxg0s9	87	2	rate	rate	NN
cord-325956-1kxxg0s9	87	3	does	do	VBZ
cord-325956-1kxxg0s9	87	4	not	not	RB
cord-325956-1kxxg0s9	87	5	show	show	VB
cord-325956-1kxxg0s9	87	6	the	the	DT
cord-325956-1kxxg0s9	87	7	complete	complete	JJ
cord-325956-1kxxg0s9	87	8	picture	picture	NN
cord-325956-1kxxg0s9	87	9	(	(	-LRB-
cord-325956-1kxxg0s9	87	10	Table	table	NN
cord-325956-1kxxg0s9	87	11	1	1	CD
cord-325956-1kxxg0s9	87	12	)	)	-RRB-
cord-325956-1kxxg0s9	87	13	.	.	.
cord-325956-1kxxg0s9	88	1	A	a	DT
cord-325956-1kxxg0s9	88	2	common	common	JJ
cord-325956-1kxxg0s9	88	3	denominator	denominator	NN
cord-325956-1kxxg0s9	88	4	is	be	VBZ
cord-325956-1kxxg0s9	88	5	required	require	VBN
cord-325956-1kxxg0s9	88	6	to	to	TO
cord-325956-1kxxg0s9	88	7	make	make	VB
cord-325956-1kxxg0s9	88	8	senses	sense	NNS
cord-325956-1kxxg0s9	88	9	of	of	IN
cord-325956-1kxxg0s9	88	10	these	these	DT
cord-325956-1kxxg0s9	88	11	numbers	number	NNS
cord-325956-1kxxg0s9	88	12	and	and	CC
cord-325956-1kxxg0s9	88	13	we	-PRON-	PRP
cord-325956-1kxxg0s9	88	14	propose	propose	VBP
cord-325956-1kxxg0s9	88	15	that	that	IN
cord-325956-1kxxg0s9	88	16	this	this	DT
cord-325956-1kxxg0s9	88	17	denominator	denominator	NN
cord-325956-1kxxg0s9	88	18	is	be	VBZ
cord-325956-1kxxg0s9	88	19	the	the	DT
cord-325956-1kxxg0s9	88	20	number	number	NN
cord-325956-1kxxg0s9	88	21	of	of	IN
cord-325956-1kxxg0s9	88	22	diagnostic	diagnostic	JJ
cord-325956-1kxxg0s9	88	23	tests	test	NNS
cord-325956-1kxxg0s9	88	24	performed	perform	VBN
cord-325956-1kxxg0s9	88	25	.	.	.
cord-325956-1kxxg0s9	89	1	In	in	IN
cord-325956-1kxxg0s9	89	2	our	-PRON-	PRP$
cord-325956-1kxxg0s9	89	3	analyses	analysis	NNS
cord-325956-1kxxg0s9	89	4	we	-PRON-	PRP
cord-325956-1kxxg0s9	89	5	showed	show	VBD
cord-325956-1kxxg0s9	89	6	the	the	DT
cord-325956-1kxxg0s9	89	7	deaths	death	NNS
cord-325956-1kxxg0s9	89	8	and	and	CC
cord-325956-1kxxg0s9	89	9	cases	case	NNS
cord-325956-1kxxg0s9	89	10	in	in	IN
cord-325956-1kxxg0s9	89	11	relation	relation	NN
cord-325956-1kxxg0s9	89	12	to	to	IN
cord-325956-1kxxg0s9	89	13	the	the	DT
cord-325956-1kxxg0s9	89	14	number	number	NN
cord-325956-1kxxg0s9	89	15	of	of	IN
cord-325956-1kxxg0s9	89	16	tests	test	NNS
cord-325956-1kxxg0s9	89	17	performed	perform	VBN
cord-325956-1kxxg0s9	89	18	and	and	CC
cord-325956-1kxxg0s9	89	19	presented	present	VBD
cord-325956-1kxxg0s9	89	20	population	population	NN
cord-325956-1kxxg0s9	89	21	level	level	NN
cord-325956-1kxxg0s9	89	22	pandemic	pandemic	NN
cord-325956-1kxxg0s9	89	23	projections	projection	NNS
cord-325956-1kxxg0s9	89	24	based	base	VBN
cord-325956-1kxxg0s9	89	25	on	on	IN
cord-325956-1kxxg0s9	89	26	these	these	DT
cord-325956-1kxxg0s9	89	27	.	.	.
cord-325956-1kxxg0s9	90	1	This	this	DT
cord-325956-1kxxg0s9	90	2	is	be	VBZ
cord-325956-1kxxg0s9	90	3	particularly	particularly	RB
cord-325956-1kxxg0s9	90	4	relevant	relevant	JJ
cord-325956-1kxxg0s9	90	5	in	in	IN
cord-325956-1kxxg0s9	90	6	the	the	DT
cord-325956-1kxxg0s9	90	7	current	current	JJ
cord-325956-1kxxg0s9	90	8	environment	environment	NN
cord-325956-1kxxg0s9	90	9	where	where	WRB
cord-325956-1kxxg0s9	90	10	testing	testing	NN
cord-325956-1kxxg0s9	90	11	parameters	parameter	NNS
cord-325956-1kxxg0s9	90	12	vary	vary	VBP
cord-325956-1kxxg0s9	90	13	across	across	IN
cord-325956-1kxxg0s9	90	14	different	different	JJ
cord-325956-1kxxg0s9	90	15	countries	country	NNS
cord-325956-1kxxg0s9	90	16	leading	lead	VBG
cord-325956-1kxxg0s9	90	17	to	to	IN
cord-325956-1kxxg0s9	90	18	non	non	JJ
cord-325956-1kxxg0s9	90	19	-	-	JJ
cord-325956-1kxxg0s9	90	20	uniformity	uniformity	NN
cord-325956-1kxxg0s9	90	21	in	in	IN
cord-325956-1kxxg0s9	90	22	projections	projection	NNS
cord-325956-1kxxg0s9	90	23	.	.	.
cord-325956-1kxxg0s9	91	1	It	-PRON-	PRP
cord-325956-1kxxg0s9	91	2	is	be	VBZ
cord-325956-1kxxg0s9	91	3	important	important	JJ
cord-325956-1kxxg0s9	91	4	to	to	TO
cord-325956-1kxxg0s9	91	5	discuss	discuss	VB
cord-325956-1kxxg0s9	91	6	each	each	DT
cord-325956-1kxxg0s9	91	7	of	of	IN
cord-325956-1kxxg0s9	91	8	our	-PRON-	PRP$
cord-325956-1kxxg0s9	91	9	different	different	JJ
cord-325956-1kxxg0s9	91	10	analyses	analysis	NNS
cord-325956-1kxxg0s9	91	11	in	in	IN
cord-325956-1kxxg0s9	91	12	turn	turn	NN
cord-325956-1kxxg0s9	91	13	,	,	,
cord-325956-1kxxg0s9	91	14	the	the	DT
cord-325956-1kxxg0s9	91	15	rationale	rationale	NN
cord-325956-1kxxg0s9	91	16	,	,	,
cord-325956-1kxxg0s9	91	17	drawbacks	drawback	NNS
cord-325956-1kxxg0s9	91	18	and	and	CC
cord-325956-1kxxg0s9	91	19	what	what	WP
cord-325956-1kxxg0s9	91	20	it	-PRON-	PRP
cord-325956-1kxxg0s9	91	21	means	mean	VBZ
cord-325956-1kxxg0s9	91	22	for	for	IN
cord-325956-1kxxg0s9	91	23	different	different	JJ
cord-325956-1kxxg0s9	91	24	countries	country	NNS
cord-325956-1kxxg0s9	91	25	.	.	.
cord-325956-1kxxg0s9	92	1	As	as	IN
cord-325956-1kxxg0s9	92	2	table	table	NN
cord-325956-1kxxg0s9	92	3	2	2	CD
cord-325956-1kxxg0s9	92	4	shows	show	NNS
cord-325956-1kxxg0s9	92	5	,	,	,
cord-325956-1kxxg0s9	92	6	the	the	DT
cord-325956-1kxxg0s9	92	7	number	number	NN
cord-325956-1kxxg0s9	92	8	of	of	IN
cord-325956-1kxxg0s9	92	9	tests	test	NNS
cord-325956-1kxxg0s9	92	10	per	per	IN
cord-325956-1kxxg0s9	92	11	positive	positive	JJ
cord-325956-1kxxg0s9	92	12	case	case	NN
cord-325956-1kxxg0s9	92	13	is	be	VBZ
cord-325956-1kxxg0s9	92	14	an	an	DT
cord-325956-1kxxg0s9	92	15	important	important	JJ
cord-325956-1kxxg0s9	92	16	parameter	parameter	NN
cord-325956-1kxxg0s9	92	17	because	because	IN
cord-325956-1kxxg0s9	92	18	it	-PRON-	PRP
cord-325956-1kxxg0s9	92	19	is	be	VBZ
cord-325956-1kxxg0s9	92	20	an	an	DT
cord-325956-1kxxg0s9	92	21	indication	indication	NN
cord-325956-1kxxg0s9	92	22	of	of	IN
cord-325956-1kxxg0s9	92	23	how	how	WRB
cord-325956-1kxxg0s9	92	24	widely	widely	RB
cord-325956-1kxxg0s9	92	25	the	the	DT
cord-325956-1kxxg0s9	92	26	testing	testing	NN
cord-325956-1kxxg0s9	92	27	policy	policy	NN
cord-325956-1kxxg0s9	92	28	of	of	IN
cord-325956-1kxxg0s9	92	29	the	the	DT
cord-325956-1kxxg0s9	92	30	respective	respective	JJ
cord-325956-1kxxg0s9	92	31	country	country	NN
cord-325956-1kxxg0s9	92	32	has	have	VBZ
cord-325956-1kxxg0s9	92	33	followed	follow	VBN
cord-325956-1kxxg0s9	92	34	the	the	DT
cord-325956-1kxxg0s9	92	35	advice	advice	NN
cord-325956-1kxxg0s9	92	36	from	from	IN
cord-325956-1kxxg0s9	92	37	the	the	DT
cord-325956-1kxxg0s9	92	38	World	World	NNP
cord-325956-1kxxg0s9	92	39	Health	Health	NNP
cord-325956-1kxxg0s9	92	40	Organisation	Organisation	NNP
cord-325956-1kxxg0s9	92	41	(	(	-LRB-
cord-325956-1kxxg0s9	92	42	WHO	who	WP
cord-325956-1kxxg0s9	92	43	)	)	-RRB-
cord-325956-1kxxg0s9	92	44	1	1	CD
cord-325956-1kxxg0s9	92	45	high	high	JJ
cord-325956-1kxxg0s9	92	46	as	as	IN
cord-325956-1kxxg0s9	92	47	the	the	DT
cord-325956-1kxxg0s9	92	48	raw	raw	JJ
cord-325956-1kxxg0s9	92	49	data	datum	NNS
cord-325956-1kxxg0s9	92	50	obtain	obtain	VBP
cord-325956-1kxxg0s9	92	51	from	from	IN
cord-325956-1kxxg0s9	92	52	this	this	DT
cord-325956-1kxxg0s9	92	53	source	source	NN
cord-325956-1kxxg0s9	92	54	but	but	CC
cord-325956-1kxxg0s9	92	55	for	for	IN
cord-325956-1kxxg0s9	92	56	consistency	consistency	NN
cord-325956-1kxxg0s9	92	57	in	in	IN
cord-325956-1kxxg0s9	92	58	dealing	deal	VBG
cord-325956-1kxxg0s9	92	59	with	with	IN
cord-325956-1kxxg0s9	92	60	all	all	PDT
cord-325956-1kxxg0s9	92	61	the	the	DT
cord-325956-1kxxg0s9	92	62	raw	raw	JJ
cord-325956-1kxxg0s9	92	63	data	datum	NNS
cord-325956-1kxxg0s9	92	64	in	in	IN
cord-325956-1kxxg0s9	92	65	the	the	DT
cord-325956-1kxxg0s9	92	66	same	same	JJ
cord-325956-1kxxg0s9	92	67	way	way	NN
cord-325956-1kxxg0s9	92	68	,	,	,
cord-325956-1kxxg0s9	92	69	we	-PRON-	PRP
cord-325956-1kxxg0s9	92	70	analysed	analyse	VBD
cord-325956-1kxxg0s9	92	71	according	accord	VBG
cord-325956-1kxxg0s9	92	72	to	to	IN
cord-325956-1kxxg0s9	92	73	the	the	DT
cord-325956-1kxxg0s9	92	74	data	datum	NNS
cord-325956-1kxxg0s9	92	75	obtained	obtain	VBN
cord-325956-1kxxg0s9	92	76	from	from	IN
cord-325956-1kxxg0s9	92	77	Worldometer	Worldometer	NNP
cord-325956-1kxxg0s9	92	78	.	.	.
cord-325956-1kxxg0s9	93	1	Of	of	RB
cord-325956-1kxxg0s9	93	2	course	course	RB
cord-325956-1kxxg0s9	93	3	similar	similar	JJ
cord-325956-1kxxg0s9	93	4	bias	bias	NN
cord-325956-1kxxg0s9	93	5	could	could	MD
cord-325956-1kxxg0s9	93	6	be	be	VB
cord-325956-1kxxg0s9	93	7	inherent	inherent	JJ
cord-325956-1kxxg0s9	93	8	for	for	IN
cord-325956-1kxxg0s9	93	9	the	the	DT
cord-325956-1kxxg0s9	93	10	testing	testing	NN
cord-325956-1kxxg0s9	93	11	data	datum	NNS
cord-325956-1kxxg0s9	93	12	for	for	IN
cord-325956-1kxxg0s9	93	13	all	all	DT
cord-325956-1kxxg0s9	93	14	countries	country	NNS
cord-325956-1kxxg0s9	93	15	but	but	CC
cord-325956-1kxxg0s9	93	16	in	in	IN
cord-325956-1kxxg0s9	93	17	our	-PRON-	PRP$
cord-325956-1kxxg0s9	93	18	defence	defence	NN
cord-325956-1kxxg0s9	93	19	we	-PRON-	PRP
cord-325956-1kxxg0s9	93	20	have	have	VBP
cord-325956-1kxxg0s9	93	21	treated	treat	VBN
cord-325956-1kxxg0s9	93	22	all	all	PDT
cord-325956-1kxxg0s9	93	23	the	the	DT
cord-325956-1kxxg0s9	93	24	raw	raw	JJ
cord-325956-1kxxg0s9	93	25	data	datum	NNS
cord-325956-1kxxg0s9	93	26	obtained	obtain	VBN
cord-325956-1kxxg0s9	93	27	in	in	IN
cord-325956-1kxxg0s9	93	28	the	the	DT
cord-325956-1kxxg0s9	93	29	same	same	JJ
cord-325956-1kxxg0s9	93	30	way	way	NN
cord-325956-1kxxg0s9	93	31	for	for	IN
cord-325956-1kxxg0s9	93	32	consistency	consistency	NN
cord-325956-1kxxg0s9	93	33	and	and	CC
cord-325956-1kxxg0s9	93	34	have	have	VBP
cord-325956-1kxxg0s9	93	35	opened	open	VBN
cord-325956-1kxxg0s9	93	36	up	up	RP
cord-325956-1kxxg0s9	93	37	the	the	DT
cord-325956-1kxxg0s9	93	38	data	datum	NNS
cord-325956-1kxxg0s9	93	39	for	for	IN
cord-325956-1kxxg0s9	93	40	scrutiny	scrutiny	NN
cord-325956-1kxxg0s9	93	41	.	.	.
cord-325956-1kxxg0s9	94	1	Another	another	DT
cord-325956-1kxxg0s9	94	2	important	important	JJ
cord-325956-1kxxg0s9	94	3	factor	factor	NN
cord-325956-1kxxg0s9	94	4	to	to	TO
cord-325956-1kxxg0s9	94	5	consider	consider	VB
cord-325956-1kxxg0s9	94	6	here	here	RB
cord-325956-1kxxg0s9	94	7	is	be	VBZ
cord-325956-1kxxg0s9	94	8	the	the	DT
cord-325956-1kxxg0s9	94	9	testing	testing	NN
cord-325956-1kxxg0s9	94	10	policy	policy	NN
cord-325956-1kxxg0s9	94	11	followed	follow	VBD
cord-325956-1kxxg0s9	94	12	in	in	IN
cord-325956-1kxxg0s9	94	13	these	these	DT
cord-325956-1kxxg0s9	94	14	countries	country	NNS
cord-325956-1kxxg0s9	94	15	.	.	.
cord-325956-1kxxg0s9	95	1	Are	be	VBP
cord-325956-1kxxg0s9	95	2	the	the	DT
cord-325956-1kxxg0s9	95	3	countries	country	NNS
cord-325956-1kxxg0s9	95	4	at	at	IN
cord-325956-1kxxg0s9	95	5	the	the	DT
cord-325956-1kxxg0s9	95	6	top	top	NN
cord-325956-1kxxg0s9	95	7	of	of	IN
cord-325956-1kxxg0s9	95	8	this	this	DT
cord-325956-1kxxg0s9	95	9	table	table	NN
cord-325956-1kxxg0s9	95	10	testing	test	VBG
cord-325956-1kxxg0s9	95	11	a	a	DT
cord-325956-1kxxg0s9	95	12	cohort	cohort	NN
cord-325956-1kxxg0s9	95	13	of	of	IN
cord-325956-1kxxg0s9	95	14	people	people	NNS
cord-325956-1kxxg0s9	95	15	who	who	WP
cord-325956-1kxxg0s9	95	16	have	have	VBP
cord-325956-1kxxg0s9	95	17	a	a	DT
cord-325956-1kxxg0s9	95	18	low	low	JJ
cord-325956-1kxxg0s9	95	19	possibility	possibility	NN
cord-325956-1kxxg0s9	95	20	of	of	IN
cord-325956-1kxxg0s9	95	21	carrying	carry	VBG
cord-325956-1kxxg0s9	95	22	this	this	DT
cord-325956-1kxxg0s9	95	23	.	.	.
cord-325956-1kxxg0s9	96	1	CC	CC	NNP
cord-325956-1kxxg0s9	96	2	-	-	:
cord-325956-1kxxg0s9	96	3	BY	by	IN
cord-325956-1kxxg0s9	96	4	4.0	4.0	CD
cord-325956-1kxxg0s9	96	5	International	international	JJ
cord-325956-1kxxg0s9	96	6	license	license	NN
cord-325956-1kxxg0s9	97	1	It	-PRON-	PRP
cord-325956-1kxxg0s9	97	2	is	be	VBZ
cord-325956-1kxxg0s9	97	3	made	make	VBN
cord-325956-1kxxg0s9	97	4	available	available	JJ
cord-325956-1kxxg0s9	97	5	under	under	IN
cord-325956-1kxxg0s9	97	6	a	a	DT
cord-325956-1kxxg0s9	98	1	is	be	VBZ
cord-325956-1kxxg0s9	98	2	the	the	DT
cord-325956-1kxxg0s9	98	3	author	author	NN
cord-325956-1kxxg0s9	98	4	/	/	SYM
cord-325956-1kxxg0s9	98	5	funder	funder	NN
cord-325956-1kxxg0s9	98	6	,	,	,
cord-325956-1kxxg0s9	98	7	who	who	WP
cord-325956-1kxxg0s9	98	8	has	have	VBZ
cord-325956-1kxxg0s9	98	9	granted	grant	VBN
cord-325956-1kxxg0s9	98	10	medRxiv	medRxiv	NNS
cord-325956-1kxxg0s9	98	11	a	a	DT
cord-325956-1kxxg0s9	98	12	license	license	NN
cord-325956-1kxxg0s9	98	13	to	to	TO
cord-325956-1kxxg0s9	98	14	display	display	VB
cord-325956-1kxxg0s9	98	15	the	the	DT
cord-325956-1kxxg0s9	98	16	preprint	preprint	NN
cord-325956-1kxxg0s9	98	17	in	in	IN
cord-325956-1kxxg0s9	98	18	perpetuity	perpetuity	NN
cord-325956-1kxxg0s9	98	19	.	.	.
cord-325956-1kxxg0s9	99	1	The	the	DT
cord-325956-1kxxg0s9	99	2	copyright	copyright	NN
cord-325956-1kxxg0s9	99	3	holder	holder	NN
cord-325956-1kxxg0s9	99	4	for	for	IN
cord-325956-1kxxg0s9	99	5	this	this	DT
cord-325956-1kxxg0s9	99	6	preprint	preprint	NN
cord-325956-1kxxg0s9	99	7	.	.	.
cord-325956-1kxxg0s9	100	1	https://doi.org/10.1101/2020.04.06.20054239	https://doi.org/10.1101/2020.04.06.20054239	NNP
cord-325956-1kxxg0s9	100	2	doi	doi	NN
cord-325956-1kxxg0s9	100	3	:	:	:
cord-325956-1kxxg0s9	101	1	medRxiv	medRxiv	NNS
cord-325956-1kxxg0s9	101	2	preprint	preprint	NN
cord-325956-1kxxg0s9	101	3	infection	infection	NN
cord-325956-1kxxg0s9	101	4	?	?	.
cord-325956-1kxxg0s9	102	1	If	if	IN
cord-325956-1kxxg0s9	102	2	only	only	RB
cord-325956-1kxxg0s9	102	3	those	those	DT
cord-325956-1kxxg0s9	102	4	with	with	IN
cord-325956-1kxxg0s9	102	5	symptoms	symptom	NNS
cord-325956-1kxxg0s9	102	6	are	be	VBP
cord-325956-1kxxg0s9	102	7	tested	test	VBN
cord-325956-1kxxg0s9	102	8	then	then	RB
cord-325956-1kxxg0s9	102	9	individuals	individual	NNS
cord-325956-1kxxg0s9	102	10	are	be	VBP
cord-325956-1kxxg0s9	102	11	more	more	RBR
cord-325956-1kxxg0s9	102	12	likely	likely	JJ
cord-325956-1kxxg0s9	102	13	to	to	TO
cord-325956-1kxxg0s9	102	14	test	test	VB
cord-325956-1kxxg0s9	102	15	positive	positive	JJ
cord-325956-1kxxg0s9	102	16	for	for	IN
cord-325956-1kxxg0s9	102	17	COVID-19	COVID-19	NNP
cord-325956-1kxxg0s9	102	18	leading	lead	VBG
cord-325956-1kxxg0s9	102	19	to	to	IN
cord-325956-1kxxg0s9	102	20	a	a	DT
cord-325956-1kxxg0s9	102	21	low	low	JJ
cord-325956-1kxxg0s9	102	22	test	test	NN
cord-325956-1kxxg0s9	102	23	per	per	IN
cord-325956-1kxxg0s9	102	24	positive	positive	JJ
cord-325956-1kxxg0s9	102	25	number	number	NN
cord-325956-1kxxg0s9	102	26	.	.	.
cord-325956-1kxxg0s9	103	1	If	if	IN
cord-325956-1kxxg0s9	103	2	these	these	DT
cord-325956-1kxxg0s9	103	3	countries	country	NNS
cord-325956-1kxxg0s9	103	4	test	test	VBP
cord-325956-1kxxg0s9	103	5	the	the	DT
cord-325956-1kxxg0s9	103	6	sickest	sick	JJS
cord-325956-1kxxg0s9	103	7	of	of	IN
cord-325956-1kxxg0s9	103	8	patients	patient	NNS
cord-325956-1kxxg0s9	103	9	as	as	IN
cord-325956-1kxxg0s9	103	10	you	-PRON-	PRP
cord-325956-1kxxg0s9	103	11	would	would	MD
cord-325956-1kxxg0s9	103	12	expect	expect	VB
cord-325956-1kxxg0s9	103	13	in	in	IN
cord-325956-1kxxg0s9	103	14	countries	country	NNS
cord-325956-1kxxg0s9	103	15	with	with	IN
cord-325956-1kxxg0s9	103	16	the	the	DT
cord-325956-1kxxg0s9	103	17	largest	large	JJS
cord-325956-1kxxg0s9	103	18	populations	population	NNS
cord-325956-1kxxg0s9	103	19	and	and	CC
cord-325956-1kxxg0s9	103	20	limited	limited	JJ
cord-325956-1kxxg0s9	103	21	testing	testing	NN
cord-325956-1kxxg0s9	103	22	kits	kit	NNS
cord-325956-1kxxg0s9	103	23	to	to	TO
cord-325956-1kxxg0s9	103	24	do	do	VB
cord-325956-1kxxg0s9	103	25	,	,	,
cord-325956-1kxxg0s9	103	26	then	then	RB
cord-325956-1kxxg0s9	103	27	high	high	JJ
cord-325956-1kxxg0s9	103	28	testing	testing	NN
cord-325956-1kxxg0s9	103	29	rates	rate	NNS
cord-325956-1kxxg0s9	103	30	per	per	IN
cord-325956-1kxxg0s9	103	31	positive	positive	JJ
cord-325956-1kxxg0s9	103	32	case	case	NN
cord-325956-1kxxg0s9	103	33	is	be	VBZ
cord-325956-1kxxg0s9	103	34	even	even	RB
cord-325956-1kxxg0s9	103	35	more	more	RBR
cord-325956-1kxxg0s9	103	36	remarkable	remarkable	JJ
cord-325956-1kxxg0s9	103	37	as	as	IN
cord-325956-1kxxg0s9	103	38	it	-PRON-	PRP
cord-325956-1kxxg0s9	103	39	may	may	MD
cord-325956-1kxxg0s9	103	40	suggest	suggest	VB
cord-325956-1kxxg0s9	103	41	lower	low	JJR
cord-325956-1kxxg0s9	103	42	virus	virus	NN
cord-325956-1kxxg0s9	103	43	rates	rate	NNS
cord-325956-1kxxg0s9	103	44	compared	compare	VBN
cord-325956-1kxxg0s9	103	45	to	to	IN
cord-325956-1kxxg0s9	103	46	other	other	JJ
cord-325956-1kxxg0s9	103	47	countries	country	NNS
cord-325956-1kxxg0s9	103	48	but	but	CC
cord-325956-1kxxg0s9	103	49	this	this	DT
cord-325956-1kxxg0s9	103	50	can	can	MD
cord-325956-1kxxg0s9	103	51	not	not	RB
cord-325956-1kxxg0s9	103	52	be	be	VB
cord-325956-1kxxg0s9	103	53	concluded	conclude	VBN
cord-325956-1kxxg0s9	103	54	from	from	IN
cord-325956-1kxxg0s9	103	55	this	this	DT
cord-325956-1kxxg0s9	103	56	study	study	NN
cord-325956-1kxxg0s9	103	57	.	.	.
cord-325956-1kxxg0s9	104	1	Furthermore	furthermore	RB
cord-325956-1kxxg0s9	104	2	,	,	,
cord-325956-1kxxg0s9	104	3	the	the	DT
cord-325956-1kxxg0s9	104	4	reliability	reliability	NN
cord-325956-1kxxg0s9	104	5	of	of	IN
cord-325956-1kxxg0s9	104	6	local	local	JJ
cord-325956-1kxxg0s9	104	7	testing	testing	NN
cord-325956-1kxxg0s9	104	8	kits	kit	NNS
cord-325956-1kxxg0s9	104	9	is	be	VBZ
cord-325956-1kxxg0s9	104	10	an	an	DT
cord-325956-1kxxg0s9	104	11	important	important	JJ
cord-325956-1kxxg0s9	104	12	factor	factor	NN
cord-325956-1kxxg0s9	104	13	as	as	IN
cord-325956-1kxxg0s9	104	14	there	there	EX
cord-325956-1kxxg0s9	104	15	are	be	VBP
cord-325956-1kxxg0s9	104	16	a	a	DT
cord-325956-1kxxg0s9	104	17	number	number	NN
cord-325956-1kxxg0s9	104	18	of	of	IN
cord-325956-1kxxg0s9	104	19	reports	report	NNS
cord-325956-1kxxg0s9	104	20	of	of	IN
cord-325956-1kxxg0s9	104	21	COVID-19	covid-19	JJ
cord-325956-1kxxg0s9	104	22	patients	patient	NNS
cord-325956-1kxxg0s9	104	23	testing	test	VBG
cord-325956-1kxxg0s9	104	24	negative	negative	JJ
cord-325956-1kxxg0s9	104	25	numerous	numerous	JJ
cord-325956-1kxxg0s9	104	26	times	time	NNS
cord-325956-1kxxg0s9	104	27	before	before	IN
cord-325956-1kxxg0s9	104	28	a	a	DT
cord-325956-1kxxg0s9	104	29	positive	positive	JJ
cord-325956-1kxxg0s9	104	30	test	test	NN
cord-325956-1kxxg0s9	104	31	11	11	CD
cord-325956-1kxxg0s9	104	32	.	.	.
cord-325956-1kxxg0s9	105	1	South	South	NNP
cord-325956-1kxxg0s9	105	2	Korea	Korea	NNP
cord-325956-1kxxg0s9	105	3	can	can	MD
cord-325956-1kxxg0s9	105	4	be	be	VB
cord-325956-1kxxg0s9	105	5	considered	consider	VBN
cord-325956-1kxxg0s9	105	6	as	as	IN
cord-325956-1kxxg0s9	105	7	an	an	DT
cord-325956-1kxxg0s9	105	8	exception	exception	NN
cord-325956-1kxxg0s9	105	9	to	to	IN
cord-325956-1kxxg0s9	105	10	this	this	DT
cord-325956-1kxxg0s9	105	11	because	because	IN
cord-325956-1kxxg0s9	105	12	following	follow	VBG
cord-325956-1kxxg0s9	105	13	an	an	DT
cord-325956-1kxxg0s9	105	14	explosion	explosion	NN
cord-325956-1kxxg0s9	105	15	of	of	IN
cord-325956-1kxxg0s9	105	16	cases	case	NNS
cord-325956-1kxxg0s9	105	17	initially	initially	RB
cord-325956-1kxxg0s9	105	18	,	,	,
cord-325956-1kxxg0s9	105	19	they	-PRON-	PRP
cord-325956-1kxxg0s9	105	20	embarked	embark	VBD
cord-325956-1kxxg0s9	105	21	on	on	IN
cord-325956-1kxxg0s9	105	22	an	an	DT
cord-325956-1kxxg0s9	105	23	extensive	extensive	JJ
cord-325956-1kxxg0s9	105	24	testing	testing	NN
cord-325956-1kxxg0s9	105	25	policy	policy	NN
cord-325956-1kxxg0s9	105	26	along	along	IN
cord-325956-1kxxg0s9	105	27	with	with	IN
cord-325956-1kxxg0s9	105	28	isolation	isolation	NN
cord-325956-1kxxg0s9	105	29	policies	policy	NNS
cord-325956-1kxxg0s9	105	30	combined	combine	VBN
cord-325956-1kxxg0s9	105	31	with	with	IN
cord-325956-1kxxg0s9	105	32	the	the	DT
cord-325956-1kxxg0s9	105	33	utility	utility	NN
cord-325956-1kxxg0s9	105	34	of	of	IN
cord-325956-1kxxg0s9	105	35	mobile	mobile	JJ
cord-325956-1kxxg0s9	105	36	tech	tech	NN
cord-325956-1kxxg0s9	105	37	and	and	CC
cord-325956-1kxxg0s9	105	38	applications	application	NNS
cord-325956-1kxxg0s9	105	39	to	to	TO
cord-325956-1kxxg0s9	105	40	inform	inform	VB
cord-325956-1kxxg0s9	105	41	the	the	DT
cord-325956-1kxxg0s9	105	42	public	public	NN
cord-325956-1kxxg0s9	105	43	about	about	IN
cord-325956-1kxxg0s9	105	44	real	real	JJ
cord-325956-1kxxg0s9	105	45	time	time	NN
cord-325956-1kxxg0s9	105	46	locations	location	NNS
cord-325956-1kxxg0s9	105	47	of	of	IN
cord-325956-1kxxg0s9	105	48	positive	positive	JJ
cord-325956-1kxxg0s9	105	49	cases	case	NNS
cord-325956-1kxxg0s9	105	50	.	.	.
cord-325956-1kxxg0s9	106	1	As	as	IN
cord-325956-1kxxg0s9	106	2	such	such	JJ
cord-325956-1kxxg0s9	106	3	,	,	,
cord-325956-1kxxg0s9	106	4	it	-PRON-	PRP
cord-325956-1kxxg0s9	106	5	is	be	VBZ
cord-325956-1kxxg0s9	106	6	widely	widely	RB
cord-325956-1kxxg0s9	106	7	accepted	accept	VBN
cord-325956-1kxxg0s9	106	8	that	that	IN
cord-325956-1kxxg0s9	106	9	South	South	NNP
cord-325956-1kxxg0s9	106	10	Korea	Korea	NNP
cord-325956-1kxxg0s9	106	11	are	be	VBP
cord-325956-1kxxg0s9	106	12	further	far	RBR
cord-325956-1kxxg0s9	106	13	along	along	IN
cord-325956-1kxxg0s9	106	14	the	the	DT
cord-325956-1kxxg0s9	106	15	pandemic	pandemic	NN
cord-325956-1kxxg0s9	106	16	curve	curve	NN
cord-325956-1kxxg0s9	106	17	and	and	CC
cord-325956-1kxxg0s9	106	18	the	the	DT
cord-325956-1kxxg0s9	106	19	rates	rate	NNS
cord-325956-1kxxg0s9	106	20	of	of	IN
cord-325956-1kxxg0s9	106	21	new	new	JJ
cord-325956-1kxxg0s9	106	22	cases	case	NNS
cord-325956-1kxxg0s9	106	23	and	and	CC
cord-325956-1kxxg0s9	106	24	deaths	death	NNS
cord-325956-1kxxg0s9	106	25	have	have	VBP
cord-325956-1kxxg0s9	106	26	significantly	significantly	RB
cord-325956-1kxxg0s9	106	27	reduced	reduce	VBN
cord-325956-1kxxg0s9	106	28	[	[	-LRB-
cord-325956-1kxxg0s9	106	29	22	22	CD
cord-325956-1kxxg0s9	106	30	]	]	-RRB-
cord-325956-1kxxg0s9	106	31	[	[	-LRB-
cord-325956-1kxxg0s9	106	32	23	23	CD
cord-325956-1kxxg0s9	106	33	]	]	-RRB-
cord-325956-1kxxg0s9	106	34	[	[	-LRB-
cord-325956-1kxxg0s9	106	35	24	24	CD
cord-325956-1kxxg0s9	106	36	]	]	-RRB-
cord-325956-1kxxg0s9	106	37	.	.	.
cord-325956-1kxxg0s9	107	1	Projections	projection	NNS
cord-325956-1kxxg0s9	107	2	for	for	IN
cord-325956-1kxxg0s9	107	3	the	the	DT
cord-325956-1kxxg0s9	107	4	pandemic	pandemic	NN
cord-325956-1kxxg0s9	107	5	on	on	IN
cord-325956-1kxxg0s9	107	6	an	an	DT
cord-325956-1kxxg0s9	107	7	individual	individual	JJ
cord-325956-1kxxg0s9	107	8	population	population	NN
cord-325956-1kxxg0s9	107	9	level	level	NN
cord-325956-1kxxg0s9	107	10	are	be	VBP
cord-325956-1kxxg0s9	107	11	very	very	RB
cord-325956-1kxxg0s9	107	12	important	important	JJ
cord-325956-1kxxg0s9	107	13	for	for	IN
cord-325956-1kxxg0s9	107	14	governments	government	NNS
cord-325956-1kxxg0s9	107	15	to	to	TO
cord-325956-1kxxg0s9	107	16	plan	plan	VB
cord-325956-1kxxg0s9	107	17	and	and	CC
cord-325956-1kxxg0s9	107	18	organise	organise	VB
cord-325956-1kxxg0s9	107	19	healthcare	healthcare	NN
cord-325956-1kxxg0s9	107	20	systems	system	NNS
cord-325956-1kxxg0s9	107	21	in	in	IN
cord-325956-1kxxg0s9	107	22	response	response	NN
cord-325956-1kxxg0s9	107	23	.	.	.
cord-325956-1kxxg0s9	108	1	COVID-19	COVID-19	NNP
cord-325956-1kxxg0s9	108	2	presents	present	VBZ
cord-325956-1kxxg0s9	108	3	a	a	DT
cord-325956-1kxxg0s9	108	4	unique	unique	JJ
cord-325956-1kxxg0s9	108	5	problem	problem	NN
cord-325956-1kxxg0s9	108	6	because	because	IN
cord-325956-1kxxg0s9	108	7	there	there	EX
cord-325956-1kxxg0s9	108	8	is	be	VBZ
cord-325956-1kxxg0s9	108	9	no	no	DT
cord-325956-1kxxg0s9	108	10	immunity	immunity	NN
cord-325956-1kxxg0s9	108	11	for	for	IN
cord-325956-1kxxg0s9	108	12	this	this	DT
cord-325956-1kxxg0s9	108	13	in	in	IN
cord-325956-1kxxg0s9	108	14	the	the	DT
cord-325956-1kxxg0s9	108	15	community	community	NN
cord-325956-1kxxg0s9	108	16	,	,	,
cord-325956-1kxxg0s9	108	17	nor	nor	CC
cord-325956-1kxxg0s9	108	18	a	a	DT
cord-325956-1kxxg0s9	108	19	vaccination	vaccination	NN
cord-325956-1kxxg0s9	108	20	or	or	CC
cord-325956-1kxxg0s9	108	21	targeted	target	VBN
cord-325956-1kxxg0s9	108	22	medical	medical	JJ
cord-325956-1kxxg0s9	108	23	treatment	treatment	NN
cord-325956-1kxxg0s9	108	24	.	.	.
cord-325956-1kxxg0s9	109	1	Given	give	VBN
cord-325956-1kxxg0s9	109	2	that	that	IN
cord-325956-1kxxg0s9	109	3	this	this	DT
cord-325956-1kxxg0s9	109	4	is	be	VBZ
cord-325956-1kxxg0s9	109	5	a	a	DT
cord-325956-1kxxg0s9	109	6	highly	highly	RB
cord-325956-1kxxg0s9	109	7	contagious	contagious	JJ
cord-325956-1kxxg0s9	109	8	disease	disease	NN
cord-325956-1kxxg0s9	109	9	that	that	WDT
cord-325956-1kxxg0s9	109	10	spreads	spread	VBZ
cord-325956-1kxxg0s9	109	11	very	very	RB
cord-325956-1kxxg0s9	109	12	quickly	quickly	RB
cord-325956-1kxxg0s9	109	13	,	,	,
cord-325956-1kxxg0s9	109	14	if	if	IN
cord-325956-1kxxg0s9	109	15	a	a	DT
cord-325956-1kxxg0s9	109	16	large	large	JJ
cord-325956-1kxxg0s9	109	17	part	part	NN
cord-325956-1kxxg0s9	109	18	of	of	IN
cord-325956-1kxxg0s9	109	19	the	the	DT
cord-325956-1kxxg0s9	109	20	population	population	NN
cord-325956-1kxxg0s9	109	21	suffer	suffer	VBP
cord-325956-1kxxg0s9	109	22	from	from	IN
cord-325956-1kxxg0s9	109	23	the	the	DT
cord-325956-1kxxg0s9	109	24	disease	disease	NN
cord-325956-1kxxg0s9	109	25	in	in	IN
cord-325956-1kxxg0s9	109	26	a	a	DT
cord-325956-1kxxg0s9	109	27	short	short	JJ
cord-325956-1kxxg0s9	109	28	space	space	NN
cord-325956-1kxxg0s9	109	29	of	of	IN
cord-325956-1kxxg0s9	109	30	time	time	NN
cord-325956-1kxxg0s9	109	31	,	,	,
cord-325956-1kxxg0s9	109	32	even	even	RB
cord-325956-1kxxg0s9	109	33	if	if	IN
cord-325956-1kxxg0s9	109	34	majority	majority	NN
cord-325956-1kxxg0s9	109	35	of	of	IN
cord-325956-1kxxg0s9	109	36	cases	case	NNS
cord-325956-1kxxg0s9	109	37	are	be	VBP
cord-325956-1kxxg0s9	109	38	mild	mild	JJ
cord-325956-1kxxg0s9	109	39	,	,	,
cord-325956-1kxxg0s9	109	40	a	a	DT
cord-325956-1kxxg0s9	109	41	small	small	JJ
cord-325956-1kxxg0s9	109	42	minority	minority	NN
cord-325956-1kxxg0s9	109	43	of	of	IN
cord-325956-1kxxg0s9	109	44	severe	severe	JJ
cord-325956-1kxxg0s9	109	45	/	/	SYM
cord-325956-1kxxg0s9	109	46	critical	critical	JJ
cord-325956-1kxxg0s9	109	47	cases	case	NNS
cord-325956-1kxxg0s9	109	48	will	will	MD
cord-325956-1kxxg0s9	109	49	still	still	RB
cord-325956-1kxxg0s9	109	50	lead	lead	VB
cord-325956-1kxxg0s9	109	51	to	to	IN
cord-325956-1kxxg0s9	109	52	significant	significant	JJ
cord-325956-1kxxg0s9	109	53	pressures	pressure	NNS
cord-325956-1kxxg0s9	109	54	on	on	IN
cord-325956-1kxxg0s9	109	55	healthcare	healthcare	NN
cord-325956-1kxxg0s9	109	56	systems	system	NNS
cord-325956-1kxxg0s9	109	57	as	as	IN
cord-325956-1kxxg0s9	109	58	now	now	RB
cord-325956-1kxxg0s9	109	59	seen	see	VBN
cord-325956-1kxxg0s9	109	60	in	in	IN
cord-325956-1kxxg0s9	109	61	Italy	Italy	NNP
cord-325956-1kxxg0s9	109	62	,	,	,
cord-325956-1kxxg0s9	109	63	Spain	Spain	NNP
cord-325956-1kxxg0s9	109	64	and	and	CC
cord-325956-1kxxg0s9	109	65	the	the	DT
cord-325956-1kxxg0s9	109	66	USA	USA	NNP
cord-325956-1kxxg0s9	109	67	(	(	-LRB-
cord-325956-1kxxg0s9	109	68	particularly	particularly	RB
cord-325956-1kxxg0s9	109	69	New	New	NNP
cord-325956-1kxxg0s9	109	70	York	York	NNP
cord-325956-1kxxg0s9	109	71	)	)	-RRB-
cord-325956-1kxxg0s9	109	72	.	.	.
cord-325956-1kxxg0s9	110	1	Globally	globally	RB
cord-325956-1kxxg0s9	110	2	lockdowns	lockdown	NNS
cord-325956-1kxxg0s9	110	3	have	have	VBP
cord-325956-1kxxg0s9	110	4	been	be	VBN
cord-325956-1kxxg0s9	110	5	instated	instate	VBN
cord-325956-1kxxg0s9	110	6	to	to	TO
cord-325956-1kxxg0s9	110	7	reduce	reduce	VB
cord-325956-1kxxg0s9	110	8	the	the	DT
cord-325956-1kxxg0s9	110	9	spread	spread	NN
cord-325956-1kxxg0s9	110	10	of	of	IN
cord-325956-1kxxg0s9	110	11	infection	infection	NN
cord-325956-1kxxg0s9	110	12	,	,	,
cord-325956-1kxxg0s9	110	13	allow	allow	VB
cord-325956-1kxxg0s9	110	14	the	the	DT
cord-325956-1kxxg0s9	110	15	healthcare	healthcare	NN
cord-325956-1kxxg0s9	110	16	systems	system	NNS
cord-325956-1kxxg0s9	110	17	to	to	TO
cord-325956-1kxxg0s9	110	18	cope	cope	VB
cord-325956-1kxxg0s9	110	19	with	with	IN
cord-325956-1kxxg0s9	110	20	the	the	DT
cord-325956-1kxxg0s9	110	21	condition	condition	NN
cord-325956-1kxxg0s9	110	22	and	and	CC
cord-325956-1kxxg0s9	110	23	"	"	``
cord-325956-1kxxg0s9	110	24	flatten	flatten	VB
cord-325956-1kxxg0s9	110	25	the	the	DT
cord-325956-1kxxg0s9	110	26	curve	curve	NN
cord-325956-1kxxg0s9	110	27	"	"	''
cord-325956-1kxxg0s9	110	28	of	of	IN
cord-325956-1kxxg0s9	110	29	the	the	DT
cord-325956-1kxxg0s9	110	30	pandemic	pandemic	NN
cord-325956-1kxxg0s9	110	31	.	.	.
cord-325956-1kxxg0s9	111	1	These	these	DT
cord-325956-1kxxg0s9	111	2	were	be	VBD
cord-325956-1kxxg0s9	111	3	not	not	RB
cord-325956-1kxxg0s9	111	4	enforced	enforce	VBN
cord-325956-1kxxg0s9	111	5	all	all	RB
cord-325956-1kxxg0s9	111	6	at	at	IN
cord-325956-1kxxg0s9	111	7	once	once	RB
cord-325956-1kxxg0s9	111	8	and	and	CC
cord-325956-1kxxg0s9	111	9	the	the	DT
cord-325956-1kxxg0s9	111	10	projections	projection	NNS
cord-325956-1kxxg0s9	111	11	in	in	IN
cord-325956-1kxxg0s9	111	12	table	table	NN
cord-325956-1kxxg0s9	111	13	3	3	CD
cord-325956-1kxxg0s9	111	14	are	be	VBP
cord-325956-1kxxg0s9	111	15	based	base	VBN
cord-325956-1kxxg0s9	111	16	on	on	IN
cord-325956-1kxxg0s9	111	17	the	the	DT
cord-325956-1kxxg0s9	111	18	data	datum	NNS
cord-325956-1kxxg0s9	111	19	available	available	JJ
cord-325956-1kxxg0s9	111	20	on	on	IN
cord-325956-1kxxg0s9	111	21	4/4/2020	4/4/2020	CD
cord-325956-1kxxg0s9	111	22	and	and	CC
cord-325956-1kxxg0s9	111	23	a	a	DT
cord-325956-1kxxg0s9	111	24	snapshot	snapshot	NN
cord-325956-1kxxg0s9	111	25	depending	depending	NN
cord-325956-1kxxg0s9	111	26	on	on	IN
cord-325956-1kxxg0s9	111	27	the	the	DT
cord-325956-1kxxg0s9	111	28	actions	action	NNS
cord-325956-1kxxg0s9	111	29	,	,	,
cord-325956-1kxxg0s9	111	30	policies	policy	NNS
cord-325956-1kxxg0s9	111	31	of	of	IN
cord-325956-1kxxg0s9	111	32	individual	individual	JJ
cord-325956-1kxxg0s9	111	33	countries	country	NNS
cord-325956-1kxxg0s9	111	34	.	.	.
cord-325956-1kxxg0s9	112	1	Much	much	RB
cord-325956-1kxxg0s9	112	2	more	more	RBR
cord-325956-1kxxg0s9	112	3	complex	complex	JJ
cord-325956-1kxxg0s9	112	4	models	model	NNS
cord-325956-1kxxg0s9	112	5	have	have	VBP
cord-325956-1kxxg0s9	112	6	been	be	VBN
cord-325956-1kxxg0s9	112	7	undertaken	undertake	VBN
cord-325956-1kxxg0s9	112	8	by	by	IN
cord-325956-1kxxg0s9	112	9	different	different	JJ
cord-325956-1kxxg0s9	112	10	groups	group	NNS
cord-325956-1kxxg0s9	112	11	which	which	WDT
cord-325956-1kxxg0s9	112	12	included	include	VBD
cord-325956-1kxxg0s9	112	13	time	time	NN
cord-325956-1kxxg0s9	112	14	as	as	IN
cord-325956-1kxxg0s9	112	15	a	a	DT
cord-325956-1kxxg0s9	112	16	variable	variable	JJ
cord-325956-1kxxg0s9	112	17	20	20	CD
cord-325956-1kxxg0s9	112	18	.	.	.
cord-325956-1kxxg0s9	113	1	However	however	RB
cord-325956-1kxxg0s9	113	2	,	,	,
cord-325956-1kxxg0s9	113	3	we	-PRON-	PRP
cord-325956-1kxxg0s9	113	4	propose	propose	VBP
cord-325956-1kxxg0s9	113	5	that	that	IN
cord-325956-1kxxg0s9	113	6	testing	testing	NN
cord-325956-1kxxg0s9	113	7	rate	rate	NN
cord-325956-1kxxg0s9	113	8	is	be	VBZ
cord-325956-1kxxg0s9	113	9	a	a	DT
cord-325956-1kxxg0s9	113	10	very	very	RB
cord-325956-1kxxg0s9	113	11	important	important	JJ
cord-325956-1kxxg0s9	113	12	parameter	parameter	NN
cord-325956-1kxxg0s9	113	13	in	in	IN
cord-325956-1kxxg0s9	113	14	projecting	project	VBG
cord-325956-1kxxg0s9	113	15	the	the	DT
cord-325956-1kxxg0s9	113	16	outcomes	outcome	NNS
cord-325956-1kxxg0s9	113	17	of	of	IN
cord-325956-1kxxg0s9	113	18	the	the	DT
cord-325956-1kxxg0s9	113	19	pandemic	pandemic	NN
cord-325956-1kxxg0s9	113	20	.	.	.
cord-325956-1kxxg0s9	114	1	Therefore	therefore	RB
cord-325956-1kxxg0s9	114	2	,	,	,
cord-325956-1kxxg0s9	114	3	whilst	whilst	IN
cord-325956-1kxxg0s9	114	4	it	-PRON-	PRP
cord-325956-1kxxg0s9	114	5	seems	seem	VBZ
cord-325956-1kxxg0s9	114	6	far	far	RB
cord-325956-1kxxg0s9	114	7	-	-	HYPH
cord-325956-1kxxg0s9	114	8	fetched	fetch	VBN
cord-325956-1kxxg0s9	114	9	to	to	TO
cord-325956-1kxxg0s9	114	10	suggest	suggest	VB
cord-325956-1kxxg0s9	114	11	that	that	IN
cord-325956-1kxxg0s9	114	12	Indonesia	Indonesia	NNP
cord-325956-1kxxg0s9	114	13	may	may	MD
cord-325956-1kxxg0s9	114	14	end	end	VB
cord-325956-1kxxg0s9	114	15	up	up	RP
cord-325956-1kxxg0s9	114	16	with	with	IN
cord-325956-1kxxg0s9	114	17	over	over	IN
cord-325956-1kxxg0s9	114	18	7	7	CD
cord-325956-1kxxg0s9	114	19	million	million	CD
cord-325956-1kxxg0s9	114	20	deaths	death	NNS
cord-325956-1kxxg0s9	114	21	from	from	IN
cord-325956-1kxxg0s9	114	22	less	less	JJR
cord-325956-1kxxg0s9	114	23	than	than	IN
cord-325956-1kxxg0s9	114	24	2000	2000	CD
cord-325956-1kxxg0s9	114	25	cases	case	NNS
cord-325956-1kxxg0s9	114	26	reported	report	VBN
cord-325956-1kxxg0s9	114	27	so	so	RB
cord-325956-1kxxg0s9	114	28	far	far	RB
cord-325956-1kxxg0s9	114	29	,	,	,
cord-325956-1kxxg0s9	114	30	we	-PRON-	PRP
cord-325956-1kxxg0s9	114	31	have	have	VBP
cord-325956-1kxxg0s9	114	32	.	.	.
cord-325956-1kxxg0s9	115	1	CC	CC	NNP
cord-325956-1kxxg0s9	115	2	-	-	:
cord-325956-1kxxg0s9	115	3	BY	by	IN
cord-325956-1kxxg0s9	115	4	4.0	4.0	CD
cord-325956-1kxxg0s9	115	5	International	international	JJ
cord-325956-1kxxg0s9	115	6	license	license	NN
cord-325956-1kxxg0s9	116	1	It	-PRON-	PRP
cord-325956-1kxxg0s9	116	2	is	be	VBZ
cord-325956-1kxxg0s9	116	3	made	make	VBN
cord-325956-1kxxg0s9	116	4	available	available	JJ
cord-325956-1kxxg0s9	116	5	under	under	IN
cord-325956-1kxxg0s9	116	6	a	a	DT
cord-325956-1kxxg0s9	117	1	is	be	VBZ
cord-325956-1kxxg0s9	117	2	the	the	DT
cord-325956-1kxxg0s9	117	3	author	author	NN
cord-325956-1kxxg0s9	117	4	/	/	SYM
cord-325956-1kxxg0s9	117	5	funder	funder	NN
cord-325956-1kxxg0s9	117	6	,	,	,
cord-325956-1kxxg0s9	117	7	who	who	WP
cord-325956-1kxxg0s9	117	8	has	have	VBZ
cord-325956-1kxxg0s9	117	9	granted	grant	VBN
cord-325956-1kxxg0s9	117	10	medRxiv	medRxiv	NNS
cord-325956-1kxxg0s9	117	11	a	a	DT
cord-325956-1kxxg0s9	117	12	license	license	NN
cord-325956-1kxxg0s9	117	13	to	to	TO
cord-325956-1kxxg0s9	117	14	display	display	VB
cord-325956-1kxxg0s9	117	15	the	the	DT
cord-325956-1kxxg0s9	117	16	preprint	preprint	NN
cord-325956-1kxxg0s9	117	17	in	in	IN
cord-325956-1kxxg0s9	117	18	perpetuity	perpetuity	NN
cord-325956-1kxxg0s9	117	19	.	.	.
cord-325956-1kxxg0s9	118	1	The	the	DT
cord-325956-1kxxg0s9	118	2	copyright	copyright	NN
cord-325956-1kxxg0s9	118	3	holder	holder	NN
cord-325956-1kxxg0s9	118	4	for	for	IN
cord-325956-1kxxg0s9	118	5	this	this	DT
cord-325956-1kxxg0s9	118	6	preprint	preprint	NN
cord-325956-1kxxg0s9	118	7	.	.	.
cord-325956-1kxxg0s9	119	1	https://doi.org/10.1101/2020.04.06.20054239	https://doi.org/10.1101/2020.04.06.20054239	NNP
cord-325956-1kxxg0s9	119	2	doi	doi	NN
cord-325956-1kxxg0s9	119	3	:	:	:
cord-325956-1kxxg0s9	120	1	medRxiv	medRxiv	NNS
cord-325956-1kxxg0s9	120	2	preprint	preprint	NN
cord-325956-1kxxg0s9	120	3	to	to	TO
cord-325956-1kxxg0s9	120	4	note	note	VB
cord-325956-1kxxg0s9	120	5	that	that	IN
cord-325956-1kxxg0s9	120	6	only	only	RB
cord-325956-1kxxg0s9	120	7	just	just	RB
cord-325956-1kxxg0s9	120	8	over	over	IN
cord-325956-1kxxg0s9	120	9	7000	7000	CD
cord-325956-1kxxg0s9	120	10	tests	test	NNS
cord-325956-1kxxg0s9	120	11	have	have	VBP
cord-325956-1kxxg0s9	120	12	been	be	VBN
cord-325956-1kxxg0s9	120	13	performed	perform	VBN
cord-325956-1kxxg0s9	120	14	for	for	IN
cord-325956-1kxxg0s9	120	15	a	a	DT
cord-325956-1kxxg0s9	120	16	country	country	NN
cord-325956-1kxxg0s9	120	17	of	of	IN
cord-325956-1kxxg0s9	120	18	283	283	CD
cord-325956-1kxxg0s9	120	19	million	million	CD
cord-325956-1kxxg0s9	120	20	.	.	.
cord-325956-1kxxg0s9	121	1	There	there	EX
cord-325956-1kxxg0s9	121	2	are	be	VBP
cord-325956-1kxxg0s9	121	3	a	a	DT
cord-325956-1kxxg0s9	121	4	number	number	NN
cord-325956-1kxxg0s9	121	5	of	of	IN
cord-325956-1kxxg0s9	121	6	factors	factor	NNS
cord-325956-1kxxg0s9	121	7	for	for	IN
cord-325956-1kxxg0s9	121	8	low	low	JJ
cord-325956-1kxxg0s9	121	9	testing	testing	NN
cord-325956-1kxxg0s9	121	10	rates	rate	NNS
cord-325956-1kxxg0s9	121	11	such	such	JJ
cord-325956-1kxxg0s9	121	12	as	as	IN
cord-325956-1kxxg0s9	121	13	local	local	JJ
cord-325956-1kxxg0s9	121	14	policies	policy	NNS
cord-325956-1kxxg0s9	121	15	,	,	,
cord-325956-1kxxg0s9	121	16	lack	lack	NN
cord-325956-1kxxg0s9	121	17	of	of	IN
cord-325956-1kxxg0s9	121	18	resources	resource	NNS
cord-325956-1kxxg0s9	121	19	and	and	CC
cord-325956-1kxxg0s9	121	20	equipment	equipment	NN
cord-325956-1kxxg0s9	121	21	and	and	CC
cord-325956-1kxxg0s9	121	22	it	-PRON-	PRP
cord-325956-1kxxg0s9	121	23	is	be	VBZ
cord-325956-1kxxg0s9	121	24	impossible	impossible	JJ
cord-325956-1kxxg0s9	121	25	to	to	TO
cord-325956-1kxxg0s9	121	26	discuss	discuss	VB
cord-325956-1kxxg0s9	121	27	them	-PRON-	PRP
cord-325956-1kxxg0s9	121	28	all	all	DT
cord-325956-1kxxg0s9	121	29	;	;	:
cord-325956-1kxxg0s9	121	30	we	-PRON-	PRP
cord-325956-1kxxg0s9	121	31	point	point	VBP
cord-325956-1kxxg0s9	121	32	out	out	RP
cord-325956-1kxxg0s9	121	33	that	that	IN
cord-325956-1kxxg0s9	121	34	testing	testing	NN
cord-325956-1kxxg0s9	121	35	rates	rate	NNS
cord-325956-1kxxg0s9	121	36	are	be	VBP
cord-325956-1kxxg0s9	121	37	extremely	extremely	RB
cord-325956-1kxxg0s9	121	38	important	important	JJ
cord-325956-1kxxg0s9	121	39	in	in	IN
cord-325956-1kxxg0s9	121	40	projecting	project	VBG
cord-325956-1kxxg0s9	121	41	the	the	DT
cord-325956-1kxxg0s9	121	42	outcomes	outcome	NNS
cord-325956-1kxxg0s9	121	43	of	of	IN
cord-325956-1kxxg0s9	121	44	the	the	DT
cord-325956-1kxxg0s9	121	45	pandemic	pandemic	NN
cord-325956-1kxxg0s9	121	46	particularly	particularly	RB
cord-325956-1kxxg0s9	121	47	in	in	IN
cord-325956-1kxxg0s9	121	48	countries	country	NNS
cord-325956-1kxxg0s9	121	49	with	with	IN
cord-325956-1kxxg0s9	121	50	large	large	JJ
cord-325956-1kxxg0s9	121	51	populations	population	NNS
cord-325956-1kxxg0s9	121	52	.	.	.
cord-325956-1kxxg0s9	122	1	In	in	IN
cord-325956-1kxxg0s9	122	2	this	this	DT
cord-325956-1kxxg0s9	122	3	context	context	NN
cord-325956-1kxxg0s9	122	4	,	,	,
cord-325956-1kxxg0s9	122	5	if	if	IN
cord-325956-1kxxg0s9	122	6	we	-PRON-	PRP
cord-325956-1kxxg0s9	122	7	look	look	VBP
cord-325956-1kxxg0s9	122	8	at	at	IN
cord-325956-1kxxg0s9	122	9	countries	country	NNS
cord-325956-1kxxg0s9	122	10	such	such	JJ
cord-325956-1kxxg0s9	122	11	as	as	IN
cord-325956-1kxxg0s9	122	12	the	the	DT
cord-325956-1kxxg0s9	122	13	UK	UK	NNP
cord-325956-1kxxg0s9	122	14	and	and	CC
cord-325956-1kxxg0s9	122	15	India	India	NNP
cord-325956-1kxxg0s9	122	16	both	both	DT
cord-325956-1kxxg0s9	122	17	of	of	IN
cord-325956-1kxxg0s9	122	18	which	which	WDT
cord-325956-1kxxg0s9	122	19	have	have	VBP
cord-325956-1kxxg0s9	122	20	tested	test	VBN
cord-325956-1kxxg0s9	122	21	over	over	IN
cord-325956-1kxxg0s9	122	22	100000	100000	CD
cord-325956-1kxxg0s9	122	23	tests	test	NNS
cord-325956-1kxxg0s9	122	24	,	,	,
cord-325956-1kxxg0s9	122	25	given	give	VBN
cord-325956-1kxxg0s9	122	26	the	the	DT
cord-325956-1kxxg0s9	122	27	large	large	JJ
cord-325956-1kxxg0s9	122	28	populations	population	NNS
cord-325956-1kxxg0s9	122	29	and	and	CC
cord-325956-1kxxg0s9	122	30	their	-PRON-	PRP$
cord-325956-1kxxg0s9	122	31	case	case	NN
cord-325956-1kxxg0s9	122	32	per	per	IN
cord-325956-1kxxg0s9	122	33	test	test	NN
cord-325956-1kxxg0s9	122	34	rate	rate	NN
cord-325956-1kxxg0s9	122	35	and	and	CC
cord-325956-1kxxg0s9	122	36	death	death	NN
cord-325956-1kxxg0s9	122	37	per	per	IN
cord-325956-1kxxg0s9	122	38	test	test	NN
cord-325956-1kxxg0s9	122	39	rate	rate	NN
cord-325956-1kxxg0s9	122	40	on	on	IN
cord-325956-1kxxg0s9	122	41	4/4/2020	4/4/2020	CD
cord-325956-1kxxg0s9	122	42	,	,	,
cord-325956-1kxxg0s9	122	43	both	both	DT
cord-325956-1kxxg0s9	122	44	countries	country	NNS
cord-325956-1kxxg0s9	122	45	have	have	VBP
cord-325956-1kxxg0s9	122	46	projections	projection	NNS
cord-325956-1kxxg0s9	122	47	for	for	IN
cord-325956-1kxxg0s9	122	48	over	over	IN
cord-325956-1kxxg0s9	122	49	1000000	1000000	CD
cord-325956-1kxxg0s9	122	50	deaths	death	NNS
cord-325956-1kxxg0s9	122	51	.	.	.
cord-325956-1kxxg0s9	123	1	As	as	IN
cord-325956-1kxxg0s9	123	2	mentioned	mention	VBD
cord-325956-1kxxg0s9	123	3	the	the	DT
cord-325956-1kxxg0s9	123	4	position	position	NN
cord-325956-1kxxg0s9	123	5	of	of	IN
cord-325956-1kxxg0s9	123	6	any	any	DT
cord-325956-1kxxg0s9	123	7	given	give	VBN
cord-325956-1kxxg0s9	123	8	country	country	NN
cord-325956-1kxxg0s9	123	9	on	on	IN
cord-325956-1kxxg0s9	123	10	the	the	DT
cord-325956-1kxxg0s9	123	11	pandemic	pandemic	NN
cord-325956-1kxxg0s9	123	12	curve	curve	NN
cord-325956-1kxxg0s9	123	13	is	be	VBZ
cord-325956-1kxxg0s9	123	14	important	important	JJ
cord-325956-1kxxg0s9	123	15	in	in	IN
cord-325956-1kxxg0s9	123	16	determining	determine	VBG
cord-325956-1kxxg0s9	123	17	population	population	NN
cord-325956-1kxxg0s9	123	18	level	level	NN
cord-325956-1kxxg0s9	123	19	projections	projection	NNS
cord-325956-1kxxg0s9	123	20	and	and	CC
cord-325956-1kxxg0s9	123	21	since	since	IN
cord-325956-1kxxg0s9	123	22	we	-PRON-	PRP
cord-325956-1kxxg0s9	123	23	proposed	propose	VBD
cord-325956-1kxxg0s9	123	24	that	that	IN
cord-325956-1kxxg0s9	123	25	testing	testing	NN
cord-325956-1kxxg0s9	123	26	rates	rate	NNS
cord-325956-1kxxg0s9	123	27	have	have	VBP
cord-325956-1kxxg0s9	123	28	an	an	DT
cord-325956-1kxxg0s9	123	29	impact	impact	NN
cord-325956-1kxxg0s9	123	30	on	on	IN
cord-325956-1kxxg0s9	123	31	projections	projection	NNS
cord-325956-1kxxg0s9	123	32	we	-PRON-	PRP
cord-325956-1kxxg0s9	123	33	adjusted	adjust	VBD
cord-325956-1kxxg0s9	123	34	all	all	DT
cord-325956-1kxxg0s9	123	35	projections	projection	NNS
cord-325956-1kxxg0s9	123	36	to	to	IN
cord-325956-1kxxg0s9	123	37	the	the	DT
cord-325956-1kxxg0s9	123	38	combined	combine	VBN
cord-325956-1kxxg0s9	123	39	case	case	NN
cord-325956-1kxxg0s9	123	40	per	per	IN
cord-325956-1kxxg0s9	123	41	test	test	NN
cord-325956-1kxxg0s9	123	42	and	and	CC
cord-325956-1kxxg0s9	123	43	death	death	NN
cord-325956-1kxxg0s9	123	44	per	per	IN
cord-325956-1kxxg0s9	123	45	test	test	NN
cord-325956-1kxxg0s9	123	46	rates	rate	NNS
cord-325956-1kxxg0s9	123	47	of	of	IN
cord-325956-1kxxg0s9	123	48	all	all	PDT
cord-325956-1kxxg0s9	123	49	the	the	DT
cord-325956-1kxxg0s9	123	50	countries	country	NNS
cord-325956-1kxxg0s9	123	51	that	that	WDT
cord-325956-1kxxg0s9	123	52	have	have	VBP
cord-325956-1kxxg0s9	123	53	performed	perform	VBN
cord-325956-1kxxg0s9	123	54	over	over	IN
cord-325956-1kxxg0s9	123	55	100000	100000	CD
cord-325956-1kxxg0s9	123	56	tests	test	NNS
cord-325956-1kxxg0s9	123	57	.	.	.
cord-325956-1kxxg0s9	124	1	This	this	DT
cord-325956-1kxxg0s9	124	2	analyses	analysis	NNS
cord-325956-1kxxg0s9	124	3	is	be	VBZ
cord-325956-1kxxg0s9	124	4	shown	show	VBN
cord-325956-1kxxg0s9	124	5	in	in	IN
cord-325956-1kxxg0s9	124	6	table	table	NN
cord-325956-1kxxg0s9	124	7	4	4	CD
cord-325956-1kxxg0s9	124	8	.	.	.
cord-325956-1kxxg0s9	125	1	We	-PRON-	PRP
cord-325956-1kxxg0s9	125	2	also	also	RB
cord-325956-1kxxg0s9	125	3	felt	feel	VBD
cord-325956-1kxxg0s9	125	4	that	that	IN
cord-325956-1kxxg0s9	125	5	projections	projection	NNS
cord-325956-1kxxg0s9	125	6	should	should	MD
cord-325956-1kxxg0s9	125	7	be	be	VB
cord-325956-1kxxg0s9	125	8	done	do	VBN
cord-325956-1kxxg0s9	125	9	on	on	IN
cord-325956-1kxxg0s9	125	10	the	the	DT
cord-325956-1kxxg0s9	125	11	case	case	NN
cord-325956-1kxxg0s9	125	12	per	per	IN
cord-325956-1kxxg0s9	125	13	test	test	NN
cord-325956-1kxxg0s9	125	14	and	and	CC
cord-325956-1kxxg0s9	125	15	death	death	NN
cord-325956-1kxxg0s9	125	16	per	per	IN
cord-325956-1kxxg0s9	125	17	test	test	NN
cord-325956-1kxxg0s9	125	18	rate	rate	NN
cord-325956-1kxxg0s9	125	19	for	for	IN
cord-325956-1kxxg0s9	125	20	South	South	NNP
cord-325956-1kxxg0s9	125	21	Korea	Korea	NNP
cord-325956-1kxxg0s9	125	22	given	give	VBN
cord-325956-1kxxg0s9	125	23	the	the	DT
cord-325956-1kxxg0s9	125	24	countries	country	NNS
cord-325956-1kxxg0s9	125	25	position	position	VB
cord-325956-1kxxg0s9	125	26	on	on	IN
cord-325956-1kxxg0s9	125	27	the	the	DT
cord-325956-1kxxg0s9	125	28	pandemic	pandemic	NN
cord-325956-1kxxg0s9	125	29	curve	curve	NN
cord-325956-1kxxg0s9	125	30	and	and	CC
cord-325956-1kxxg0s9	125	31	are	be	VBP
cord-325956-1kxxg0s9	125	32	shown	show	VBN
cord-325956-1kxxg0s9	125	33	in	in	IN
cord-325956-1kxxg0s9	125	34	table	table	NN
cord-325956-1kxxg0s9	125	35	4	4	CD
cord-325956-1kxxg0s9	125	36	[	[	-LRB-
cord-325956-1kxxg0s9	125	37	22	22	CD
cord-325956-1kxxg0s9	125	38	]	]	-RRB-
cord-325956-1kxxg0s9	126	1	[	[	-LRB-
cord-325956-1kxxg0s9	126	2	23	23	CD
cord-325956-1kxxg0s9	126	3	]	]	-RRB-
cord-325956-1kxxg0s9	126	4	[	[	-LRB-
cord-325956-1kxxg0s9	126	5	24	24	CD
cord-325956-1kxxg0s9	126	6	]	]	-RRB-
cord-325956-1kxxg0s9	126	7	.	.	.
cord-325956-1kxxg0s9	127	1	Both	both	CC
cord-325956-1kxxg0s9	127	2	these	these	DT
cord-325956-1kxxg0s9	127	3	analyses	analysis	NNS
cord-325956-1kxxg0s9	127	4	are	be	VBP
cord-325956-1kxxg0s9	127	5	biased	bias	VBN
cord-325956-1kxxg0s9	127	6	in	in	IN
cord-325956-1kxxg0s9	127	7	terms	term	NNS
cord-325956-1kxxg0s9	127	8	of	of	IN
cord-325956-1kxxg0s9	127	9	predications	predication	NNS
cord-325956-1kxxg0s9	127	10	for	for	IN
cord-325956-1kxxg0s9	127	11	total	total	JJ
cord-325956-1kxxg0s9	127	12	deaths	death	NNS
cord-325956-1kxxg0s9	127	13	for	for	IN
cord-325956-1kxxg0s9	127	14	countries	country	NNS
cord-325956-1kxxg0s9	127	15	with	with	IN
cord-325956-1kxxg0s9	127	16	larger	large	JJR
cord-325956-1kxxg0s9	127	17	populations	population	NNS
cord-325956-1kxxg0s9	127	18	.	.	.
cord-325956-1kxxg0s9	128	1	For	for	IN
cord-325956-1kxxg0s9	128	2	example	example	NN
cord-325956-1kxxg0s9	128	3	in	in	IN
cord-325956-1kxxg0s9	128	4	spite	spite	NN
cord-325956-1kxxg0s9	128	5	of	of	IN
cord-325956-1kxxg0s9	128	6	the	the	DT
cord-325956-1kxxg0s9	128	7	case	case	NN
cord-325956-1kxxg0s9	128	8	per	per	IN
cord-325956-1kxxg0s9	128	9	test	test	NN
cord-325956-1kxxg0s9	128	10	and	and	CC
cord-325956-1kxxg0s9	128	11	deaths	death	NNS
cord-325956-1kxxg0s9	128	12	per	per	IN
cord-325956-1kxxg0s9	128	13	test	test	NN
cord-325956-1kxxg0s9	128	14	rate	rate	NN
cord-325956-1kxxg0s9	128	15	being	be	VBG
cord-325956-1kxxg0s9	128	16	low	low	JJ
cord-325956-1kxxg0s9	128	17	in	in	IN
cord-325956-1kxxg0s9	128	18	India	India	NNP
cord-325956-1kxxg0s9	128	19	,	,	,
cord-325956-1kxxg0s9	128	20	as	as	IN
cord-325956-1kxxg0s9	128	21	the	the	DT
cord-325956-1kxxg0s9	128	22	population	population	NN
cord-325956-1kxxg0s9	128	23	of	of	IN
cord-325956-1kxxg0s9	128	24	the	the	DT
cord-325956-1kxxg0s9	128	25	country	country	NN
cord-325956-1kxxg0s9	128	26	is	be	VBZ
cord-325956-1kxxg0s9	128	27	large	large	JJ
cord-325956-1kxxg0s9	128	28	,	,	,
cord-325956-1kxxg0s9	128	29	the	the	DT
cord-325956-1kxxg0s9	128	30	projections	projection	NNS
cord-325956-1kxxg0s9	128	31	are	be	VBP
cord-325956-1kxxg0s9	128	32	still	still	RB
cord-325956-1kxxg0s9	128	33	over	over	IN
cord-325956-1kxxg0s9	128	34	10	10	CD
cord-325956-1kxxg0s9	128	35	millions	million	NNS
cord-325956-1kxxg0s9	128	36	deaths	death	NNS
cord-325956-1kxxg0s9	128	37	as	as	IN
cord-325956-1kxxg0s9	128	38	per	per	IN
cord-325956-1kxxg0s9	128	39	table	table	NN
cord-325956-1kxxg0s9	128	40	4	4	CD
cord-325956-1kxxg0s9	128	41	(	(	-LRB-
cord-325956-1kxxg0s9	128	42	adjustment	adjustment	NN
cord-325956-1kxxg0s9	128	43	according	accord	VBG
cord-325956-1kxxg0s9	128	44	to	to	IN
cord-325956-1kxxg0s9	128	45	countries	country	NNS
cord-325956-1kxxg0s9	128	46	which	which	WDT
cord-325956-1kxxg0s9	128	47	have	have	VBP
cord-325956-1kxxg0s9	128	48	performed	perform	VBN
cord-325956-1kxxg0s9	128	49	more	more	JJR
cord-325956-1kxxg0s9	128	50	than	than	IN
cord-325956-1kxxg0s9	128	51	100,000	100,000	CD
cord-325956-1kxxg0s9	128	52	tests	test	NNS
cord-325956-1kxxg0s9	128	53	)	)	-RRB-
cord-325956-1kxxg0s9	128	54	and	and	CC
cord-325956-1kxxg0s9	128	55	500,000	500,000	CD
cord-325956-1kxxg0s9	128	56	deaths	death	NNS
cord-325956-1kxxg0s9	128	57	as	as	IN
cord-325956-1kxxg0s9	128	58	per	per	IN
cord-325956-1kxxg0s9	128	59	table	table	NN
cord-325956-1kxxg0s9	128	60	5	5	CD
cord-325956-1kxxg0s9	128	61	(	(	-LRB-
cord-325956-1kxxg0s9	128	62	South	South	NNP
cord-325956-1kxxg0s9	128	63	Korea	Korea	NNP
cord-325956-1kxxg0s9	128	64	adjustment	adjustment	NN
cord-325956-1kxxg0s9	128	65	)	)	-RRB-
cord-325956-1kxxg0s9	128	66	.	.	.
cord-325956-1kxxg0s9	129	1	It	-PRON-	PRP
cord-325956-1kxxg0s9	129	2	is	be	VBZ
cord-325956-1kxxg0s9	129	3	also	also	RB
cord-325956-1kxxg0s9	129	4	no	no	DT
cord-325956-1kxxg0s9	129	5	coincidence	coincidence	NN
cord-325956-1kxxg0s9	129	6	that	that	IN
cord-325956-1kxxg0s9	129	7	none	none	NN
cord-325956-1kxxg0s9	129	8	of	of	IN
cord-325956-1kxxg0s9	129	9	the	the	DT
cord-325956-1kxxg0s9	129	10	top	top	JJ
cord-325956-1kxxg0s9	129	11	10	10	CD
cord-325956-1kxxg0s9	129	12	countries	country	NNS
cord-325956-1kxxg0s9	129	13	in	in	IN
cord-325956-1kxxg0s9	129	14	table	table	NN
cord-325956-1kxxg0s9	129	15	4	4	CD
cord-325956-1kxxg0s9	129	16	or	or	CC
cord-325956-1kxxg0s9	129	17	table	table	NN
cord-325956-1kxxg0s9	129	18	5	5	CD
cord-325956-1kxxg0s9	129	19	have	have	VBP
cord-325956-1kxxg0s9	129	20	tested	test	VBN
cord-325956-1kxxg0s9	129	21	at	at	IN
cord-325956-1kxxg0s9	129	22	least	least	JJS
cord-325956-1kxxg0s9	129	23	1	1	CD
cord-325956-1kxxg0s9	129	24	%	%	NN
cord-325956-1kxxg0s9	129	25	of	of	IN
cord-325956-1kxxg0s9	129	26	the	the	DT
cord-325956-1kxxg0s9	129	27	total	total	JJ
cord-325956-1kxxg0s9	129	28	population	population	NN
cord-325956-1kxxg0s9	129	29	.	.	.
cord-325956-1kxxg0s9	130	1	We	-PRON-	PRP
cord-325956-1kxxg0s9	130	2	looked	look	VBD
cord-325956-1kxxg0s9	130	3	at	at	IN
cord-325956-1kxxg0s9	130	4	the	the	DT
cord-325956-1kxxg0s9	130	5	countries	country	NNS
cord-325956-1kxxg0s9	130	6	that	that	WDT
cord-325956-1kxxg0s9	130	7	have	have	VBP
cord-325956-1kxxg0s9	130	8	tested	test	VBN
cord-325956-1kxxg0s9	130	9	at	at	IN
cord-325956-1kxxg0s9	130	10	least	least	JJS
cord-325956-1kxxg0s9	130	11	1	1	CD
cord-325956-1kxxg0s9	130	12	%	%	NN
cord-325956-1kxxg0s9	130	13	of	of	IN
cord-325956-1kxxg0s9	130	14	their	-PRON-	PRP$
cord-325956-1kxxg0s9	130	15	populations	population	NNS
cord-325956-1kxxg0s9	130	16	and	and	CC
cord-325956-1kxxg0s9	130	17	looked	look	VBD
cord-325956-1kxxg0s9	130	18	at	at	IN
cord-325956-1kxxg0s9	130	19	their	-PRON-	PRP$
cord-325956-1kxxg0s9	130	20	cases	case	NNS
cord-325956-1kxxg0s9	130	21	fatality	fatality	NN
cord-325956-1kxxg0s9	130	22	rate	rate	NN
cord-325956-1kxxg0s9	130	23	.	.	.
cord-325956-1kxxg0s9	131	1	We	-PRON-	PRP
cord-325956-1kxxg0s9	131	2	excluded	exclude	VBD
cord-325956-1kxxg0s9	131	3	the	the	DT
cord-325956-1kxxg0s9	131	4	10	10	CD
cord-325956-1kxxg0s9	131	5	th	th	XX
cord-325956-1kxxg0s9	131	6	country	country	NN
cord-325956-1kxxg0s9	131	7	on	on	IN
cord-325956-1kxxg0s9	131	8	the	the	DT
cord-325956-1kxxg0s9	131	9	list	list	NN
cord-325956-1kxxg0s9	131	10	-Italy	-Italy	VBZ
cord-325956-1kxxg0s9	131	11	because	because	IN
cord-325956-1kxxg0s9	131	12	of	of	IN
cord-325956-1kxxg0s9	131	13	its	-PRON-	PRP$
cord-325956-1kxxg0s9	131	14	high	high	JJ
cord-325956-1kxxg0s9	131	15	case	case	NN
cord-325956-1kxxg0s9	131	16	fatality	fatality	NN
cord-325956-1kxxg0s9	131	17	rate	rate	NN
cord-325956-1kxxg0s9	131	18	of	of	IN
cord-325956-1kxxg0s9	131	19	12.25	12.25	CD
cord-325956-1kxxg0s9	131	20	%	%	NN
cord-325956-1kxxg0s9	131	21	.	.	.
cord-325956-1kxxg0s9	132	1	All	all	DT
cord-325956-1kxxg0s9	132	2	other	other	JJ
cord-325956-1kxxg0s9	132	3	countries	country	NNS
cord-325956-1kxxg0s9	132	4	had	have	VBD
cord-325956-1kxxg0s9	132	5	a	a	DT
cord-325956-1kxxg0s9	132	6	case	case	NN
cord-325956-1kxxg0s9	132	7	fatality	fatality	NN
cord-325956-1kxxg0s9	132	8	rate	rate	NN
cord-325956-1kxxg0s9	132	9	of	of	IN
cord-325956-1kxxg0s9	132	10	3	3	CD
cord-325956-1kxxg0s9	132	11	%	%	NN
cord-325956-1kxxg0s9	132	12	or	or	CC
cord-325956-1kxxg0s9	132	13	lower	low	JJR
cord-325956-1kxxg0s9	132	14	.	.	.
cord-325956-1kxxg0s9	133	1	We	-PRON-	PRP
cord-325956-1kxxg0s9	133	2	then	then	RB
cord-325956-1kxxg0s9	133	3	correlated	correlate	VBD
cord-325956-1kxxg0s9	133	4	the	the	DT
cord-325956-1kxxg0s9	133	5	case	case	NN
cord-325956-1kxxg0s9	133	6	fatality	fatality	NN
cord-325956-1kxxg0s9	133	7	rate	rate	NN
cord-325956-1kxxg0s9	133	8	with	with	IN
cord-325956-1kxxg0s9	133	9	percentage	percentage	NN
cord-325956-1kxxg0s9	133	10	of	of	IN
cord-325956-1kxxg0s9	133	11	the	the	DT
cord-325956-1kxxg0s9	133	12	population	population	NN
cord-325956-1kxxg0s9	133	13	tested	test	VBN
cord-325956-1kxxg0s9	133	14	as	as	IN
cord-325956-1kxxg0s9	133	15	shown	show	VBN
cord-325956-1kxxg0s9	133	16	in	in	IN
cord-325956-1kxxg0s9	133	17	figure	figure	NN
cord-325956-1kxxg0s9	133	18	1	1	CD
cord-325956-1kxxg0s9	133	19	.	.	.
cord-325956-1kxxg0s9	134	1	This	this	DT
cord-325956-1kxxg0s9	134	2	approach	approach	NN
cord-325956-1kxxg0s9	134	3	showed	show	VBD
cord-325956-1kxxg0s9	134	4	higher	high	JJR
cord-325956-1kxxg0s9	134	5	percentage	percentage	NN
cord-325956-1kxxg0s9	134	6	of	of	IN
cord-325956-1kxxg0s9	134	7	population	population	NN
cord-325956-1kxxg0s9	134	8	tested	test	VBN
cord-325956-1kxxg0s9	134	9	in	in	IN
cord-325956-1kxxg0s9	134	10	countries	country	NNS
cord-325956-1kxxg0s9	134	11	with	with	IN
cord-325956-1kxxg0s9	134	12	lower	low	JJR
cord-325956-1kxxg0s9	134	13	populations	population	NNS
cord-325956-1kxxg0s9	134	14	who	who	WP
cord-325956-1kxxg0s9	134	15	have	have	VBP
cord-325956-1kxxg0s9	134	16	tested	test	VBN
cord-325956-1kxxg0s9	134	17	a	a	DT
cord-325956-1kxxg0s9	134	18	higher	high	JJR
cord-325956-1kxxg0s9	134	19	proportion	proportion	NN
cord-325956-1kxxg0s9	134	20	of	of	IN
cord-325956-1kxxg0s9	134	21	their	-PRON-	PRP$
cord-325956-1kxxg0s9	134	22	total	total	JJ
cord-325956-1kxxg0s9	134	23	population	population	NN
cord-325956-1kxxg0s9	134	24	,	,	,
cord-325956-1kxxg0s9	134	25	but	but	CC
cord-325956-1kxxg0s9	134	26	not	not	RB
cord-325956-1kxxg0s9	134	27	in	in	IN
cord-325956-1kxxg0s9	134	28	all	all	DT
cord-325956-1kxxg0s9	134	29	cases	case	NNS
cord-325956-1kxxg0s9	134	30	.	.	.
cord-325956-1kxxg0s9	135	1	Both	both	DT
cord-325956-1kxxg0s9	135	2	.	.	.
cord-325956-1kxxg0s9	136	1	CC	CC	NNP
cord-325956-1kxxg0s9	136	2	-	-	:
cord-325956-1kxxg0s9	136	3	BY	by	IN
cord-325956-1kxxg0s9	136	4	4.0	4.0	CD
cord-325956-1kxxg0s9	136	5	International	international	JJ
cord-325956-1kxxg0s9	136	6	license	license	NN
cord-325956-1kxxg0s9	137	1	It	-PRON-	PRP
cord-325956-1kxxg0s9	137	2	is	be	VBZ
cord-325956-1kxxg0s9	137	3	made	make	VBN
cord-325956-1kxxg0s9	137	4	available	available	JJ
cord-325956-1kxxg0s9	137	5	under	under	IN
cord-325956-1kxxg0s9	137	6	a	a	DT
cord-325956-1kxxg0s9	138	1	is	be	VBZ
cord-325956-1kxxg0s9	138	2	the	the	DT
cord-325956-1kxxg0s9	138	3	author	author	NN
cord-325956-1kxxg0s9	138	4	/	/	SYM
cord-325956-1kxxg0s9	138	5	funder	funder	NN
cord-325956-1kxxg0s9	138	6	,	,	,
cord-325956-1kxxg0s9	138	7	who	who	WP
cord-325956-1kxxg0s9	138	8	has	have	VBZ
cord-325956-1kxxg0s9	138	9	granted	grant	VBN
cord-325956-1kxxg0s9	138	10	medRxiv	medRxiv	NNS
cord-325956-1kxxg0s9	138	11	a	a	DT
cord-325956-1kxxg0s9	138	12	license	license	NN
cord-325956-1kxxg0s9	138	13	to	to	TO
cord-325956-1kxxg0s9	138	14	display	display	VB
cord-325956-1kxxg0s9	138	15	the	the	DT
cord-325956-1kxxg0s9	138	16	preprint	preprint	NN
cord-325956-1kxxg0s9	138	17	in	in	IN
cord-325956-1kxxg0s9	138	18	perpetuity	perpetuity	NN
cord-325956-1kxxg0s9	138	19	.	.	.
cord-325956-1kxxg0s9	139	1	The	the	DT
cord-325956-1kxxg0s9	139	2	copyright	copyright	NN
cord-325956-1kxxg0s9	139	3	holder	holder	NN
cord-325956-1kxxg0s9	139	4	for	for	IN
cord-325956-1kxxg0s9	139	5	this	this	DT
cord-325956-1kxxg0s9	139	6	preprint	preprint	NN
cord-325956-1kxxg0s9	139	7	.	.	.
cord-325956-1kxxg0s9	140	1	https://doi.org/10.1101/2020.04.06.20054239	https://doi.org/10.1101/2020.04.06.20054239	NNP
cord-325956-1kxxg0s9	140	2	doi	doi	NN
cord-325956-1kxxg0s9	140	3	:	:	:
cord-325956-1kxxg0s9	141	1	medRxiv	medRxiv	NNP
cord-325956-1kxxg0s9	141	2	preprint	preprint	NN
cord-325956-1kxxg0s9	141	3	Germany	Germany	NNP
cord-325956-1kxxg0s9	141	4	(	(	-LRB-
cord-325956-1kxxg0s9	141	5	population	population	NN
cord-325956-1kxxg0s9	141	6	83	83	CD
cord-325956-1kxxg0s9	141	7	million	million	CD
cord-325956-1kxxg0s9	141	8	)	)	-RRB-
cord-325956-1kxxg0s9	141	9	and	and	CC
cord-325956-1kxxg0s9	141	10	to	to	IN
cord-325956-1kxxg0s9	141	11	a	a	DT
cord-325956-1kxxg0s9	141	12	lesser	less	JJR
cord-325956-1kxxg0s9	141	13	extent	extent	NN
cord-325956-1kxxg0s9	141	14	Australia	Australia	NNP
cord-325956-1kxxg0s9	141	15	(	(	-LRB-
cord-325956-1kxxg0s9	141	16	population	population	NN
cord-325956-1kxxg0s9	141	17	25million	25million	CD
cord-325956-1kxxg0s9	141	18	)	)	-RRB-
cord-325956-1kxxg0s9	141	19	and	and	CC
cord-325956-1kxxg0s9	141	20	have	have	VBP
cord-325956-1kxxg0s9	141	21	tested	test	VBN
cord-325956-1kxxg0s9	141	22	more	more	JJR
cord-325956-1kxxg0s9	141	23	than	than	IN
cord-325956-1kxxg0s9	141	24	1	1	CD
cord-325956-1kxxg0s9	141	25	%	%	NN
cord-325956-1kxxg0s9	141	26	of	of	IN
cord-325956-1kxxg0s9	141	27	their	-PRON-	PRP$
cord-325956-1kxxg0s9	141	28	population	population	NN
cord-325956-1kxxg0s9	141	29	and	and	CC
cord-325956-1kxxg0s9	141	30	showed	show	VBD
cord-325956-1kxxg0s9	141	31	low	low	JJ
cord-325956-1kxxg0s9	141	32	case	case	NN
cord-325956-1kxxg0s9	141	33	fatality	fatality	NN
cord-325956-1kxxg0s9	141	34	rates	rate	NNS
cord-325956-1kxxg0s9	141	35	(	(	-LRB-
cord-325956-1kxxg0s9	141	36	1.4	1.4	CD
cord-325956-1kxxg0s9	141	37	%	%	NN
cord-325956-1kxxg0s9	141	38	Germany	Germany	NNP
cord-325956-1kxxg0s9	141	39	and	and	CC
cord-325956-1kxxg0s9	141	40	0.54	0.54	CD
cord-325956-1kxxg0s9	141	41	%	%	NN
cord-325956-1kxxg0s9	141	42	Australia	Australia	NNP
cord-325956-1kxxg0s9	141	43	)	)	-RRB-
cord-325956-1kxxg0s9	141	44	.	.	.
cord-325956-1kxxg0s9	142	1	Provided	provide	VBN
cord-325956-1kxxg0s9	142	2	that	that	IN
cord-325956-1kxxg0s9	142	3	their	-PRON-	PRP$
cord-325956-1kxxg0s9	142	4	testing	testing	NN
cord-325956-1kxxg0s9	142	5	criteria	criterion	NNS
cord-325956-1kxxg0s9	142	6	is	be	VBZ
cord-325956-1kxxg0s9	142	7	reliable	reliable	JJ
cord-325956-1kxxg0s9	142	8	,	,	,
cord-325956-1kxxg0s9	142	9	these	these	DT
cord-325956-1kxxg0s9	142	10	figures	figure	NNS
cord-325956-1kxxg0s9	142	11	may	may	MD
cord-325956-1kxxg0s9	142	12	serve	serve	VB
cord-325956-1kxxg0s9	142	13	as	as	IN
cord-325956-1kxxg0s9	142	14	early	early	JJ
cord-325956-1kxxg0s9	142	15	indicators	indicator	NNS
cord-325956-1kxxg0s9	142	16	of	of	IN
cord-325956-1kxxg0s9	142	17	the	the	DT
cord-325956-1kxxg0s9	142	18	actual	actual	JJ
cord-325956-1kxxg0s9	142	19	mortality	mortality	NN
cord-325956-1kxxg0s9	142	20	rate	rate	NN
cord-325956-1kxxg0s9	142	21	for	for	IN
cord-325956-1kxxg0s9	142	22	COVID-19	covid-19	NN
cord-325956-1kxxg0s9	142	23	and	and	CC
cord-325956-1kxxg0s9	142	24	these	these	DT
cord-325956-1kxxg0s9	142	25	low	low	JJ
cord-325956-1kxxg0s9	142	26	figures	figure	NNS
cord-325956-1kxxg0s9	142	27	are	be	VBP
cord-325956-1kxxg0s9	142	28	encouraging	encouraging	JJ
cord-325956-1kxxg0s9	142	29	.	.	.
cord-325956-1kxxg0s9	143	1	None	none	NN
cord-325956-1kxxg0s9	143	2	of	of	IN
cord-325956-1kxxg0s9	143	3	these	these	DT
cord-325956-1kxxg0s9	143	4	methods	method	NNS
cord-325956-1kxxg0s9	143	5	used	use	VBN
cord-325956-1kxxg0s9	143	6	for	for	IN
cord-325956-1kxxg0s9	143	7	projections	projection	NNS
cord-325956-1kxxg0s9	143	8	are	be	VBP
cord-325956-1kxxg0s9	143	9	likely	likely	JJ
cord-325956-1kxxg0s9	143	10	to	to	TO
cord-325956-1kxxg0s9	143	11	hold	hold	VB
cord-325956-1kxxg0s9	143	12	true	true	JJ
cord-325956-1kxxg0s9	143	13	in	in	IN
cord-325956-1kxxg0s9	143	14	reality	reality	NN
cord-325956-1kxxg0s9	143	15	.	.	.
cord-325956-1kxxg0s9	144	1	If	if	IN
cord-325956-1kxxg0s9	144	2	we	-PRON-	PRP
cord-325956-1kxxg0s9	144	3	go	go	VBP
cord-325956-1kxxg0s9	144	4	back	back	RB
cord-325956-1kxxg0s9	144	5	to	to	IN
cord-325956-1kxxg0s9	144	6	the	the	DT
cord-325956-1kxxg0s9	144	7	analyses	analysis	NNS
cord-325956-1kxxg0s9	144	8	for	for	IN
cord-325956-1kxxg0s9	144	9	South	South	NNP
cord-325956-1kxxg0s9	144	10	Korea	Korea	NNP
cord-325956-1kxxg0s9	144	11	and	and	CC
cord-325956-1kxxg0s9	144	12	its	-PRON-	PRP$
cord-325956-1kxxg0s9	144	13	projections	projection	NNS
cord-325956-1kxxg0s9	144	14	of	of	IN
cord-325956-1kxxg0s9	144	15	approximately	approximately	RB
cord-325956-1kxxg0s9	144	16	20,000	20,000	CD
cord-325956-1kxxg0s9	144	17	deaths	death	NNS
cord-325956-1kxxg0s9	144	18	,	,	,
cord-325956-1kxxg0s9	144	19	there	there	EX
cord-325956-1kxxg0s9	144	20	have	have	VBP
cord-325956-1kxxg0s9	144	21	been	be	VBN
cord-325956-1kxxg0s9	144	22	only	only	RB
cord-325956-1kxxg0s9	144	23	177	177	CD
cord-325956-1kxxg0s9	144	24	deaths	death	NNS
cord-325956-1kxxg0s9	144	25	in	in	IN
cord-325956-1kxxg0s9	144	26	South	South	NNP
cord-325956-1kxxg0s9	144	27	Korea	Korea	NNP
cord-325956-1kxxg0s9	144	28	so	so	RB
cord-325956-1kxxg0s9	144	29	far	far	RB
cord-325956-1kxxg0s9	144	30	.	.	.
cord-325956-1kxxg0s9	145	1	It	-PRON-	PRP
cord-325956-1kxxg0s9	145	2	seems	seem	VBZ
cord-325956-1kxxg0s9	145	3	highly	highly	RB
cord-325956-1kxxg0s9	145	4	improbable	improbable	JJ
cord-325956-1kxxg0s9	145	5	that	that	IN
cord-325956-1kxxg0s9	145	6	for	for	IN
cord-325956-1kxxg0s9	145	7	a	a	DT
cord-325956-1kxxg0s9	145	8	country	country	NN
cord-325956-1kxxg0s9	145	9	where	where	WRB
cord-325956-1kxxg0s9	145	10	the	the	DT
cord-325956-1kxxg0s9	145	11	number	number	NN
cord-325956-1kxxg0s9	145	12	of	of	IN
cord-325956-1kxxg0s9	145	13	cases	case	NNS
cord-325956-1kxxg0s9	145	14	and	and	CC
cord-325956-1kxxg0s9	145	15	deaths	death	NNS
cord-325956-1kxxg0s9	145	16	have	have	VBP
cord-325956-1kxxg0s9	145	17	significantly	significantly	RB
cord-325956-1kxxg0s9	145	18	tailed	tail	VBN
cord-325956-1kxxg0s9	145	19	off	off	RP
cord-325956-1kxxg0s9	145	20	would	would	MD
cord-325956-1kxxg0s9	145	21	end	end	VB
cord-325956-1kxxg0s9	145	22	up	up	RP
cord-325956-1kxxg0s9	145	23	with	with	IN
cord-325956-1kxxg0s9	145	24	19,952	19,952	CD
cord-325956-1kxxg0s9	145	25	deaths	death	NNS
cord-325956-1kxxg0s9	145	26	.	.	.
cord-325956-1kxxg0s9	146	1	Furthermore	furthermore	RB
cord-325956-1kxxg0s9	146	2	,	,	,
cord-325956-1kxxg0s9	146	3	the	the	DT
cord-325956-1kxxg0s9	146	4	herd	herd	NN
cord-325956-1kxxg0s9	146	5	immunity	immunity	NN
cord-325956-1kxxg0s9	146	6	concept	concept	NN
cord-325956-1kxxg0s9	146	7	has	have	VBZ
cord-325956-1kxxg0s9	146	8	been	be	VBN
cord-325956-1kxxg0s9	146	9	a	a	DT
cord-325956-1kxxg0s9	146	10	strategy	strategy	NN
cord-325956-1kxxg0s9	146	11	to	to	TO
cord-325956-1kxxg0s9	146	12	contain	contain	VB
cord-325956-1kxxg0s9	146	13	disease	disease	NN
cord-325956-1kxxg0s9	146	14	spread	spread	VBN
cord-325956-1kxxg0s9	146	15	not	not	RB
cord-325956-1kxxg0s9	146	16	only	only	RB
cord-325956-1kxxg0s9	146	17	for	for	IN
cord-325956-1kxxg0s9	146	18	COVID-19	COVID-19	NNP
cord-325956-1kxxg0s9	146	19	but	but	CC
cord-325956-1kxxg0s9	146	20	across	across	IN
cord-325956-1kxxg0s9	146	21	a	a	DT
cord-325956-1kxxg0s9	146	22	number	number	NN
cord-325956-1kxxg0s9	146	23	of	of	IN
cord-325956-1kxxg0s9	146	24	pandemics	pandemic	NNS
cord-325956-1kxxg0s9	146	25	such	such	JJ
cord-325956-1kxxg0s9	146	26	as	as	IN
cord-325956-1kxxg0s9	146	27	Swine	Swine	NNP
cord-325956-1kxxg0s9	146	28	Flu	Flu	NNP
cord-325956-1kxxg0s9	146	29	26	26	CD
cord-325956-1kxxg0s9	146	30	.	.	.
cord-325956-1kxxg0s9	147	1	Although	although	IN
cord-325956-1kxxg0s9	147	2	it	-PRON-	PRP
cord-325956-1kxxg0s9	147	3	is	be	VBZ
cord-325956-1kxxg0s9	147	4	widely	widely	RB
cord-325956-1kxxg0s9	147	5	debated	debate	VBN
cord-325956-1kxxg0s9	147	6	as	as	IN
cord-325956-1kxxg0s9	147	7	to	to	IN
cord-325956-1kxxg0s9	147	8	what	what	WDT
cord-325956-1kxxg0s9	147	9	percentage	percentage	NN
cord-325956-1kxxg0s9	147	10	of	of	IN
cord-325956-1kxxg0s9	147	11	the	the	DT
cord-325956-1kxxg0s9	147	12	population	population	NN
cord-325956-1kxxg0s9	147	13	would	would	MD
cord-325956-1kxxg0s9	147	14	need	need	VB
cord-325956-1kxxg0s9	147	15	to	to	TO
cord-325956-1kxxg0s9	147	16	be	be	VB
cord-325956-1kxxg0s9	147	17	affected	affect	VBN
cord-325956-1kxxg0s9	147	18	by	by	IN
cord-325956-1kxxg0s9	147	19	the	the	DT
cord-325956-1kxxg0s9	147	20	disease	disease	NN
cord-325956-1kxxg0s9	147	21	to	to	TO
cord-325956-1kxxg0s9	147	22	confer	confer	VB
cord-325956-1kxxg0s9	147	23	herd	herd	NN
cord-325956-1kxxg0s9	147	24	immunity	immunity	NN
cord-325956-1kxxg0s9	147	25	,	,	,
cord-325956-1kxxg0s9	147	26	a	a	DT
cord-325956-1kxxg0s9	147	27	figure	figure	NN
cord-325956-1kxxg0s9	147	28	of	of	IN
cord-325956-1kxxg0s9	147	29	60	60	CD
cord-325956-1kxxg0s9	147	30	%	%	NN
cord-325956-1kxxg0s9	147	31	has	have	VBZ
cord-325956-1kxxg0s9	147	32	been	be	VBN
cord-325956-1kxxg0s9	147	33	widely	widely	RB
cord-325956-1kxxg0s9	147	34	used	use	VBN
cord-325956-1kxxg0s9	147	35	[	[	-LRB-
cord-325956-1kxxg0s9	147	36	27	27	CD
cord-325956-1kxxg0s9	147	37	]	]	-RRB-
cord-325956-1kxxg0s9	148	1	[	[	-LRB-
cord-325956-1kxxg0s9	148	2	28	28	CD
cord-325956-1kxxg0s9	148	3	]	]	-RRB-
cord-325956-1kxxg0s9	148	4	[	[	-LRB-
cord-325956-1kxxg0s9	148	5	29	29	CD
cord-325956-1kxxg0s9	148	6	]	]	-RRB-
cord-325956-1kxxg0s9	148	7	.	.	.
cord-325956-1kxxg0s9	149	1	Even	even	RB
cord-325956-1kxxg0s9	149	2	if	if	IN
cord-325956-1kxxg0s9	149	3	we	-PRON-	PRP
cord-325956-1kxxg0s9	149	4	adjust	adjust	VBP
cord-325956-1kxxg0s9	149	5	the	the	DT
cord-325956-1kxxg0s9	149	6	South	South	NNP
cord-325956-1kxxg0s9	149	7	Korea	Korea	NNP
cord-325956-1kxxg0s9	149	8	figures	figure	NNS
cord-325956-1kxxg0s9	149	9	(	(	-LRB-
cord-325956-1kxxg0s9	149	10	table	table	NN
cord-325956-1kxxg0s9	149	11	5	5	CD
cord-325956-1kxxg0s9	149	12	)	)	-RRB-
cord-325956-1kxxg0s9	149	13	to	to	IN
cord-325956-1kxxg0s9	149	14	60	60	CD
cord-325956-1kxxg0s9	149	15	%	%	NN
cord-325956-1kxxg0s9	149	16	,	,	,
cord-325956-1kxxg0s9	149	17	we	-PRON-	PRP
cord-325956-1kxxg0s9	149	18	will	will	MD
cord-325956-1kxxg0s9	149	19	probably	probably	RB
cord-325956-1kxxg0s9	149	20	still	still	RB
cord-325956-1kxxg0s9	149	21	over	over	IN
cord-325956-1kxxg0s9	149	22	estimate	estimate	NN
cord-325956-1kxxg0s9	149	23	the	the	DT
cord-325956-1kxxg0s9	149	24	number	number	NN
cord-325956-1kxxg0s9	149	25	of	of	IN
cord-325956-1kxxg0s9	149	26	deaths	death	NNS
cord-325956-1kxxg0s9	149	27	.	.	.
cord-325956-1kxxg0s9	150	1	Where	where	WRB
cord-325956-1kxxg0s9	150	2	does	do	VBZ
cord-325956-1kxxg0s9	150	3	all	all	DT
cord-325956-1kxxg0s9	150	4	of	of	IN
cord-325956-1kxxg0s9	150	5	this	this	DT
cord-325956-1kxxg0s9	150	6	leave	leave	VB
cord-325956-1kxxg0s9	150	7	us	-PRON-	PRP
cord-325956-1kxxg0s9	150	8	and	and	CC
cord-325956-1kxxg0s9	150	9	what	what	WP
cord-325956-1kxxg0s9	150	10	is	be	VBZ
cord-325956-1kxxg0s9	150	11	the	the	DT
cord-325956-1kxxg0s9	150	12	point	point	NN
cord-325956-1kxxg0s9	150	13	of	of	IN
cord-325956-1kxxg0s9	150	14	all	all	PDT
cord-325956-1kxxg0s9	150	15	these	these	DT
cord-325956-1kxxg0s9	150	16	statistics	statistic	NNS
cord-325956-1kxxg0s9	150	17	and	and	CC
cord-325956-1kxxg0s9	150	18	analyses	analysis	NNS
cord-325956-1kxxg0s9	150	19	?	?	.
cord-325956-1kxxg0s9	151	1	Clearly	clearly	RB
cord-325956-1kxxg0s9	151	2	from	from	IN
cord-325956-1kxxg0s9	151	3	the	the	DT
cord-325956-1kxxg0s9	151	4	example	example	NN
cord-325956-1kxxg0s9	151	5	of	of	IN
cord-325956-1kxxg0s9	151	6	South	South	NNP
cord-325956-1kxxg0s9	151	7	Korea	Korea	NNP
cord-325956-1kxxg0s9	151	8	we	-PRON-	PRP
cord-325956-1kxxg0s9	151	9	can	can	MD
cord-325956-1kxxg0s9	151	10	contain	contain	VB
cord-325956-1kxxg0s9	151	11	COVID-19	covid-19	VB
cord-325956-1kxxg0s9	151	12	and	and	CC
cord-325956-1kxxg0s9	151	13	in	in	IN
cord-325956-1kxxg0s9	151	14	spite	spite	NN
cord-325956-1kxxg0s9	151	15	of	of	IN
cord-325956-1kxxg0s9	151	16	differences	difference	NNS
cord-325956-1kxxg0s9	151	17	of	of	IN
cord-325956-1kxxg0s9	151	18	the	the	DT
cord-325956-1kxxg0s9	151	19	specific	specific	JJ
cord-325956-1kxxg0s9	151	20	policies	policy	NNS
cord-325956-1kxxg0s9	151	21	of	of	IN
cord-325956-1kxxg0s9	151	22	lockdown	lockdown	NN
cord-325956-1kxxg0s9	151	23	between	between	IN
cord-325956-1kxxg0s9	151	24	countries	country	NNS
cord-325956-1kxxg0s9	151	25	,	,	,
cord-325956-1kxxg0s9	151	26	social	social	JJ
cord-325956-1kxxg0s9	151	27	distancing	distancing	NN
cord-325956-1kxxg0s9	151	28	and	and	CC
cord-325956-1kxxg0s9	151	29	limiting	limit	VBG
cord-325956-1kxxg0s9	151	30	spread	spread	NN
cord-325956-1kxxg0s9	151	31	are	be	VBP
cord-325956-1kxxg0s9	151	32	the	the	DT
cord-325956-1kxxg0s9	151	33	broad	broad	JJ
cord-325956-1kxxg0s9	151	34	themes	theme	NNS
cord-325956-1kxxg0s9	151	35	to	to	TO
cord-325956-1kxxg0s9	151	36	take	take	VB
cord-325956-1kxxg0s9	151	37	forward	forward	RB
cord-325956-1kxxg0s9	151	38	.	.	.
cord-325956-1kxxg0s9	152	1	The	the	DT
cord-325956-1kxxg0s9	152	2	analyses	analysis	NNS
cord-325956-1kxxg0s9	152	3	in	in	IN
cord-325956-1kxxg0s9	152	4	this	this	DT
cord-325956-1kxxg0s9	152	5	study	study	NN
cord-325956-1kxxg0s9	152	6	highlight	highlight	VB
cord-325956-1kxxg0s9	152	7	the	the	DT
cord-325956-1kxxg0s9	152	8	importance	importance	NN
cord-325956-1kxxg0s9	152	9	of	of	IN
cord-325956-1kxxg0s9	152	10	testing	testing	NN
cord-325956-1kxxg0s9	152	11	as	as	IN
cord-325956-1kxxg0s9	152	12	the	the	DT
cord-325956-1kxxg0s9	152	13	relevant	relevant	JJ
cord-325956-1kxxg0s9	152	14	denominator	denominator	NN
cord-325956-1kxxg0s9	152	15	for	for	IN
cord-325956-1kxxg0s9	152	16	which	which	WDT
cord-325956-1kxxg0s9	152	17	all	all	PDT
cord-325956-1kxxg0s9	152	18	the	the	DT
cord-325956-1kxxg0s9	152	19	COVID-19	COVID-19	NNP
cord-325956-1kxxg0s9	152	20	data	datum	NNS
cord-325956-1kxxg0s9	152	21	should	should	MD
cord-325956-1kxxg0s9	152	22	be	be	VB
cord-325956-1kxxg0s9	152	23	related	relate	VBN
cord-325956-1kxxg0s9	152	24	to	to	IN
cord-325956-1kxxg0s9	152	25	.	.	.
cord-325956-1kxxg0s9	153	1	The	the	DT
cord-325956-1kxxg0s9	153	2	testing	testing	NN
cord-325956-1kxxg0s9	153	3	policy	policy	NN
cord-325956-1kxxg0s9	153	4	is	be	VBZ
cord-325956-1kxxg0s9	153	5	advocated	advocate	VBN
cord-325956-1kxxg0s9	153	6	strongly	strongly	RB
cord-325956-1kxxg0s9	153	7	by	by	IN
cord-325956-1kxxg0s9	153	8	the	the	DT
cord-325956-1kxxg0s9	153	9	WHO	WHO	NNP
cord-325956-1kxxg0s9	153	10	in	in	IN
cord-325956-1kxxg0s9	153	11	their	-PRON-	PRP$
cord-325956-1kxxg0s9	153	12	COVID-19	COVID-19	NNP
cord-325956-1kxxg0s9	153	13	statements	statement	NNS
cord-325956-1kxxg0s9	153	14	1	1	CD
cord-325956-1kxxg0s9	153	15	.	.	.
cord-325956-1kxxg0s9	154	1	The	the	DT
cord-325956-1kxxg0s9	154	2	suggested	suggest	VBN
cord-325956-1kxxg0s9	154	3	early	early	JJ
cord-325956-1kxxg0s9	154	4	indication	indication	NN
cord-325956-1kxxg0s9	154	5	of	of	IN
cord-325956-1kxxg0s9	154	6	a	a	DT
cord-325956-1kxxg0s9	154	7	low	low	JJ
cord-325956-1kxxg0s9	154	8	mortality	mortality	NN
cord-325956-1kxxg0s9	154	9	rate	rate	NN
cord-325956-1kxxg0s9	154	10	from	from	IN
cord-325956-1kxxg0s9	154	11	our	-PRON-	PRP$
cord-325956-1kxxg0s9	154	12	analyses	analysis	NNS
cord-325956-1kxxg0s9	154	13	,	,	,
cord-325956-1kxxg0s9	154	14	coupled	couple	VBN
cord-325956-1kxxg0s9	154	15	with	with	IN
cord-325956-1kxxg0s9	154	16	the	the	DT
cord-325956-1kxxg0s9	154	17	fact	fact	NN
cord-325956-1kxxg0s9	154	18	that	that	IN
cord-325956-1kxxg0s9	154	19	COVID-19	COVID-19	NNP
cord-325956-1kxxg0s9	154	20	is	be	VBZ
cord-325956-1kxxg0s9	154	21	a	a	DT
cord-325956-1kxxg0s9	154	22	new	new	JJ
cord-325956-1kxxg0s9	154	23	disease	disease	NN
cord-325956-1kxxg0s9	154	24	affecting	affect	VBG
cord-325956-1kxxg0s9	154	25	the	the	DT
cord-325956-1kxxg0s9	154	26	globe	globe	NN
cord-325956-1kxxg0s9	154	27	in	in	IN
cord-325956-1kxxg0s9	154	28	a	a	DT
cord-325956-1kxxg0s9	154	29	short	short	JJ
cord-325956-1kxxg0s9	154	30	time	time	NN
cord-325956-1kxxg0s9	154	31	,	,	,
cord-325956-1kxxg0s9	154	32	it	-PRON-	PRP
cord-325956-1kxxg0s9	154	33	is	be	VBZ
cord-325956-1kxxg0s9	154	34	highly	highly	RB
cord-325956-1kxxg0s9	154	35	plausible	plausible	JJ
cord-325956-1kxxg0s9	154	36	that	that	IN
cord-325956-1kxxg0s9	154	37	the	the	DT
cord-325956-1kxxg0s9	154	38	serious	serious	JJ
cord-325956-1kxxg0s9	154	39	cases	case	NNS
cord-325956-1kxxg0s9	154	40	and	and	CC
cord-325956-1kxxg0s9	154	41	deaths	death	NNS
cord-325956-1kxxg0s9	154	42	we	-PRON-	PRP
cord-325956-1kxxg0s9	154	43	are	be	VBP
cord-325956-1kxxg0s9	154	44	seeing	see	VBG
cord-325956-1kxxg0s9	154	45	in	in	IN
cord-325956-1kxxg0s9	154	46	the	the	DT
cord-325956-1kxxg0s9	154	47	some	some	DT
cord-325956-1kxxg0s9	154	48	countries	country	NNS
cord-325956-1kxxg0s9	154	49	may	may	MD
cord-325956-1kxxg0s9	154	50	be	be	VB
cord-325956-1kxxg0s9	154	51	the	the	DT
cord-325956-1kxxg0s9	154	52	tip	tip	NN
cord-325956-1kxxg0s9	154	53	of	of	IN
cord-325956-1kxxg0s9	154	54	the	the	DT
cord-325956-1kxxg0s9	154	55	iceberg	iceberg	NN
cord-325956-1kxxg0s9	154	56	of	of	IN
cord-325956-1kxxg0s9	154	57	a	a	DT
cord-325956-1kxxg0s9	154	58	disease	disease	NN
cord-325956-1kxxg0s9	154	59	that	that	WDT
cord-325956-1kxxg0s9	154	60	has	have	VBZ
cord-325956-1kxxg0s9	154	61	spread	spread	VBN
cord-325956-1kxxg0s9	154	62	widely	widely	RB
cord-325956-1kxxg0s9	154	63	.	.	.
cord-325956-1kxxg0s9	155	1	If	if	IN
cord-325956-1kxxg0s9	155	2	we	-PRON-	PRP
cord-325956-1kxxg0s9	155	3	look	look	VBP
cord-325956-1kxxg0s9	155	4	at	at	IN
cord-325956-1kxxg0s9	155	5	influenza	influenza	NN
cord-325956-1kxxg0s9	155	6	data	datum	NNS
cord-325956-1kxxg0s9	155	7	there	there	EX
cord-325956-1kxxg0s9	155	8	are	be	VBP
cord-325956-1kxxg0s9	155	9	millions	million	NNS
cord-325956-1kxxg0s9	155	10	of	of	IN
cord-325956-1kxxg0s9	155	11	cases	case	NNS
cord-325956-1kxxg0s9	155	12	and	and	CC
cord-325956-1kxxg0s9	155	13	up	up	IN
cord-325956-1kxxg0s9	155	14	to	to	TO
cord-325956-1kxxg0s9	155	15	half	half	PDT
cord-325956-1kxxg0s9	155	16	a	a	DT
cord-325956-1kxxg0s9	155	17	million	million	CD
cord-325956-1kxxg0s9	155	18	deaths	death	NNS
cord-325956-1kxxg0s9	155	19	worldwide	worldwide	RB
cord-325956-1kxxg0s9	155	20	every	every	DT
cord-325956-1kxxg0s9	155	21	year	year	NN
cord-325956-1kxxg0s9	155	22	due	due	IN
cord-325956-1kxxg0s9	155	23	to	to	IN
cord-325956-1kxxg0s9	155	24	flu	flu	NN
cord-325956-1kxxg0s9	155	25	and	and	CC
cord-325956-1kxxg0s9	155	26	these	these	DT
cord-325956-1kxxg0s9	155	27	tend	tend	VBP
cord-325956-1kxxg0s9	155	28	to	to	TO
cord-325956-1kxxg0s9	155	29	be	be	VB
cord-325956-1kxxg0s9	155	30	seasonal	seasonal	JJ
cord-325956-1kxxg0s9	155	31	in	in	IN
cord-325956-1kxxg0s9	155	32	spite	spite	NN
cord-325956-1kxxg0s9	155	33	of	of	IN
cord-325956-1kxxg0s9	155	34	vaccination	vaccination	NN
cord-325956-1kxxg0s9	155	35	programmes	programme	NNS
cord-325956-1kxxg0s9	155	36	and	and	CC
cord-325956-1kxxg0s9	155	37	herd	herd	VB
cord-325956-1kxxg0s9	155	38	immunity	immunity	NN
cord-325956-1kxxg0s9	155	39	to	to	IN
cord-325956-1kxxg0s9	155	40	some	some	DT
cord-325956-1kxxg0s9	155	41	extent	extent	NN
cord-325956-1kxxg0s9	155	42	[	[	-LRB-
cord-325956-1kxxg0s9	155	43	27	27	CD
cord-325956-1kxxg0s9	155	44	]	]	-RRB-
cord-325956-1kxxg0s9	156	1	[	[	-LRB-
cord-325956-1kxxg0s9	156	2	28	28	CD
cord-325956-1kxxg0s9	156	3	]	]	-RRB-
cord-325956-1kxxg0s9	157	1	[	[	-LRB-
cord-325956-1kxxg0s9	157	2	29	29	CD
cord-325956-1kxxg0s9	157	3	]	]	-RRB-
cord-325956-1kxxg0s9	157	4	[	[	-LRB-
cord-325956-1kxxg0s9	157	5	30	30	CD
cord-325956-1kxxg0s9	157	6	]	]	-RRB-
cord-325956-1kxxg0s9	157	7	.	.	.
cord-325956-1kxxg0s9	158	1	In	in	IN
cord-325956-1kxxg0s9	158	2	the	the	DT
cord-325956-1kxxg0s9	158	3	case	case	NN
cord-325956-1kxxg0s9	158	4	of	of	IN
cord-325956-1kxxg0s9	158	5	COVID-19	COVID-19	NNP
cord-325956-1kxxg0s9	158	6	we	-PRON-	PRP
cord-325956-1kxxg0s9	158	7	might	may	MD
cord-325956-1kxxg0s9	158	8	be	be	VB
cord-325956-1kxxg0s9	158	9	experiencing	experience	VBG
cord-325956-1kxxg0s9	158	10	the	the	DT
cord-325956-1kxxg0s9	158	11	full	full	JJ
cord-325956-1kxxg0s9	158	12	whammy	whammy	NN
cord-325956-1kxxg0s9	158	13	of	of	IN
cord-325956-1kxxg0s9	158	14	a	a	DT
cord-325956-1kxxg0s9	158	15	disease	disease	NN
cord-325956-1kxxg0s9	158	16	without	without	IN
cord-325956-1kxxg0s9	158	17	.	.	.
cord-325956-1kxxg0s9	159	1	CC	CC	NNP
cord-325956-1kxxg0s9	159	2	-	-	:
cord-325956-1kxxg0s9	159	3	BY	by	IN
cord-325956-1kxxg0s9	159	4	4.0	4.0	CD
cord-325956-1kxxg0s9	159	5	International	international	JJ
cord-325956-1kxxg0s9	159	6	license	license	NN
cord-325956-1kxxg0s9	160	1	It	-PRON-	PRP
cord-325956-1kxxg0s9	160	2	is	be	VBZ
cord-325956-1kxxg0s9	160	3	made	make	VBN
cord-325956-1kxxg0s9	160	4	available	available	JJ
cord-325956-1kxxg0s9	160	5	under	under	IN
cord-325956-1kxxg0s9	160	6	a	a	DT
cord-325956-1kxxg0s9	161	1	is	be	VBZ
cord-325956-1kxxg0s9	161	2	the	the	DT
cord-325956-1kxxg0s9	161	3	author	author	NN
cord-325956-1kxxg0s9	161	4	/	/	SYM
cord-325956-1kxxg0s9	161	5	funder	funder	NN
cord-325956-1kxxg0s9	161	6	,	,	,
cord-325956-1kxxg0s9	161	7	who	who	WP
cord-325956-1kxxg0s9	161	8	has	have	VBZ
cord-325956-1kxxg0s9	161	9	granted	grant	VBN
cord-325956-1kxxg0s9	161	10	medRxiv	medRxiv	NNS
cord-325956-1kxxg0s9	161	11	a	a	DT
cord-325956-1kxxg0s9	161	12	license	license	NN
cord-325956-1kxxg0s9	161	13	to	to	TO
cord-325956-1kxxg0s9	161	14	display	display	VB
cord-325956-1kxxg0s9	161	15	the	the	DT
cord-325956-1kxxg0s9	161	16	preprint	preprint	NN
cord-325956-1kxxg0s9	161	17	in	in	IN
cord-325956-1kxxg0s9	161	18	perpetuity	perpetuity	NN
cord-325956-1kxxg0s9	161	19	.	.	.
cord-325956-1kxxg0s9	162	1	The	the	DT
cord-325956-1kxxg0s9	162	2	copyright	copyright	NN
cord-325956-1kxxg0s9	162	3	holder	holder	NN
cord-325956-1kxxg0s9	162	4	for	for	IN
cord-325956-1kxxg0s9	162	5	this	this	DT
cord-325956-1kxxg0s9	162	6	preprint	preprint	NN
cord-325956-1kxxg0s9	162	7	.	.	.
cord-325956-1kxxg0s9	163	1	https://doi.org/10.1101/2020.04.06.20054239	https://doi.org/10.1101/2020.04.06.20054239	NNP
cord-325956-1kxxg0s9	163	2	doi	doi	NN
cord-325956-1kxxg0s9	163	3	:	:	:
cord-325956-1kxxg0s9	164	1	medRxiv	medRxiv	NNS
cord-325956-1kxxg0s9	164	2	preprint	preprint	NN
cord-325956-1kxxg0s9	164	3	immunity	immunity	NN
cord-325956-1kxxg0s9	164	4	,	,	,
cord-325956-1kxxg0s9	164	5	globally	globally	RB
cord-325956-1kxxg0s9	164	6	all	all	DT
cord-325956-1kxxg0s9	164	7	at	at	IN
cord-325956-1kxxg0s9	164	8	once	once	RB
cord-325956-1kxxg0s9	164	9	resulting	result	VBG
cord-325956-1kxxg0s9	164	10	in	in	IN
cord-325956-1kxxg0s9	164	11	deaths	death	NNS
cord-325956-1kxxg0s9	164	12	.	.	.
cord-325956-1kxxg0s9	165	1	The	the	DT
cord-325956-1kxxg0s9	165	2	magnitude	magnitude	NN
cord-325956-1kxxg0s9	165	3	of	of	IN
cord-325956-1kxxg0s9	165	4	these	these	DT
cord-325956-1kxxg0s9	165	5	deaths	death	NNS
cord-325956-1kxxg0s9	165	6	in	in	IN
cord-325956-1kxxg0s9	165	7	perspective	perspective	NN
cord-325956-1kxxg0s9	165	8	to	to	IN
cord-325956-1kxxg0s9	165	9	other	other	JJ
cord-325956-1kxxg0s9	165	10	diseases	disease	NNS
cord-325956-1kxxg0s9	165	11	such	such	JJ
cord-325956-1kxxg0s9	165	12	as	as	IN
cord-325956-1kxxg0s9	165	13	Influenza	Influenza	NNP
cord-325956-1kxxg0s9	165	14	may	may	MD
cord-325956-1kxxg0s9	165	15	not	not	RB
cord-325956-1kxxg0s9	165	16	be	be	VB
cord-325956-1kxxg0s9	165	17	high	high	JJ
cord-325956-1kxxg0s9	165	18	30	30	CD
cord-325956-1kxxg0s9	165	19	.	.	.
cord-325956-1kxxg0s9	166	1	Our	-PRON-	PRP$
cord-325956-1kxxg0s9	166	2	analyses	analysis	NNS
cord-325956-1kxxg0s9	166	3	in	in	IN
cord-325956-1kxxg0s9	166	4	this	this	DT
cord-325956-1kxxg0s9	166	5	study	study	NN
cord-325956-1kxxg0s9	166	6	do	do	VBP
cord-325956-1kxxg0s9	166	7	not	not	RB
cord-325956-1kxxg0s9	166	8	prove	prove	VB
cord-325956-1kxxg0s9	166	9	this	this	DT
cord-325956-1kxxg0s9	166	10	theory	theory	NN
cord-325956-1kxxg0s9	166	11	but	but	CC
cord-325956-1kxxg0s9	166	12	the	the	DT
cord-325956-1kxxg0s9	166	13	only	only	JJ
cord-325956-1kxxg0s9	166	14	thing	thing	NN
cord-325956-1kxxg0s9	166	15	that	that	WDT
cord-325956-1kxxg0s9	166	16	can	can	MD
cord-325956-1kxxg0s9	166	17	is	be	VBZ
cord-325956-1kxxg0s9	166	18	continued	continue	VBN
cord-325956-1kxxg0s9	166	19	extensive	extensive	JJ
cord-325956-1kxxg0s9	166	20	and	and	CC
cord-325956-1kxxg0s9	166	21	rapid	rapid	JJ
cord-325956-1kxxg0s9	166	22	testing	testing	NN
cord-325956-1kxxg0s9	166	23	across	across	IN
cord-325956-1kxxg0s9	166	24	the	the	DT
cord-325956-1kxxg0s9	166	25	globe	globe	NN
cord-325956-1kxxg0s9	166	26	.	.	.
cord-325956-1kxxg0s9	167	1	This	this	DT
cord-325956-1kxxg0s9	167	2	may	may	MD
cord-325956-1kxxg0s9	167	3	be	be	VB
cord-325956-1kxxg0s9	167	4	the	the	DT
cord-325956-1kxxg0s9	167	5	only	only	JJ
cord-325956-1kxxg0s9	167	6	exit	exit	NN
cord-325956-1kxxg0s9	167	7	strategy	strategy	NN
cord-325956-1kxxg0s9	167	8	to	to	TO
cord-325956-1kxxg0s9	167	9	prevent	prevent	VB
cord-325956-1kxxg0s9	167	10	COVID-19	COVID-19	NNP
cord-325956-1kxxg0s9	167	11	related	related	JJ
cord-325956-1kxxg0s9	167	12	economic	economic	JJ
cord-325956-1kxxg0s9	167	13	and	and	CC
cord-325956-1kxxg0s9	167	14	social	social	JJ
cord-325956-1kxxg0s9	167	15	breakdown	breakdown	NN
cord-325956-1kxxg0s9	167	16	.	.	.
cord-325956-1kxxg0s9	167	17	.	.	.
cord-325956-1kxxg0s9	168	1	CC	CC	NNP
cord-325956-1kxxg0s9	168	2	-	-	:
cord-325956-1kxxg0s9	168	3	BY	by	IN
cord-325956-1kxxg0s9	168	4	4.0	4.0	CD
cord-325956-1kxxg0s9	168	5	International	international	JJ
cord-325956-1kxxg0s9	168	6	license	license	NN
cord-325956-1kxxg0s9	169	1	It	-PRON-	PRP
cord-325956-1kxxg0s9	169	2	is	be	VBZ
cord-325956-1kxxg0s9	169	3	made	make	VBN
cord-325956-1kxxg0s9	169	4	available	available	JJ
cord-325956-1kxxg0s9	169	5	under	under	IN
cord-325956-1kxxg0s9	169	6	a	a	DT
cord-325956-1kxxg0s9	170	1	is	be	VBZ
cord-325956-1kxxg0s9	170	2	the	the	DT
cord-325956-1kxxg0s9	170	3	author	author	NN
cord-325956-1kxxg0s9	170	4	/	/	SYM
cord-325956-1kxxg0s9	170	5	funder	funder	NN
cord-325956-1kxxg0s9	170	6	,	,	,
cord-325956-1kxxg0s9	170	7	who	who	WP
cord-325956-1kxxg0s9	170	8	has	have	VBZ
cord-325956-1kxxg0s9	170	9	granted	grant	VBN
cord-325956-1kxxg0s9	170	10	medRxiv	medRxiv	NNS
cord-325956-1kxxg0s9	170	11	a	a	DT
cord-325956-1kxxg0s9	170	12	license	license	NN
cord-325956-1kxxg0s9	170	13	to	to	TO
cord-325956-1kxxg0s9	170	14	display	display	VB
cord-325956-1kxxg0s9	170	15	the	the	DT
cord-325956-1kxxg0s9	170	16	preprint	preprint	NN
cord-325956-1kxxg0s9	170	17	in	in	IN
cord-325956-1kxxg0s9	170	18	perpetuity	perpetuity	NN
cord-325956-1kxxg0s9	170	19	.	.	.
cord-325956-1kxxg0s9	171	1	The	the	DT
cord-325956-1kxxg0s9	171	2	copyright	copyright	NN
cord-325956-1kxxg0s9	171	3	holder	holder	NN
cord-325956-1kxxg0s9	171	4	for	for	IN
cord-325956-1kxxg0s9	171	5	this	this	DT
cord-325956-1kxxg0s9	171	6	preprint	preprint	NN
cord-325956-1kxxg0s9	171	7	.	.	.
cord-325956-1kxxg0s9	172	1	https://doi.org/10.1101/2020.04.06.20054239	https://doi.org/10.1101/2020.04.06.20054239	NNP
cord-325956-1kxxg0s9	172	2	doi	doi	NN
cord-325956-1kxxg0s9	172	3	:	:	:
cord-325956-1kxxg0s9	173	1	medRxiv	medRxiv	NNP
cord-325956-1kxxg0s9	173	2	preprint	preprint	NN
cord-325956-1kxxg0s9	173	3	.	.	.
cord-325956-1kxxg0s9	174	1	CC	CC	NNP
cord-325956-1kxxg0s9	174	2	-	-	:
cord-325956-1kxxg0s9	174	3	BY	by	IN
cord-325956-1kxxg0s9	174	4	4.0	4.0	CD
cord-325956-1kxxg0s9	174	5	International	international	JJ
cord-325956-1kxxg0s9	174	6	license	license	NN
cord-325956-1kxxg0s9	175	1	It	-PRON-	PRP
cord-325956-1kxxg0s9	175	2	is	be	VBZ
cord-325956-1kxxg0s9	175	3	made	make	VBN
cord-325956-1kxxg0s9	175	4	available	available	JJ
cord-325956-1kxxg0s9	175	5	under	under	IN
cord-325956-1kxxg0s9	175	6	a	a	DT
cord-325956-1kxxg0s9	176	1	is	be	VBZ
cord-325956-1kxxg0s9	176	2	the	the	DT
cord-325956-1kxxg0s9	176	3	author	author	NN
cord-325956-1kxxg0s9	176	4	/	/	SYM
cord-325956-1kxxg0s9	176	5	funder	funder	NN
cord-325956-1kxxg0s9	176	6	,	,	,
cord-325956-1kxxg0s9	176	7	who	who	WP
cord-325956-1kxxg0s9	176	8	has	have	VBZ
cord-325956-1kxxg0s9	176	9	granted	grant	VBN
cord-325956-1kxxg0s9	176	10	medRxiv	medRxiv	NNS
cord-325956-1kxxg0s9	176	11	a	a	DT
cord-325956-1kxxg0s9	176	12	license	license	NN
cord-325956-1kxxg0s9	176	13	to	to	TO
cord-325956-1kxxg0s9	176	14	display	display	VB
cord-325956-1kxxg0s9	176	15	the	the	DT
cord-325956-1kxxg0s9	176	16	preprint	preprint	NN
cord-325956-1kxxg0s9	176	17	in	in	IN
cord-325956-1kxxg0s9	176	18	perpetuity	perpetuity	NN
cord-325956-1kxxg0s9	176	19	.	.	.
cord-325956-1kxxg0s9	176	20	.	.	.
cord-325956-1kxxg0s9	177	1	CC	CC	NNP
cord-325956-1kxxg0s9	177	2	-	-	:
cord-325956-1kxxg0s9	177	3	BY	by	IN
cord-325956-1kxxg0s9	177	4	4.0	4.0	CD
cord-325956-1kxxg0s9	177	5	International	international	JJ
cord-325956-1kxxg0s9	177	6	license	license	NN
cord-325956-1kxxg0s9	178	1	It	-PRON-	PRP
cord-325956-1kxxg0s9	178	2	is	be	VBZ
cord-325956-1kxxg0s9	178	3	made	make	VBN
cord-325956-1kxxg0s9	178	4	available	available	JJ
cord-325956-1kxxg0s9	178	5	under	under	IN
cord-325956-1kxxg0s9	178	6	a	a	DT
cord-325956-1kxxg0s9	179	1	is	be	VBZ
cord-325956-1kxxg0s9	179	2	the	the	DT
cord-325956-1kxxg0s9	179	3	author	author	NN
cord-325956-1kxxg0s9	179	4	/	/	SYM
cord-325956-1kxxg0s9	179	5	funder	funder	NN
cord-325956-1kxxg0s9	179	6	,	,	,
cord-325956-1kxxg0s9	179	7	who	who	WP
cord-325956-1kxxg0s9	179	8	has	have	VBZ
cord-325956-1kxxg0s9	179	9	granted	grant	VBN
cord-325956-1kxxg0s9	179	10	medRxiv	medRxiv	NNS
cord-325956-1kxxg0s9	179	11	a	a	DT
cord-325956-1kxxg0s9	179	12	license	license	NN
cord-325956-1kxxg0s9	179	13	to	to	TO
cord-325956-1kxxg0s9	179	14	display	display	VB
cord-325956-1kxxg0s9	179	15	the	the	DT
cord-325956-1kxxg0s9	179	16	preprint	preprint	NN
cord-325956-1kxxg0s9	179	17	in	in	IN
cord-325956-1kxxg0s9	179	18	perpetuity	perpetuity	NN
cord-325956-1kxxg0s9	179	19	.	.	.
cord-325956-1kxxg0s9	180	1	(	(	-LRB-
cord-325956-1kxxg0s9	180	2	which	which	WDT
cord-325956-1kxxg0s9	180	3	was	be	VBD
cord-325956-1kxxg0s9	180	4	not	not	RB
cord-325956-1kxxg0s9	180	5	peer	peer	NN
cord-325956-1kxxg0s9	180	6	-	-	HYPH
cord-325956-1kxxg0s9	180	7	reviewed	review	VBN
cord-325956-1kxxg0s9	180	8	)	)	-RRB-
cord-325956-1kxxg0s9	181	1	The	the	DT
cord-325956-1kxxg0s9	181	2	copyright	copyright	NN
cord-325956-1kxxg0s9	181	3	holder	holder	NN
cord-325956-1kxxg0s9	181	4	for	for	IN
cord-325956-1kxxg0s9	181	5	this	this	DT
cord-325956-1kxxg0s9	181	6	preprint	preprint	NN
cord-325956-1kxxg0s9	181	7	.	.	.
cord-325956-1kxxg0s9	182	1	https://doi.org/10.1101/2020.04.06.20054239	https://doi.org/10.1101/2020.04.06.20054239	NNP
cord-325956-1kxxg0s9	182	2	doi	doi	NN
cord-325956-1kxxg0s9	182	3	:	:	:
cord-325956-1kxxg0s9	183	1	medRxiv	medRxiv	NNP
cord-325956-1kxxg0s9	183	2	preprint	preprint	NN
cord-325956-1kxxg0s9	183	3	WHO	who	WP
cord-325956-1kxxg0s9	183	4	.	.	.
cord-325956-1kxxg0s9	184	1	Coronavirus	Coronavirus	NNP
cord-325956-1kxxg0s9	184	2	disease	disease	NN
cord-325956-1kxxg0s9	184	3	2019	2019	CD
cord-325956-1kxxg0s9	184	4	(	(	-LRB-
cord-325956-1kxxg0s9	185	1	COVID-19	covid-19	LS
cord-325956-1kxxg0s9	185	2	)	)	-RRB-
cord-325956-1kxxg0s9	185	3	situation	situation	NN
cord-325956-1kxxg0s9	185	4	report-43	report-43	XX
cord-325956-1kxxg0s9	186	1	Clinical	clinical	JJ
cord-325956-1kxxg0s9	186	2	features	feature	NNS
cord-325956-1kxxg0s9	186	3	of	of	IN
cord-325956-1kxxg0s9	186	4	patients	patient	NNS
cord-325956-1kxxg0s9	186	5	infected	infect	VBN
cord-325956-1kxxg0s9	186	6	with	with	IN
cord-325956-1kxxg0s9	186	7	2019	2019	CD
cord-325956-1kxxg0s9	186	8	novel	novel	JJ
cord-325956-1kxxg0s9	186	9	coronavirus	coronavirus	NN
cord-325956-1kxxg0s9	186	10	in	in	IN
cord-325956-1kxxg0s9	186	11	Wuhan	Wuhan	NNP
cord-325956-1kxxg0s9	186	12	European	European	NNP
cord-325956-1kxxg0s9	186	13	Centre	Centre	NNP
cord-325956-1kxxg0s9	186	14	For	for	IN
cord-325956-1kxxg0s9	186	15	Disease	Disease	NNP
cord-325956-1kxxg0s9	186	16	Prevention	Prevention	NNP
cord-325956-1kxxg0s9	186	17	And	and	CC
cord-325956-1kxxg0s9	186	18	Control	Control	NNP
cord-325956-1kxxg0s9	186	19	Ecdc	Ecdc	NNP
cord-325956-1kxxg0s9	186	20	Public	Public	NNP
cord-325956-1kxxg0s9	186	21	Health	Health	NNP
cord-325956-1kxxg0s9	186	22	Emergency	Emergency	NNP
cord-325956-1kxxg0s9	186	23	Team	Team	NNP
cord-325956-1kxxg0s9	186	24	.	.	.
cord-325956-1kxxg0s9	187	1	Rapidly	rapidly	RB
cord-325956-1kxxg0s9	187	2	increasing	increase	VBG
cord-325956-1kxxg0s9	187	3	cumulative	cumulative	JJ
cord-325956-1kxxg0s9	187	4	incidence	incidence	NN
cord-325956-1kxxg0s9	187	5	of	of	IN
cord-325956-1kxxg0s9	187	6	coronavirus	coronavirus	NN
cord-325956-1kxxg0s9	187	7	disease	disease	NN
cord-325956-1kxxg0s9	187	8	(	(	-LRB-
cord-325956-1kxxg0s9	187	9	COVID-19	covid-19	VB
cord-325956-1kxxg0s9	187	10	)	)	-RRB-
cord-325956-1kxxg0s9	187	11	in	in	IN
cord-325956-1kxxg0s9	187	12	the	the	DT
cord-325956-1kxxg0s9	187	13	European	European	NNP
cord-325956-1kxxg0s9	187	14	Union	Union	NNP
cord-325956-1kxxg0s9	187	15	/	/	SYM
cord-325956-1kxxg0s9	187	16	European	European	NNP
cord-325956-1kxxg0s9	187	17	Economic	Economic	NNP
cord-325956-1kxxg0s9	187	18	Area	Area	NNP
cord-325956-1kxxg0s9	187	19	and	and	CC
cord-325956-1kxxg0s9	187	20	the	the	DT
cord-325956-1kxxg0s9	187	21	United	United	NNP
cord-325956-1kxxg0s9	187	22	Kingdom	Kingdom	NNP
cord-325956-1kxxg0s9	187	23	Retrospective	Retrospective	NNP
cord-325956-1kxxg0s9	187	24	analysis	analysis	NN
cord-325956-1kxxg0s9	187	25	of	of	IN
cord-325956-1kxxg0s9	187	26	the	the	DT
cord-325956-1kxxg0s9	187	27	possibility	possibility	NN
cord-325956-1kxxg0s9	187	28	of	of	IN
cord-325956-1kxxg0s9	187	29	predicting	predict	VBG
cord-325956-1kxxg0s9	187	30	the	the	DT
cord-325956-1kxxg0s9	187	31	COVID-19	covid-19	JJ
cord-325956-1kxxg0s9	187	32	outbreak	outbreak	NN
cord-325956-1kxxg0s9	187	33	from	from	IN
cord-325956-1kxxg0s9	187	34	Internet	internet	NN
cord-325956-1kxxg0s9	187	35	searches	search	NNS
cord-325956-1kxxg0s9	187	36	and	and	CC
cord-325956-1kxxg0s9	187	37	social	social	JJ
cord-325956-1kxxg0s9	187	38	media	medium	NNS
cord-325956-1kxxg0s9	187	39	data	datum	NNS
cord-325956-1kxxg0s9	187	40	,	,	,
cord-325956-1kxxg0s9	187	41	China	China	NNP
cord-325956-1kxxg0s9	187	42	Correlation	Correlation	NNP
cord-325956-1kxxg0s9	187	43	of	of	IN
cord-325956-1kxxg0s9	187	44	Chest	Chest	NNP
cord-325956-1kxxg0s9	187	45	CT	CT	NNP
cord-325956-1kxxg0s9	187	46	and	and	CC
cord-325956-1kxxg0s9	187	47	RT	RT	NNP
cord-325956-1kxxg0s9	187	48	-	-	HYPH
cord-325956-1kxxg0s9	187	49	PCR	PCR	NNP
cord-325956-1kxxg0s9	187	50	Testing	Testing	NNP
cord-325956-1kxxg0s9	187	51	in	in	IN
cord-325956-1kxxg0s9	187	52	Coronavirus	Coronavirus	NNP
cord-325956-1kxxg0s9	187	53	Disease	Disease	NNP
cord-325956-1kxxg0s9	187	54	Estimating	Estimating	NNP
cord-325956-1kxxg0s9	187	55	the	the	DT
cord-325956-1kxxg0s9	187	56	Unreported	unreported	JJ
cord-325956-1kxxg0s9	187	57	Number	Number	NNP
cord-325956-1kxxg0s9	187	58	of	of	IN
cord-325956-1kxxg0s9	187	59	Novel	Novel	NNP
cord-325956-1kxxg0s9	187	60	Coronavirus	Coronavirus	NNP
cord-325956-1kxxg0s9	187	61	(	(	-LRB-
cord-325956-1kxxg0s9	187	62	2019-nCoV	2019-ncov	CD
cord-325956-1kxxg0s9	187	63	)	)	-RRB-
cord-325956-1kxxg0s9	187	64	Cases	case	NNS
cord-325956-1kxxg0s9	187	65	in	in	IN
cord-325956-1kxxg0s9	187	66	China	China	NNP
cord-325956-1kxxg0s9	187	67	in	in	IN
cord-325956-1kxxg0s9	187	68	the	the	DT
cord-325956-1kxxg0s9	187	69	First	first	JJ
cord-325956-1kxxg0s9	187	70	Half	Half	NNP
cord-325956-1kxxg0s9	187	71	of	of	IN
cord-325956-1kxxg0s9	187	72	January	January	NNP
cord-325956-1kxxg0s9	187	73	2020	2020	CD
cord-325956-1kxxg0s9	187	74	:	:	:
cord-325956-1kxxg0s9	188	1	A	a	DT
cord-325956-1kxxg0s9	188	2	Data	data	NN
cord-325956-1kxxg0s9	188	3	-	-	HYPH
cord-325956-1kxxg0s9	188	4	Driven	Driven	NNP
cord-325956-1kxxg0s9	188	5	Modelling	Modelling	NNP
cord-325956-1kxxg0s9	188	6	Analysis	Analysis	NNP
cord-325956-1kxxg0s9	188	7	of	of	IN
cord-325956-1kxxg0s9	188	8	the	the	DT
cord-325956-1kxxg0s9	188	9	Early	early	JJ
cord-325956-1kxxg0s9	188	10	Outbreak	Outbreak	NNP
cord-325956-1kxxg0s9	188	11	Nowcasting	Nowcasting	NNP
cord-325956-1kxxg0s9	188	12	and	and	CC
cord-325956-1kxxg0s9	188	13	forecasting	forecast	VBG
cord-325956-1kxxg0s9	188	14	the	the	DT
cord-325956-1kxxg0s9	188	15	potential	potential	JJ
cord-325956-1kxxg0s9	188	16	domestic	domestic	JJ
cord-325956-1kxxg0s9	188	17	and	and	CC
cord-325956-1kxxg0s9	188	18	international	international	JJ
cord-325956-1kxxg0s9	188	19	spread	spread	NN
cord-325956-1kxxg0s9	188	20	of	of	IN
cord-325956-1kxxg0s9	188	21	the	the	DT
cord-325956-1kxxg0s9	188	22	2019-nCoV	2019-ncov	CD
cord-325956-1kxxg0s9	188	23	outbreak	outbreak	NN
cord-325956-1kxxg0s9	188	24	originating	originate	VBG
cord-325956-1kxxg0s9	188	25	in	in	IN
cord-325956-1kxxg0s9	188	26	Wuhan	Wuhan	NNP
cord-325956-1kxxg0s9	188	27	,	,	,
cord-325956-1kxxg0s9	188	28	China	China	NNP
cord-325956-1kxxg0s9	188	29	:	:	:
cord-325956-1kxxg0s9	188	30	a	a	DT
cord-325956-1kxxg0s9	188	31	modelling	modelling	NN
cord-325956-1kxxg0s9	188	32	study	study	NN
cord-325956-1kxxg0s9	188	33	Early	Early	NNP
cord-325956-1kxxg0s9	188	34	Transmission	Transmission	NNP
cord-325956-1kxxg0s9	188	35	Dynamics	Dynamics	NNPS
cord-325956-1kxxg0s9	188	36	in	in	IN
cord-325956-1kxxg0s9	188	37	Wuhan	Wuhan	NNP
cord-325956-1kxxg0s9	188	38	,	,	,
cord-325956-1kxxg0s9	188	39	China	China	NNP
cord-325956-1kxxg0s9	188	40	,	,	,
cord-325956-1kxxg0s9	188	41	of	of	IN
cord-325956-1kxxg0s9	188	42	Novel	Novel	NNP
cord-325956-1kxxg0s9	188	43	Coronavirus	Coronavirus	NNP
cord-325956-1kxxg0s9	188	44	-	-	HYPH
cord-325956-1kxxg0s9	188	45	Infected	infect	VBN
cord-325956-1kxxg0s9	188	46	Pneumonia	pneumonia	NN
cord-325956-1kxxg0s9	189	1	the	the	DT
cord-325956-1kxxg0s9	189	2	author	author	NN
cord-325956-1kxxg0s9	189	3	/	/	SYM
cord-325956-1kxxg0s9	189	4	funder	funder	NN
cord-325956-1kxxg0s9	189	5	,	,	,
cord-325956-1kxxg0s9	189	6	who	who	WP
cord-325956-1kxxg0s9	189	7	has	have	VBZ
cord-325956-1kxxg0s9	189	8	granted	grant	VBN
cord-325956-1kxxg0s9	189	9	medRxiv	medRxiv	NNS
cord-325956-1kxxg0s9	189	10	a	a	DT
cord-325956-1kxxg0s9	189	11	license	license	NN
cord-325956-1kxxg0s9	189	12	to	to	TO
cord-325956-1kxxg0s9	189	13	display	display	VB
cord-325956-1kxxg0s9	189	14	the	the	DT
cord-325956-1kxxg0s9	189	15	preprint	preprint	NN
cord-325956-1kxxg0s9	189	16	in	in	IN
cord-325956-1kxxg0s9	189	17	perpetuity	perpetuity	NN
cord-325956-1kxxg0s9	189	18	.	.	.
cord-325956-1kxxg0s9	190	1	(	(	-LRB-
cord-325956-1kxxg0s9	190	2	which	which	WDT
cord-325956-1kxxg0s9	190	3	was	be	VBD
cord-325956-1kxxg0s9	190	4	not	not	RB
cord-325956-1kxxg0s9	190	5	peer	peer	NN
cord-325956-1kxxg0s9	190	6	-	-	HYPH
cord-325956-1kxxg0s9	190	7	reviewed	review	VBN
cord-325956-1kxxg0s9	190	8	)	)	-RRB-
cord-325956-1kxxg0s9	191	1	The	the	DT
cord-325956-1kxxg0s9	191	2	copyright	copyright	NN
cord-325956-1kxxg0s9	191	3	holder	holder	NN
cord-325956-1kxxg0s9	191	4	for	for	IN
cord-325956-1kxxg0s9	191	5	this	this	DT
cord-325956-1kxxg0s9	191	6	preprint	preprint	NN
cord-325956-1kxxg0s9	191	7	Novel	Novel	NNP
cord-325956-1kxxg0s9	191	8	Coronavirus	Coronavirus	NNP
cord-325956-1kxxg0s9	191	9	Infection	Infection	NNP
cord-325956-1kxxg0s9	191	10	(	(	-LRB-
cord-325956-1kxxg0s9	191	11	COVID-19	covid-19	VB
cord-325956-1kxxg0s9	191	12	)	)	-RRB-
cord-325956-1kxxg0s9	191	13	in	in	IN
cord-325956-1kxxg0s9	191	14	Humans	human	NNS
cord-325956-1kxxg0s9	191	15	:	:	:
cord-325956-1kxxg0s9	192	1	A	a	DT
cord-325956-1kxxg0s9	192	2	Scoping	Scoping	NNP
cord-325956-1kxxg0s9	192	3	Review	Review	NNP
cord-325956-1kxxg0s9	192	4	and	and	CC
cord-325956-1kxxg0s9	192	5	Meta	Meta	NNP
cord-325956-1kxxg0s9	192	6	-	-	HYPH
cord-325956-1kxxg0s9	192	7	Analysis	Analysis	NNP
cord-325956-1kxxg0s9	192	8	Opportunities	Opportunities	NNPS
cord-325956-1kxxg0s9	192	9	and	and	CC
cord-325956-1kxxg0s9	192	10	Threats	Threats	NNPS
cord-325956-1kxxg0s9	192	11	(	(	-LRB-
cord-325956-1kxxg0s9	192	12	SWOT	SWOT	NNP
cord-325956-1kxxg0s9	192	13	)	)	-RRB-
cord-325956-1kxxg0s9	192	14	Analysis	Analysis	NNP
cord-325956-1kxxg0s9	192	15	of	of	IN
cord-325956-1kxxg0s9	192	16	China	China	NNP
cord-325956-1kxxg0s9	192	17	's	's	POS
cord-325956-1kxxg0s9	192	18	Prevention	Prevention	NNP
cord-325956-1kxxg0s9	192	19	and	and	CC
cord-325956-1kxxg0s9	192	20	Control	Control	NNP
cord-325956-1kxxg0s9	192	21	Strategy	Strategy	NNP
cord-325956-1kxxg0s9	192	22	for	for	IN
cord-325956-1kxxg0s9	192	23	the	the	DT
cord-325956-1kxxg0s9	192	24	COVID-19	COVID-19	NNP
cord-325956-1kxxg0s9	192	25	Epidemic	Epidemic	NNP
cord-325956-1kxxg0s9	192	26	Coronavirus	Coronavirus	NNP
cord-325956-1kxxg0s9	192	27	disease	disease	NN
cord-325956-1kxxg0s9	192	28	2019	2019	CD
cord-325956-1kxxg0s9	192	29	:	:	:
cord-325956-1kxxg0s9	192	30	the	the	DT
cord-325956-1kxxg0s9	192	31	harms	harm	NNS
cord-325956-1kxxg0s9	192	32	of	of	IN
cord-325956-1kxxg0s9	192	33	exaggerated	exaggerated	JJ
cord-325956-1kxxg0s9	192	34	information	information	NN
cord-325956-1kxxg0s9	192	35	and	and	CC
cord-325956-1kxxg0s9	192	36	nonevidence	nonevidence	NN
cord-325956-1kxxg0s9	192	37	-	-	HYPH
cord-325956-1kxxg0s9	192	38	based	base	VBN
cord-325956-1kxxg0s9	192	39	measures	measure	NNS
cord-325956-1kxxg0s9	192	40	Coronavirus	Coronavirus	NNP
cord-325956-1kxxg0s9	192	41	disease	disease	NN
cord-325956-1kxxg0s9	192	42	2019	2019	CD
cord-325956-1kxxg0s9	192	43	:	:	:
cord-325956-1kxxg0s9	192	44	the	the	DT
cord-325956-1kxxg0s9	192	45	harms	harm	NNS
cord-325956-1kxxg0s9	192	46	of	of	IN
cord-325956-1kxxg0s9	192	47	exaggerated	exaggerated	JJ
cord-325956-1kxxg0s9	192	48	information	information	NN
cord-325956-1kxxg0s9	192	49	and	and	CC
cord-325956-1kxxg0s9	192	50	nonevidence	nonevidence	NN
cord-325956-1kxxg0s9	192	51	-	-	HYPH
cord-325956-1kxxg0s9	192	52	based	base	VBN
cord-325956-1kxxg0s9	192	53	measures	measure	NNS
cord-325956-1kxxg0s9	193	1	Effects	effect	NNS
cord-325956-1kxxg0s9	193	2	of	of	IN
cord-325956-1kxxg0s9	193	3	media	medium	NNS
cord-325956-1kxxg0s9	193	4	reporting	report	VBG
cord-325956-1kxxg0s9	193	5	on	on	IN
cord-325956-1kxxg0s9	193	6	mitigating	mitigate	VBG
cord-325956-1kxxg0s9	193	7	spread	spread	NN
cord-325956-1kxxg0s9	193	8	of	of	IN
cord-325956-1kxxg0s9	193	9	COVID-19	covid-19	NN
cord-325956-1kxxg0s9	193	10	in	in	IN
cord-325956-1kxxg0s9	193	11	the	the	DT
cord-325956-1kxxg0s9	193	12	early	early	JJ
cord-325956-1kxxg0s9	193	13	phase	phase	NN
cord-325956-1kxxg0s9	193	14	of	of	IN
cord-325956-1kxxg0s9	193	15	the	the	DT
cord-325956-1kxxg0s9	193	16	outbreak	outbreak	NN
cord-325956-1kxxg0s9	193	17	the	the	DT
cord-325956-1kxxg0s9	193	18	author	author	NN
cord-325956-1kxxg0s9	193	19	/	/	SYM
cord-325956-1kxxg0s9	193	20	funder	funder	NN
cord-325956-1kxxg0s9	193	21	,	,	,
cord-325956-1kxxg0s9	193	22	who	who	WP
cord-325956-1kxxg0s9	193	23	has	have	VBZ
cord-325956-1kxxg0s9	193	24	granted	grant	VBN
cord-325956-1kxxg0s9	193	25	medRxiv	medRxiv	NNS
cord-325956-1kxxg0s9	193	26	a	a	DT
cord-325956-1kxxg0s9	193	27	license	license	NN
cord-325956-1kxxg0s9	193	28	to	to	TO
cord-325956-1kxxg0s9	193	29	display	display	VB
cord-325956-1kxxg0s9	193	30	the	the	DT
cord-325956-1kxxg0s9	193	31	preprint	preprint	NN
cord-325956-1kxxg0s9	193	32	in	in	IN
cord-325956-1kxxg0s9	193	33	perpetuity	perpetuity	NN
cord-325956-1kxxg0s9	193	34	.	.	.
cord-325956-1kxxg0s9	194	1	(	(	-LRB-
cord-325956-1kxxg0s9	194	2	which	which	WDT
cord-325956-1kxxg0s9	194	3	was	be	VBD
cord-325956-1kxxg0s9	194	4	not	not	RB
cord-325956-1kxxg0s9	194	5	peer	peer	NN
cord-325956-1kxxg0s9	194	6	-	-	HYPH
cord-325956-1kxxg0s9	194	7	reviewed	review	VBN
cord-325956-1kxxg0s9	194	8	)	)	-RRB-
cord-325956-1kxxg0s9	195	1	The	the	DT
cord-325956-1kxxg0s9	195	2	copyright	copyright	NN
cord-325956-1kxxg0s9	195	3	holder	holder	NN
cord-325956-1kxxg0s9	195	4	for	for	IN
cord-325956-1kxxg0s9	195	5	this	this	DT
cord-325956-1kxxg0s9	195	6	preprint	preprint	NN
cord-325956-1kxxg0s9	195	7	Estimates	estimate	NNS
cord-325956-1kxxg0s9	195	8	of	of	IN
cord-325956-1kxxg0s9	195	9	the	the	DT
cord-325956-1kxxg0s9	195	10	severity	severity	NN
cord-325956-1kxxg0s9	195	11	of	of	IN
cord-325956-1kxxg0s9	195	12	coronavirus	coronavirus	NN
cord-325956-1kxxg0s9	195	13	disease	disease	NN
cord-325956-1kxxg0s9	195	14	2019	2019	CD
cord-325956-1kxxg0s9	195	15	:	:	:
cord-325956-1kxxg0s9	195	16	a	a	DT
cord-325956-1kxxg0s9	195	17	model	model	NN
cord-325956-1kxxg0s9	195	18	-	-	HYPH
cord-325956-1kxxg0s9	195	19	based	base	VBN
cord-325956-1kxxg0s9	195	20	analysis	analysis	NN
cord-325956-1kxxg0s9	195	21	Korean	Korean	NNP
cord-325956-1kxxg0s9	195	22	Society	Society	NNP
cord-325956-1kxxg0s9	195	23	of	of	IN
cord-325956-1kxxg0s9	195	24	Infectious	Infectious	NNP
cord-325956-1kxxg0s9	195	25	Diseases	Diseases	NNPS
cord-325956-1kxxg0s9	195	26	;	;	:
cord-325956-1kxxg0s9	195	27	Korean	Korean	NNP
cord-325956-1kxxg0s9	195	28	Society	Society	NNP
cord-325956-1kxxg0s9	195	29	of	of	IN
cord-325956-1kxxg0s9	195	30	Pediatric	Pediatric	NNP
cord-325956-1kxxg0s9	195	31	Infectious	Infectious	NNP
cord-325956-1kxxg0s9	195	32	Diseases	Diseases	NNPS
cord-325956-1kxxg0s9	196	1	Korean	Korean	NNP
cord-325956-1kxxg0s9	196	2	Society	Society	NNP
cord-325956-1kxxg0s9	196	3	for	for	IN
cord-325956-1kxxg0s9	196	4	Antimicrobial	Antimicrobial	NNP
cord-325956-1kxxg0s9	196	5	Therapy	Therapy	NNP
cord-325956-1kxxg0s9	197	1	;	;	:
cord-325956-1kxxg0s9	197	2	Korean	Korean	NNP
cord-325956-1kxxg0s9	197	3	Society	Society	NNP
cord-325956-1kxxg0s9	197	4	for	for	IN
cord-325956-1kxxg0s9	197	5	Healthcare	Healthcare	NNP
cord-325956-1kxxg0s9	197	6	-	-	HYPH
cord-325956-1kxxg0s9	197	7	associated	associated	NNP
cord-325956-1kxxg0s9	197	8	Infection	Infection	NNP
cord-325956-1kxxg0s9	197	9	Control	Control	NNP
cord-325956-1kxxg0s9	197	10	and	and	CC
cord-325956-1kxxg0s9	197	11	Prevention	Prevention	NNP
cord-325956-1kxxg0s9	197	12	COVID-19	COVID-19	NNP
cord-325956-1kxxg0s9	197	13	)	)	-RRB-
cord-325956-1kxxg0s9	197	14	Outbreak	outbreak	NN
cord-325956-1kxxg0s9	197	15	in	in	IN
cord-325956-1kxxg0s9	197	16	the	the	DT
cord-325956-1kxxg0s9	197	17	Republic	Republic	NNP
cord-325956-1kxxg0s9	197	18	of	of	IN
cord-325956-1kxxg0s9	197	19	Korea	Korea	NNP
cord-325956-1kxxg0s9	197	20	from	from	IN
cord-325956-1kxxg0s9	197	21	Estimating	estimate	VBG
cord-325956-1kxxg0s9	197	22	the	the	DT
cord-325956-1kxxg0s9	197	23	reproductive	reproductive	JJ
cord-325956-1kxxg0s9	197	24	number	number	NN
cord-325956-1kxxg0s9	197	25	and	and	CC
cord-325956-1kxxg0s9	197	26	the	the	DT
cord-325956-1kxxg0s9	197	27	outbreak	outbreak	NN
cord-325956-1kxxg0s9	197	28	size	size	NN
cord-325956-1kxxg0s9	197	29	of	of	IN
cord-325956-1kxxg0s9	197	30	Novel	Novel	NNP
cord-325956-1kxxg0s9	197	31	Coronavirus	Coronavirus	NNP
cord-325956-1kxxg0s9	197	32	disease	disease	NN
cord-325956-1kxxg0s9	197	33	(	(	-LRB-
cord-325956-1kxxg0s9	197	34	COVID-19	covid-19	VB
cord-325956-1kxxg0s9	197	35	)	)	-RRB-
cord-325956-1kxxg0s9	197	36	using	use	VBG
cord-325956-1kxxg0s9	197	37	mathematical	mathematical	JJ
cord-325956-1kxxg0s9	197	38	model	model	NN
cord-325956-1kxxg0s9	197	39	in	in	IN
cord-325956-1kxxg0s9	197	40	Republic	Republic	NNP
cord-325956-1kxxg0s9	197	41	of	of	IN
cord-325956-1kxxg0s9	197	42	Korea	Korea	NNP
cord-325956-1kxxg0s9	197	43	.	.	.
cord-325956-1kxxg0s9	198	1	Epidemiol	Epidemiol	NNP
cord-325956-1kxxg0s9	198	2	Health	Health	NNP
cord-325956-1kxxg0s9	199	1	How	how	WRB
cord-325956-1kxxg0s9	199	2	is	be	VBZ
cord-325956-1kxxg0s9	199	3	COVID-19	COVID-19	NNP
cord-325956-1kxxg0s9	199	4	affecting	affect	VBG
cord-325956-1kxxg0s9	199	5	South	South	NNP
cord-325956-1kxxg0s9	199	6	Korea	Korea	NNP
cord-325956-1kxxg0s9	199	7	?	?	.
cord-325956-1kxxg0s9	200	1	What	what	WP
cord-325956-1kxxg0s9	200	2	is	be	VBZ
cord-325956-1kxxg0s9	200	3	our	-PRON-	PRP$
cord-325956-1kxxg0s9	200	4	current	current	JJ
cord-325956-1kxxg0s9	200	5	strategy	strategy	NN
cord-325956-1kxxg0s9	200	6	?	?	.
cord-325956-1kxxg0s9	201	1	Disaster	Disaster	NNP
cord-325956-1kxxg0s9	201	2	Med	Med	NNP
cord-325956-1kxxg0s9	201	3	Public	Public	NNP
cord-325956-1kxxg0s9	201	4	Health	Health	NNP
cord-325956-1kxxg0s9	201	5	Prep	Prep	NNP
cord-325956-1kxxg0s9	201	6	COVID-19	COVID-19	NNP
cord-325956-1kxxg0s9	201	7	)	)	-RRB-
cord-325956-1kxxg0s9	201	8	Testing	testing	NN
cord-325956-1kxxg0s9	201	9	:	:	:
cord-325956-1kxxg0s9	201	10	Status	status	NN
cord-325956-1kxxg0s9	201	11	Update	update	NN
cord-325956-1kxxg0s9	201	12	History	history	NN
cord-325956-1kxxg0s9	201	13	and	and	CC
cord-325956-1kxxg0s9	201	14	epidemiology	epidemiology	NN
cord-325956-1kxxg0s9	201	15	of	of	IN
cord-325956-1kxxg0s9	201	16	Swine	Swine	NNP
cord-325956-1kxxg0s9	201	17	influenza	influenza	NN
cord-325956-1kxxg0s9	201	18	in	in	IN
cord-325956-1kxxg0s9	201	19	Europe	Europe	NNP
cord-325956-1kxxg0s9	202	1	The	the	DT
cord-325956-1kxxg0s9	202	2	vaccination	vaccination	NN
cord-325956-1kxxg0s9	202	3	coverage	coverage	NN
cord-325956-1kxxg0s9	202	4	required	require	VBN
cord-325956-1kxxg0s9	202	5	to	to	TO
cord-325956-1kxxg0s9	202	6	establish	establish	VB
cord-325956-1kxxg0s9	202	7	herd	herd	NN
cord-325956-1kxxg0s9	202	8	immunity	immunity	NN
cord-325956-1kxxg0s9	202	9	against	against	IN
cord-325956-1kxxg0s9	202	10	influenza	influenza	NN
cord-325956-1kxxg0s9	202	11	viruses	virus	NNS
cord-325956-1kxxg0s9	202	12	Back	back	RB
cord-325956-1kxxg0s9	202	13	to	to	IN
cord-325956-1kxxg0s9	202	14	the	the	DT
cord-325956-1kxxg0s9	202	15	Future	Future	NNP
cord-325956-1kxxg0s9	202	16	for	for	IN
cord-325956-1kxxg0s9	202	17	Influenza	Influenza	NNP
cord-325956-1kxxg0s9	202	18	Preimmunity	Preimmunity	NNP
cord-325956-1kxxg0s9	202	19	-	-	HYPH
cord-325956-1kxxg0s9	202	20	Looking	look	VBG
cord-325956-1kxxg0s9	202	21	Back	back	RB
cord-325956-1kxxg0s9	202	22	at	at	IN
cord-325956-1kxxg0s9	202	23	Influenza	Influenza	NNP
cord-325956-1kxxg0s9	202	24	Virus	Virus	NNP
cord-325956-1kxxg0s9	202	25	History	history	NN
cord-325956-1kxxg0s9	202	26	to	to	TO
cord-325956-1kxxg0s9	202	27	Infer	infer	VB
cord-325956-1kxxg0s9	202	28	the	the	DT
cord-325956-1kxxg0s9	202	29	Outcome	outcome	NN
cord-325956-1kxxg0s9	202	30	of	of	IN
cord-325956-1kxxg0s9	202	31	Future	Future	NNP
cord-325956-1kxxg0s9	202	32	Infections	Infections	NNPS
cord-325956-1kxxg0s9	202	33	Pandemic	Pandemic	NNP
cord-325956-1kxxg0s9	202	34	dynamics	dynamic	NNS
cord-325956-1kxxg0s9	202	35	and	and	CC
cord-325956-1kxxg0s9	202	36	the	the	DT
cord-325956-1kxxg0s9	202	37	breakdown	breakdown	NN
cord-325956-1kxxg0s9	202	38	of	of	IN
cord-325956-1kxxg0s9	202	39	herd	herd	NN
cord-325956-1kxxg0s9	202	40	immunity	immunity	NN
cord-325956-1kxxg0s9	202	41	y	y	NNP
cord-325956-1kxxg0s9	202	42	the	the	DT
cord-325956-1kxxg0s9	202	43	author	author	NN
cord-325956-1kxxg0s9	202	44	/	/	SYM
cord-325956-1kxxg0s9	202	45	funder	funder	NN
cord-325956-1kxxg0s9	202	46	,	,	,
cord-325956-1kxxg0s9	202	47	who	who	WP
cord-325956-1kxxg0s9	202	48	has	have	VBZ
cord-325956-1kxxg0s9	202	49	granted	grant	VBN
cord-325956-1kxxg0s9	202	50	medRxiv	medRxiv	NNS
cord-325956-1kxxg0s9	202	51	a	a	DT
cord-325956-1kxxg0s9	202	52	license	license	NN
cord-325956-1kxxg0s9	202	53	to	to	TO
cord-325956-1kxxg0s9	202	54	display	display	VB
cord-325956-1kxxg0s9	202	55	the	the	DT
cord-325956-1kxxg0s9	202	56	preprint	preprint	NN
cord-325956-1kxxg0s9	202	57	in	in	IN
cord-325956-1kxxg0s9	202	58	perpetuity	perpetuity	NN
cord-325956-1kxxg0s9	202	59	.	.	.
cord-325956-1kxxg0s9	203	1	(	(	-LRB-
cord-325956-1kxxg0s9	203	2	which	which	WDT
cord-325956-1kxxg0s9	203	3	was	be	VBD
cord-325956-1kxxg0s9	203	4	not	not	RB
cord-325956-1kxxg0s9	203	5	peer	peer	NN
cord-325956-1kxxg0s9	203	6	-	-	HYPH
cord-325956-1kxxg0s9	203	7	reviewed	review	VBN
cord-325956-1kxxg0s9	203	8	)	)	-RRB-
cord-325956-1kxxg0s9	204	1	The	the	DT
cord-325956-1kxxg0s9	204	2	copyright	copyright	NN
cord-325956-1kxxg0s9	204	3	holder	holder	NN
cord-325956-1kxxg0s9	204	4	for	for	IN
cord-325956-1kxxg0s9	204	5	this	this	DT
cord-325956-1kxxg0s9	204	6	preprint	preprint	NN
cord-325956-1kxxg0s9	204	7	.	.	.
cord-325956-1kxxg0s9	205	1	CC	CC	NNP
cord-325956-1kxxg0s9	205	2	-	-	:
cord-325956-1kxxg0s9	205	3	BY	by	IN
cord-325956-1kxxg0s9	205	4	4.0	4.0	CD
cord-325956-1kxxg0s9	205	5	International	international	JJ
cord-325956-1kxxg0s9	205	6	license	license	NN
cord-325956-1kxxg0s9	206	1	It	-PRON-	PRP
cord-325956-1kxxg0s9	206	2	is	be	VBZ
cord-325956-1kxxg0s9	206	3	made	make	VBN
cord-325956-1kxxg0s9	206	4	available	available	JJ
cord-325956-1kxxg0s9	206	5	under	under	IN
cord-325956-1kxxg0s9	206	6	a	a	DT
cord-325956-1kxxg0s9	207	1	is	be	VBZ
cord-325956-1kxxg0s9	207	2	the	the	DT
cord-325956-1kxxg0s9	207	3	author	author	NN
cord-325956-1kxxg0s9	207	4	/	/	SYM
cord-325956-1kxxg0s9	207	5	funder	funder	NN
cord-325956-1kxxg0s9	207	6	,	,	,
cord-325956-1kxxg0s9	207	7	who	who	WP
cord-325956-1kxxg0s9	207	8	has	have	VBZ
cord-325956-1kxxg0s9	207	9	granted	grant	VBN
cord-325956-1kxxg0s9	207	10	medRxiv	medRxiv	NNS
cord-325956-1kxxg0s9	207	11	a	a	DT
cord-325956-1kxxg0s9	207	12	license	license	NN
cord-325956-1kxxg0s9	207	13	to	to	TO
cord-325956-1kxxg0s9	207	14	display	display	VB
cord-325956-1kxxg0s9	207	15	the	the	DT
cord-325956-1kxxg0s9	207	16	preprint	preprint	NN
cord-325956-1kxxg0s9	207	17	in	in	IN
cord-325956-1kxxg0s9	207	18	perpetuity	perpetuity	NN
cord-325956-1kxxg0s9	207	19	.	.	.
cord-325956-1kxxg0s9	208	1	The	the	DT
cord-325956-1kxxg0s9	208	2	copyright	copyright	NN
cord-325956-1kxxg0s9	208	3	holder	holder	NN
cord-325956-1kxxg0s9	208	4	for	for	IN
cord-325956-1kxxg0s9	208	5	this	this	DT
cord-325956-1kxxg0s9	208	6	preprint	preprint	NN
cord-325956-1kxxg0s9	208	7	.	.	.
cord-325956-1kxxg0s9	209	1	https://doi.org/10.1101/2020.04.06.20054239	https://doi.org/10.1101/2020.04.06.20054239	NNP
cord-325956-1kxxg0s9	209	2	doi	doi	NN
cord-325956-1kxxg0s9	209	3	:	:	:
cord-325956-1kxxg0s9	210	1	medRxiv	medRxiv	NNP
cord-325956-1kxxg0s9	210	2	preprint	preprint	NNP